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ABSTRACT 
 
The Effect of C8-Arylguanine Adducts on B/Z-DNA Equilibrium:  
Implications in Aryl Hydrazine Carcinogenesis 
 
Vorasit Vongsutilers 
 
 
Aryl hydrazines and related compounds have been shown to be carcinogenic but 
the mechanism is still unclear. C8-Arylguanine adducts, formed from oxidative 
metabolites of aryl hydrazines, are suspected to be the cause of carcinogenesis. Z-DNA 
formation facilitated by the aryl adduct are among the potential mechanisms and has been 
investigated in this study. Z-DNA may be involved in carcinogenesis as several studies 
have indicated that Z-DNA may play an important role in gene expression and to induce 
mutagenic genetic deletions. C8-Arylguanine adducts may cause carcinogenesis by 
promoting the formation of Z-DNA which in turn disturbing gene regulation and leading 
to mutagenesis. To investigate this hypothesis, we have set out to 1) study the effect of 
aryl adducts formed from carcinogenic aryl hydrazines on B/Z-DNA equilibrium and 2) 
seek the relevancy between Z-DNA formation and aryl hydrazine carcinogenesis. 
Here, alternating CG decamers containing C8-arylguanine modifications 
(d(CGCGCG*CGCG)2, G* = C8-tolyl, C8-carboxyphenyl, C8-methoxymethylphenyl, or 
C8-hydroxymethylphenyl guanine), were prepared through Suzuki coupling and 
phosphoramidite chemistry. The effect of the aryl adducts on the B/Z-DNA equilibrium 
were determined by CD and NMR analysis. The experimental results supported by 
computational study have suggested that all of the aryl modifications examined facilitate 
B-Z transition by destabilizing the B conformation and/or stabilizing the Z conformation 
relative to the corresponding unmodified oligonucleotide. Among the aryl adducts, C8-
carboxyphenyl adduct has been shown to be best at facilitating B-Z transition followed 
by C8-phenyl, C8-methoxymethylphenyl, C8-hydroxymethylphenyl, and C8-tolyl 
respectively. The effect of aryl adducts on B-Z transition is generally correlated with the 
reported V79 mutagenicity of the aryl hydrazines precursors. This preliminary study has 
suggested that Z-DNA may be involved or plays a role in aryl hydrazine carcinogenesis. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Carcinogenicity of Aryl Hydrazines and Related Compound 
 Aryl hydrazines and related compounds can be found in a variety of sources 
including natural products, pharmaceutical agents, synthetic chemicals used in industry, 
and agricultural substances1 (Figure 1.1). Agaricus bisporus, the most produced 
mushroom in the United States, contains Agaritine which was found to be carcinogenic in 
mice after bioactivation2,3. Several medicines, such as isoniazid and hydralazine, contain 
aryl hydrazines or related functional groups. Though they display a wide range of 
carcinogenic activities, most of the aryl hydrazines that have been studied are 
carcinogenic4. However, though the carcinogenicity of aryl hydrazines has being 
investigated for more than thirty years, the mechanism(s) with respect to carcinogenesis 
remains unclear and is still being investigated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Figure 1.1 Structure of aryl hydrazines and related compounds found in everyday life 
(1) agaritine from the button mushroom Agaricus bisporus, (2) antitubercular agent 
isoniazid, and (3) antihypertensive hydralazine.  
 2
Oxidative metabolism of aryl hydrazines is believed to produce reactive 
intermediates that are related to the carcinogenicity of aryl hydrazines.  Metabolism of 
aryl hydrazines by cytochrome P450 has been shown to lead to the production of the 
reactive intermediate arenediazonium ions, as first demonstrated by trapping with 2-
naphthol5,6. In vivo, arenediazonium ions may react directly or, after reduction, to 
reactive aryl radicals (Scheme 1.1). 
 
 
 
 
 
 
 
 
 
       
Both arenediazonium ions and aryl radicals are reactive electrophiles and they can 
react with DNA either directly or indirectly.  Direct reaction of the aryl radical leads to 
the formation of DNA adducts.  Reaction with water or oxygen results in the formation of 
reactive oxygen species (ROS) which may, in turn, react with DNA. ROS can be 
produced by both chemical processes7 and during enzymatic metabolism of aryl 
hydrazines, as shown for example, when methylphenyl hydrazines are incubated with 
microsomes from C50 cells7,8.  
Several ROS intermediates have been implicated in genetic alterations and 
carcinogenesis through oxidative DNA damage9-11. 8-Hydroxyguanine, also known as 8-
oxoguanine, is one of the products resulting from ROS production and subsequesnt 
reaction with DNA, ultimately leading to base mis-pairs as Cheng K.C. et al. have 
Scheme 1.1 Metabolism of aryl hydrazine leads to formation of arenediazonium ion and 
aryl radical.  
 
 3
shown12. Generation of ROS, or the related reactive nitrogen specied (RNS) through 
metabolism may be a part of mechanism behind aryl hydrazine carcinogenesis. However, 
previous studies have not provided sufficient results to indicate a direct relationship 
between aryl hydrazines carcinogenesis and ROS/RNS production. Runge-Morris et al. 
suggested that hydrazine-mediated DNA damage is more likely to occur through organic 
free radical (carbon-centered) than from ROS13. In turn, the importance of direct DNA 
adducts formation has been increased, significantly, due to several studies that indicate 
the possibility of DNA adducts can alter either local or global DNA conformation.  
The C8 position of the purine bases has been shown to be a common target for 
radical species such as aryl radicals formed from aryl hydrazines. As shown in Scheme 
1.2, adenine can react with both the arenediazonium ion and aryl radicals to form a C8-
aryl adenine adduct while C8-aryl guanine adduct formation generally occurs by reaction 
with the aryl radical directly14. Aryl radicals can react at the C8 position of purine bases 
to form carbon centered radical intermediates.  This intermediate, then, must undergo an 
oxidation and loss of a proton to produce the neutral adduct.  In the case of adenine, 
reaction at C6-N can also occur which yields a triazene.  The triazene is unstable and can 
decompose, with the loss of nitrogen and the resulting aryl radical can react at C8.  
Tautomerization then leads to the final C8-aryl purine adduct. 
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DNA adducts have been extensively investigated for their potential to cause 
cancer development. Miscoding15 and DNA strand breakage16 have been studied in 
relation to C8-aryl purine adducts, however none of these processes has unequivocally 
been related to aryl hydrazine carcinogenesis. Study of DNA adducts has often focused 
on the relationship of the observed conformational changes and the resulting genetic 
mutations. Of the many known C8 guanine adducts, the 2-aminofluorene17, bromine18,19, 
and methyl20,21 adducts have all been shown to shift the B/Z equilibrium toward Z-DNA 
in alternating purine-pyrimidine sequences, along with the phenyl22 adduct formed from 
 aryl hydrazines. The effects of C8-aryl adduct on Z-DNA and B-DNA were examined 
throughout this study in order to evaluate the significance of the B-Z conversion in aryl 
hydrazine carcinogenesis. 
Scheme 1.2 Mechanisms of C8-arylpurine adduct formation: The upper scheme shows 
C8-arylguanine adduct formation while the lower scheme shows C8-aryladenine adduct 
formation. 
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1.2 Z-DNA: Structure and Biological Role 
1.2.1 Structure and Chemistry of Z-DNA 
Z-DNA was first identified by X-ray crystallography in 1979 by Wang et. al.23. 
The X-ray crystal structure indicated that a self complementary CG hexamer was in a 
non-canonical, left-handed double helix as shown in Figure 1.2. Although both B and Z-
DNA are anti-parallel, double stranded helices that are composed of Watson-Crick 
hydrogen bonding base-pairs, their structures are very different. Unlike B-DNA in which 
all of the bases are in anti conformation about the glycosidic bond, in Z-DNA the 
pyrimidine bases are anti and the purines adopt the syn conformation (Figure 1.3). This 
structural feature leads to a zigzag phosphate backbone of the left-handed DNA which, in 
turn, gave rise to the name Z-DNA. Studies have shown that purine bases are more prone 
to adopt the syn conformation than pyrimidine bases mainly due to the energy penalty 
from van der Waals crowding24. Therefore, alternating purine-pyrimidine sequences are 
the most prone to form Z-DNA. In addition, Z-DNA does not have as visually distinct 
major groove and minor groove as seen in B-DNA. It does have a very narrow and deep 
minor groove while; what is technically the major groove, is nearly flat or even convex. 
The positions of the base-pairs, within the helix, are also significantly displaced from the 
helical axis in Z-DNA relative to the B form. This reduces stacking interactions among 
bases25 and lowers the stability of the left-handed DNA form. Under standard 
physiological conditions B-DNA is typically lower in energy, though certain factors can 
stabilize Z-DNA relative to B-DNA and thus facilitate B to Z conversion. 
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Figure 1.2 Structure of B-DNA (left) and Z-DNA (right) of the duplex CG decamers 
Figure 1.3 Structure of guanosine in B-DNA and Z-DNA. In B-DNA, the glycosidic 
bond in is in anti conformation and the deoxyribose adopts the C2′ endo orientation. In 
Z-DNA, the glycosidic bond is in syn  and the deoxyribose contains is C3′ endo. 
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Several studies have investigated the factors affecting the stability of Z-DNA. 
Alternating purine-pyrimidine sequences are more common to form Z-DNA due to the 
previously described preferences for purines to adopt syn glycosidic bonds. Certain 
chemical modifications like N7 guanine methylation26 or C5 cytosine methylation,27  help 
stabilize Z-DNA and/or destabilize B-DNA and drive the B to Z conversion. A very  
interesting target is the C8 position of guanine since several modifications including 
methylation, bromination, and phenylation, have been shown to facilitate B-Z transition 
via C8 guanine adduct formation. The addition of a group to the C8 of guanine or adenine 
causes the syn conformation to be favored, at least at the nucleoside level, due to less 
steric hindrance compared to anti conformation. In anti position, the C8-substituent 
sterically interacts with the C2′-proton.  
Organic and inorganic cations can stabilize Z-DNA and molecules with those 
bearing multiple positive charges are even more efficient at stabilization of the Z-DNA 
conformation than monovalent cations as has been shown in poly GC sequences28. The 
reason for the stabilizating effect of cations is, in Z-DNA, the phosphate groups are closer 
together than in B-DNA and under normal physiological conditions give rise to 
electrostatic repulsion among the negatively charged phosphate backbone. Positive 
charged species such as Na+, K+, Mg+, spermine, and spermidine diminish the 
electrostatic effect by screening and thereby lower the energy level of Z-DNA.  
In 1982, another factor that stabilizes Z-DNA was discovered. Negative 
supercoiling, which occurs during transcription, has been shown to facilitate B to Z 
conversion.  This factor was originally detected with gel electrophoresis29 and a Z-DNA 
antibody binding assay30. The level of negative supercoiling required to stabilized Z-
 8
DNA depends on the length of alternating purine-pyrimidine track. Generally longer 
tracks of purine-pyrimidine repeats require a lower level of  negative supercoiling to 
stabilize the Z conformation25. The discovery of the stabilization effect that negative 
supercoiling has on the Z-DNA conformation suggested possible biological roles for Z-
DNA since supercoiling tends to be interrelated with biological function (e.g., 
transcription). Further details regarding supercoiling and biological significant of Z-DNA 
are discussed in the following section.  
 
1.2.2 Biological Relevance of Z-DNA  
Although many chemical aspects of left-handed DNA have been investigated and 
elucidated, the biological role has not.  A major impediment is the lack of data regarding 
the formation of Z-DNA under physiological conditions, even after 30 years of research 
following the discovery of Z-DNA. However, in the past decade several studies have 
shown that Z-DNA may play significant roles in biological systems and investigations 
into its biological functions are being revived. The evidence that suggested that negative 
supercoiling stabilizes Z-DNA has redirected biologists to have renewed interest in Z-
DNA function31.  
In 1987, study of DNA supercoiling during transcription by Liu L.F. and Wang 
J.C. 32 showed the possible biological relevance of Z-DNA in gene transcription. The 
study showed that, in the process of transcription, RNA polymerase actually plows 
through DNA helices instead of rotating around DNA, as believed in the past. Because 
the DNA has a fixed end, the movement of RNA polymerase complex unwinds the DNA 
and generates a negative supercoil behind the moving polymerase. The left-handed Z-
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DNA form, then, may form to reduce the negative torsional strain caused by the unwound 
DNA. The information from this study supports the ideas that Z-DNA may have a 
biological function(s).  
A computational study was conducted to map the potential Z-DNA forming 
sequences in 137 human genes33. The result has shown that potential Z-DNA forming 
sequences are located non-randomly near transcription initiation sites. Further evidence 
from a more recent computational study in 200434 also suggests that Z-DNA coupled 
transcription may be possible since the results show the distribution of Z-DNA forming 
regions across chromosome 22 toward the transcription start sites. To gain more direct 
evidence of Z-DNA associated with transcription, the level of Z-DNA during 
transcription in permeabilized mammalian cell nuclei was detected by a Z-DNA antibody 
binding assay35. This study has discovered that transcription is directly associated with 
the binding of anti Z-DNA antibodies; inhibition of RNA transcription results in 
decreasing Z-DNA antibody binding.  
Specific gene expression, for example, of c-myc, has also been shown to correlate 
with the formation of Z-DNA in permeabilized nuclei36. In 2001, Liu R. et al. proposed 
one possible mechanism to explain how Z-DNA initiates transcription37. To activate the 
colony stimulating factor-1 (CSF-1) promoter, the activity of the NFI-BAF complex 
required the transition of B-DNA to Z-DNA. Binding of NFI to CSF-1 facilitates the 
activation of the promoter by BAF which in turn initiates the unwinding of chromatin 
structure. Negative supercoiling would then be increased and stabilized by the transition 
of B to Z-DNA. This discovery has shown that Z-DNA could not form nucleosomes38. 
Therefore, stabilization of Z-DNA, TG repeats in this case, by negative supercoiling 
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further opens the chromatin structure and allows other transcription factors to engage and 
to initiate transcription. Z-DNA formation is only transient and will relax back to B-DNA 
after transcription ends. The evidence of Z-DNA coupled CSF-1 transcription has 
demonstrated a significant biological role of Z-DNA.  
In addition to Z-DNA coupled transcription, other studies have found the 
occurrence of Z-DNA binding proteins. A screening technique to identify selective Z-
DNA binding proteins has been described by Herbert et al.39 It led to the isolation of 
several specific Z-DNA binding proteins. One of the Z-DNA binding proteins that is 
worthy of mention is double stranded RNA adenosine deaminase (ADAR1)40. ADAR1 
binds to the double stranded part of RNA that forms in pre-mRNA31 and activates 
deamination of adenosine to give inosine, interpreted as guanine by ribosome. The 
activity of ADAR1 may regulate the expression of multiple proteins from single encoded 
genes through the alteration of amino acid sequence of the encoded protein. Although the 
in vivo experiment on Z-DNA binding domain of ADAR1 has been studied41 and the co-
crystallization of Z-DNA and ADAR1 has been conducted42, a regulatory role of Z-DNA 
on ADAR1 function is still not completely elucidated. 
       
1.2.3 Z-DNA Induces Genetic Instability 
From previous studies, the biological relevance of Z-DNA has been demonstrated 
mainly in a transcription process. Since Z-DNA seems to have a biological role in gene 
expression, it has been speculated that Z-DNA may play a role in carcinogenesis. 
Considering the suggestion that Z-DNA may regulate transcription, over-stabilization of 
the Z-DNA conformation may have negative consequences. As explained earlier that Z-
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DNA formation only occurs transiently, initiating transcription and over stabilized Z-
DNA may prolong Z-DNA formation and therefore, potentially over-expression of a 
gene. In addition, increasing the stability of Z-DNA may affect the regulatory role of Z-
DNA on ADAR1 activity and can result in translation errors from improper guanine 
substitution. Furthermore,  Z-DNA prone sequences have been shown to be highly 
recombinogenic and often result in genetic deletions43. In 1989, Spitzner, J. R. et al. 44 
demonstrated that alternating purine-pyrimidine repeats were sensitive to strand breaking 
by DNA topoisomerases. The study suggested that the Z-DNA forming sequence may be 
a hot spot that is vulnerable to DNA damage. Recently, Wang G. et al45 have confirmed 
that Z-DNA may cause genetic instability. They demonstrated Z-DNA is a genomic hot 
spot that can induce genetic instability in both bacterial and mammalian cells. Thus, a Z-
DNA prone sequence induced double strand breaks close to the Z-DNA and result in 
large scale deletions. The result from this study has again suggested the mutagenic 
potential of Z-DNA. Considering that several C8 guanine adducts including C8-phenyl 
adduct formed from phenyl hydrazine22 can stabilize the left-handed DNA, Z-DNA 
stabilization may be related to aryl hydrazine carcinogenesis. 
 
1.3 Effect of C8-Arylguanine Adduct on Aryl Hydrazine Carcinogenesis: The 
Possibility of Z-DNA Mediated Carcinogenesis 
Previous studies have shown a correlation between C8-arylguanine adduct 
formation and carcinogenicity of the parent aryl hydrazines22,46. Thus, through 
bioactivation of aryl hydrazines, arenediazonium ions and/or aryl radicals are produced 
and lead to the formation of DNA aryl adducts.  This process may be the cause of aryl 
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hydrazine carcinogenesis. Several attempts have been made to determine  how the DNA 
aryl adduct facilitates cancer development. Kohda et al.15 has suggested that the C8-
phenyl guanine adduct may be  mis-read by DNA polymerase and can cause miscoding 
through G→T and G→C transversions. However, the C8-arylguanine adducts are not 
efficiently read and when read, tend to be read correctly.  Consequently, aryl hydrazine 
carcinogenesis is likely caused by other mechanisms22.  
Four different p-substituted arenediazonium ions (Figure 1.4) including MBD, 
HMBD, MMBD, and CBD have been shown to be capable of inducing DNA damage 
through DNA-DNA cross linking (except for MBD) and single strand breaks in  Chinese 
hamster lung fibroblast V79 cells46. It has been suggested that either the reactive azo 
group of arenediazonium ions or, after reduction to an aryl radical (metabolically or 
chemically), reaction with DNA occurs to form the C8-arylguanine adduct.  
Subsequently, p-substituents (-CH2OH, -CH2OCH3, -COOH, CH3) may then react with 
another base to form DNA cross linking47. The methyl functional group in MBD does not 
bear any leaving groups and, therefore, no reactions with other bases are possible and no 
DNA cross links form. The mechanism of DNA single strand breaks caused by reaction 
of the arenediazonium ions or aryl radicals is still not clear and will require additional 
research to elucidate the mechanism.  
 
 
 
 
 Figure 1.4 Structures of carcinogenic arenediazonium ions a) MBD, b) HMBD, c) 
MMBD, and d) CBD. 
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Studies of carcinogenic polycyclic aromatic hydrocarbons have demonstrated that 
the C8-aryl modified guanosine formation through the oxidation of benzo[α]pyrene can 
result in the loss of the pendant sugar residue48. Identification of depurination in both in 
vitro and in vivo studies49,50 have been conducted and the results suggest that the C8-
benzo[α]pyrene adduct formation facilitates the depurination of the modified guanine. 
Furthermore, the formation of apurinic sites has been correlated with the mutagenic level 
of benzo[α]pyrenes49. Depurination is a common occurance in cells and is usually taken 
care by DNA repair enzymes51,52. However, an excessive exposure to certain types of 
chemicals, for example carcinogens, may overwhelm the DNA repair enzymes. In this 
case, the abasic sites may cause several types of DNA lesions and may lead to 
mutagenesis51. DNA strand breaks can occur through the abasic sites since the aldehydic 
lesions are vulnerable to oxidative strand scission53. Misincorporation by DNA 
polymerase through depurination can occur as explained by Boiteux and Laval’s 
observation54 that E. coli DNA polymerase preferentially incorporates dAMP over dGMP 
opposite the abasic site. In addition, Dutta et al.55 have shown that the abasic sites can 
generate interstrand cross links through the reaction of the aldehyde of the abasic site and 
N2-amino group of guanine residue in the opposite strand.   
Apurinic site formation has also been detected, albeit indirectly, by high pressure 
liquid chromatography (HPLC) analysis as C8-aryl modified bases can be detected from 
solutions resulting from calf thymus DNA or C50 cells treated with with MBD, HMBD, 
or CBD7,14. As a result of C8-aryl purine adduct formation, the glycosidic bond is more 
vulnerable to hydrolysis and the depurination rate is increased. This suggested that aryl 
hydrazines may induce carcinogenesis via depurination of C8-aryl modified purine. This 
 14
depurination, facilitated by C8-aryl adduct formation, may explain the previous result 
that aryl hydrazines mediated DNA single strand breaks and DNA cross links in V79 
cells. Nevertheless, further study needs to be conducted to explore this possibility. 
Another possible mechanism that will be addressed throughout this dissertation is 
Z-DNA mediated aryl hydrazine carcinogenesis. As described in the previous section, 
several studies have suggested the biological role of Z-DNA in the transcription process. 
Furthermore, there is mounting evidence that indicates the mutagenic potential of Z-
DNA. These results lead to the idea that Z-DNA “over” stabilization is likely to cause 
genetic alteration by disturbing transcription balance and/or increasing vulnerability of 
DNA to damage. Given the results from several studies that  C8-guanine adducts can 
promote the conversion of B- to Z-DNA by destabilizing B-DNA and/or stabilizing Z-
DNA, aryl hydrazine carcinogenesis through Z-DNA formation by C8-aryl adduct seems 
to be possible.  
Previously22 our group has shown that the C8-phenyl guanine adducts promote B-
Z conversion in CG8Ph (d(5′-CGCGCG*CGCG-3′)2, G* = C8-phenyl modified guanine). 
The aryl modified DNA requires much lower NaCl concentrations to stabilize the Z 
conformation compared with the unmodified DNA, indicating the stabilization effect of 
C8-phenyl guanine adduct on Z-DNA. The result from this initial study confirmed the 
possibility that B-Z transition may play a role in aryl hydrazine carcinogenesis and has 
opened the opportunity of further explore the effect the C8-arylguanine adduct has on Z-
DNA stabilization or B-DNA destabilization. Given that Z-DNA is suspected to play a 
significant role in cancer development, the C8-aryl adduct formed from the carcinogenic 
aryl hydrazines should, in general, promote the Z-DNA formation. To prove this concept 
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and to determine the correlation between Z-DNA formation and carcinogenesis, several 
C8-arylguanines, modified DNA including CG8Tol, CG8HMPh, CG8MMPh, and CG8CPh (d(5′-
CGCGCG*CGCG-3′)2, G* = 8-p-tolyl, 8-p-hydroxymethylphenyl, 8-p-
methoxymethylphenyl, or 8-p-carboxyphenyl guanine) were made. These modified 
oligonucleotides are formed from the arenediazonium ions (MBD, HMBD, MMBD, and 
CBD, respectively), via aryl radicals, and all have been shown to be mutagenic4,46. In this 
study, the effects of each C8-aryl adduct on B/Z-DNA equilibrium was investigated.  
The next chapter provides fundamental knowledge regarding methodologies and 
experimental techniques that have been used in this research. The experimental results 
are reported in Chapter 3 (DNA synthesis) and 4 (structural and conformational analysis). 
The computational study of the modified DNA, conducted to help explain the 
experimental results, is described in Chapter 5. Finally in Chapter 6, the effect of C8-
arylguanine adducts on B/Z-DNA equilibrium and the significance of Z-DNA in aryl 
hydrazine carcinogenesis are discussed.  
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Figure 2.1 Structures of the phosphoramidites used in DNA synthesis. 
  
CHAPTER 2 
EXPERIMENTAL TECHNIQUES 
 
2.1 Synthesis of CG Decamers Containing C8-Aryl Modified Guanine  
Generally, most short length oligonucleotide sequences can be efficiently made 
through use of an automated DNA synthesizer that utilizes phosphoramidite chemistry. 
The DNA synthesizer uses nucleoside cyanoethyl phosphoramidites (dA CE-PA, dG CE-
PA, dT CE-PA, dC CE-PA, Figure 2.1) as the building blocks for the chemical synthesis 
of oligonucleotides. However, in order to make CG decamer with C8-arylguanine adduct, 
the modified C8-aryl-dG phosphoramidites (Figure 2.1) must be made as they are 
commercially unavailable. In this section, an overview of the chemistry behind 
automated DNA synthesis and the synthesis of C8-aryl-dG phosphoramidites will be 
described. 
 
 
 
 
 
 
 
 
 
 
 
 17
2.1.1 Chemistry for Automated DNA synthesis56 
Fundamentally, chemical synthesis of DNA works on the basis that the 
oligonucleotide can be elongated by coupling the reactive 3′-phosphoramidite of one 
nucleoside and the 5′-hydroxyl of the existing oligonucleotide. The synthesis occurs on 
the controlled pore glass (CPG) solid phase column with the first 3′ base attached to the 
column through an ester linkage57. All phosphoramidites, reactants, and solvents are 
flushed through the synthesis column with the oligonucleotide being extended from the 3′ 
end toward the 5′ end. Each base extension cycle is composed of four steps (Scheme 2.1) 
including detritylation of 5′-hydroxyl, base coupling, capping of unextended DNA, and 
oxidation. The reaction cycle repeats, for each base addition, until the DNA sequence is 
completed. 
 
 
Scheme 2.1 The DNA synthesis cycle is including Detritylation, Coupling, Capping, 
and Oxidation. (B = A, G, C, T) 
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Detritylation deprotects the 5′-hydroxyl of the nucleoside bound to the solid phase 
and renders it a nucleophile for coupling in the next reaction (AÆB). Trichloroacetic acid 
(TCA) in CH2Cl2, a protic acid, is used as a deprotecting agent as the DMTr group is acid 
labile. The protonation on the 5′-hydroxyl leads to DMTr cation loss and the detritylation 
can be driven to completion by removal of DMTr cations.  
After removal of excess TCA in detritylation step, the phosphoramidite is 
activated by tetrazole which transfers a proton to the nitrogen of the diisopropyl group on 
the 3′-phosphorous making the protonated amine a better leaving group. The nucleophilic 
tetrazole then attacks the phosphorous to form a tetrazolyl phosphoramidite. The molar 
excess of tetrazole ensures that most of the phosphoramidite is activated. The solid 
supported end 5′-hydroxyl reacts with the 3′-tetrazolyl phosphoramidite to form the 
internucleotide phosphite linkage (BÆC). As a result, the oligonucleotide is extended.  
The coupling reaction between nucleotides may not proceed completely leaving 
some of the oligonucleotide attached to the solid support unextended. To prevent the 
unreacted oligonucleotide from being extended and giving rise to undesirable 
oligonucleotide sequences, unreacted material is capped. Acetic anhydride and 
methylimidazole are used as a capping reagent and are delivered to the synthesis column 
simultaneously. The two reagents react and give a reactive acetylating agent which, in 
turn, reacts with the 5′-hydroxyl of the unextended oligonucleotide to inactivate the 
moiety from further reaction (CÆD). 
The last step is to oxidize the freshly formed internucleotide trivalent phosphite to 
pentavalent phosphodiester. Iodine in an aqueous pyridine-tetrahydrofuran (THF) 
solution is used as a mild oxidizing agent. The iodine-pyridine complex forms a di-iodo 
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adduct with the phosphate that is subsequently hydrolyzed by water to form the 
internucleotide phosphodiester linkage.     
To maximize DNA synthesis yield, each step of the synthesis cycle is followed by 
an acetonitrile (ACN) and argon flush to make sure that no reagents from the previous 
reaction remain to interfere with the next cycle. Following the oxidation of the final base, 
the DMTr protected 5′-hydroxyl group of the completed sequence can be detritylated. 
After the completion of the DNA synthesis the amine protecting groups and the solid 
support linkage are removed by incubating the synthesis column in a basic ammonium 
hydroxide solution for 15 hrs at 55°C. The crude oligonucleotide can be purified if 
necessary. 
 
2.1.2 Synthesis of C8-Arylguanine Phosphoramidites  
To incorporate C8-arylguanine adduct to the CG decamer, the modified C8-aryl 
dG phosphoramidites are required. The phosphoramidite used in the DNA synthesis 
contains several required functional groups including a diisopropylamino cyanoethyl 
phosphorous on 3′-hydroxyl, a DMTr on 5′-hydroxyl, and a protecting group of the 
exocyclic amine of nucleoside base. In case of the C8-aryl modified guanosine 
phosphoramidite, the purine ring has an additional aryl substituent at C8. Several 
reactions need to be performed in order to add these functional groups to prepare the aryl 
modified phosphoramidite. Our scheme starts with attachment of the aryl group to the C8 
position of 2′-deoxyguanosine.  Next the exocyclic amine is protected, followed by 5′-
hydroxyl and 3′-hydroxyl groups are functionalized, respectively. 
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2.1.2.1 Synthesis of C8-Aryl dG Using the Suzuki Coupling       
The 8-aryl-dG can be made through the chemical reaction between 
arenediazonium ion and dG as described by Kohda K. et al.15 To make 8-phenyl-dG, the 
BD solution was freshly made from the reaction between aniline and NaNO2. After 
reacted with BD in basic condition for 24 hrs, dG was arylated and 8-aryl-dG was 
collected from crystallization. Despite the success of making 8-phenyl-dG, using the 
carcinogenic arenediazonium ions as the arylating agents is quite hazardous requiring 
special handling. In addition, the reaction produces nitrogen which causes foaming, is 
difficult to contain, and to filter after the reaction is complete. It is also not very efficient, 
and provides relatively low yields (40%) in the case where the aryl group is phenyl.  
Finally, while this reaction works with some substituted phenyl groups it is unlikely to 
work with many substituted phenyl groups that are of interest. Improved methods that 
provide a safer, more convenient protocol, higher product yields and simple purification 
to isolate the product is preferred.  
Palladium catalyzed cross coupling reactions have been successfully used for 
carbon modification of nucleosides58,59. Among the cross coupling reactions, Suzuki 
coupling between halonucleosides and arylboronic acids have been shown to be an 
effective way to make aryl modified nucleosides60,61. In general, the Suzuki coupling is 
the important carbon-carbon bond forming reaction that can be used to make biaryl 
compounds through palladium catalysis of the reaction between arylboronic acids or 
esters and aryl halides, sulfonates, or diazonium salts in basic condition62,63 as shown in 
Scheme 2.2.  
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The general mechanism64-66 of the coupling reaction is described in Scheme 2.3. 
The reaction begins with the arylhalide (or other electrophilic aryl reactant) reacting with 
the Pd(0) catalyst by oxidative addition to form an arylpalladium (II) halide. The 
hydroxide (or other negatively charge bases such as alkoxide, carbonate, or phosphate 
etc.) then attacks the boron atom in the arylboronic acid to give an aryl borate- ate 
complex. In addition, the nucleophilic base also reacts with the arylpalladium (II) halide 
to generate an arylpalladium (II) hydroxide. The aryl borate and the arylpalladium (II) 
hydroxide then react and form a diarylpalladium (II) complex which eventually 
undergoes a reduction-elimination reaction that leads to the formation of a biaryl product 
and the regeneration of the Pd(0) catalyst.  
Several factors affect the efficiency of the Suzuki coupling reaction62. Because the 
reaction requires basic conditions, base selection is very important. Using different bases 
can give different products from the coupling. Weaker bases such as triethylamine (TEA) 
usually are less efficient with respect to product formation. The solvent system is also 
crucial since it strongly determines the solubility and basicity of the base that used in the 
coupling. In our case, making the modified nucleoside, that contains the hydrophilic 
sugar moiety, requires an aqueous solvent system. This limits the range of bases that can 
 
                                 Base, Pd catalyst 
Ar-X       +       Ar′-B(OR)2                    Ar-Ar′ 
 
              X = I, Br, Cl, OTf, OTs, OMs, N2+BF4- 
               
              R = H or Alkyls 
 
Scheme 2.2 The synthesis of biaryls from arylboronic acids or esters and electrophilic 
aryl reactants by Suzuki coupling 
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be used to water soluble base. Generally, carbonate or hydroxide have been used and 
seem to work well.  
 
 
 
 
 
 
 
 
 
The homogeneous mixture from water and water-miscible organic solvent such as 
ACN or THF can be used to improve the solubility of the hydrophobic reactants. In case 
this is necessary, the biphasic solvent mixture from organic solvent and water can be used 
if the lipophilic part is needed. The palladium catalyst is probably the most important part 
in the Suzuki coupling reaction. Pd(0) is the actual catalytic species but is usually 
generated in situ by reduction of Pd(II). Once formed, the Pd(0) must be kept in solution 
and, since it is sensitive to oxidation, the reaction is conducted under an inert gas such as 
argon or nitrogen to prevent reaction with oxygen. In addition, using a suitable and 
soluble palladium ligand is also essential to solubilize and stabilize Pd(0) in solution.       
Shaughnessy et al.67 have developed an the efficient way to synthesize biaryl 
compounds from an aqueous based Suzuki coupling using ACN as a co-solvent. The key 
discovery was that sterically demanding water soluble ligands can be successfully used 
Scheme 2.3 The general mechanism of the Suzuki coupling reaction 
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with palladium acetate (Pd(OAc)2) to catalyze the coupling reaction. The idea seemed to 
be suitable for preparation of  aryl modified nucleosides and has since been used to  
synthesize C8-arylpurine, as was demonstrated by Western E.C, et al.61 in 2003. The 
successful aqueous Suzuki coupling of 8-Bromo-2′-deoxyguanosine (8-BrdG) and several 
arylboronic acids were reported in this study with the product yield in range of 70-90 %. 
The reaction is conducted at 80°C with Na2CO3 as the base in deoxygenated aqueous 
acetonitrile with Pd(OAc)2  as the catalyst in a presence of the palladium ligand TPPTS 
(tris-(3-sulfonatophenyl)phosphine) ligand (Figure 2.4). 
These studies provided a relatively efficient and convenient method to synthesize 
8-aryl dG for the C8-arylguanine modified DNA synthesis. The protocols of making 8-
aryl dG used in this study were followed and/or further developed. 
 
 
 
 
 
 
        
 
2.1.2.2 Synthesis of the TBS Protected p-Hydroxymethylphenylboronic acid 
Most of the arylboronic acids needed here, including phenyl, p-tolyl, p-
hydroxymethylphenyl, p-methoxymethylphenyl, and p-carboxyphenyl boronic acids, are 
commercially available and have been successfully used directly to make the modified 
Scheme 2.4 The synthesis of C8-aryl dG using the Suzuki coupling 
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DNAs except for the p-hydroxymethylphenyl derivative. The 8-(p-
hydroxymethylphenyl)-dG phosphoramidite has been synthesized, however using it in for 
the modified DNA synthesis failed to unequivocally produce the desired DNA, as 
suggested by mass spectral analysis. This synthesis failure may occur due to the 
nucleophilic nature of the benzyl hydroxyl group that can interfere with the DNA 
synthesis. In order to prevent the hydroxyl substituent from interfering with the DNA 
synthesis, a protecting group was needed on the hydroxyl group. The t-butyldimethylsilyl 
(TBS) protecting group has been used as a 2′-hydroxyl protection group of 
ribonucleosides68 and is cleaved by exposure to concentrated ammonium hydroxide after 
DNA synthesis along with other protecting groups. Therefore TBS was chosen for use as 
the protecting group for the p-hydroxyl substituent.  
The arylboronic acids can be made through the classical Grignard reaction62 
between aryllithiums and trialkyl borates. The reaction generates arylboronic esters 
which are hydrolyzed by acid to form the arylboronic acids69. From this reaction, one can 
vary the p-substituent of aryllithiums to make various p-substitute arylboronic acids. 
Zheng N. et al.70 has shown the efficient way to make the TBS protected p-
hydroxymethylphenylboronic acid in a pilot scale by utilizing a Grignard reaction. The 
synthesis protocol is shown in Scheme 2.5 starting with the protection of the hydroxyl of 
4-bromobenzyl alcohol by using TBS-Cl to give the TBS protected product. The 
protected p-hydroxymethylphenylbromide is then reacted with t-buthyl lithium to form 
the TBS protected p-hydroxymethylphenyl lithium which is then treated with tri-
isopropylborate to form the TBS protected p-hydroxymethylphenylboronic ester. After 
acid hydrolysis, the TBS protected p-hydroxymethylphenylboronic acid was isolated. 
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This final product was then used to prepare the modified guanine phosphoramidite which 
was successfully used to synthesize the hydroxymethylphenyl guanine adduct containing 
DNA. This arylboronic acid synthesis protocol is potentially useful for making other 
substituted arylboronic acids that may require protecting groups. 
 
 
 
 
 
 
 
 
2.1.2.3 Syntheses of Protected C8-Aryl dG and Phosphoramidites  
Methods to prepare the C8 modified dG phosphoramidites for the oligonucleotide 
synthesis15,71,72 have been published. The routes typically begin with C8-arylation of dG 
and are then followed by several reactions to prepare the modified dG phosphoramidite 
monomers for use in automated DNA synthesis as shown in Scheme 2.5.  
 
 
Scheme 2.5 The synthesis of 4-(TBS-O-methyl)-phenylboronic acid 
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Various amine protecting groups including benzoyl, isobutyryl, and N,N-
dimethylformamidine can be used to protect the N2 position of the aryl modified dG. The 
latter group has been shown to improve the stability of the nucleosides73 toward acid and 
was used here for the synthesis of the C8-aryl dG phosphoramidites. To attach the N2-
(N,N-dimethylformamidine) protecting group, N,N-dimethylformamide dimethyl acetal 
is reacted with the 8-aryl dG in dry methanol. The protecting group, which is a protected 
amide, forms a formamidine with the N2 amino group of the 8-aryl dG. The reaction has 
been found to be very sensitive to moisture.  Water will hydrolyze the protected amide to 
N,N-dimethylformamide (DMF) which is inactive for the amine protection reaction. 
Generally, the methanol that used in the reaction must be dried over molecular sieves 
under inert gases such as nitrogen or argon. The reaction proceeds to the completion 
within 24 hrs, at room temperature, with product yields of approximately 90%. The 
Scheme 2.6 The synthesis of the phosphoramidite monomer. The reaction conditions are 
including A) N’N-Dimethylformamide dimethyl acetal, MeOH; B) DMTr-Cl, pyridine, 
TEA; C) 2-Cyanoethydiisopropylchlorophosphoramidite, CH2Cl2, TEA. 
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amine protected 8-aryl dG may be purified using normal phase column chromatography. 
However, the purification is usually unnecessary because the crude reaction product is 
quite pure as found by NMR of the crude reaction product. Simply drying in vacuo has 
proven to be sufficient to prepare the crude product for the next reaction. 
After the protection of the N2 amine group, the 5′-hydroxy group of the 8-aryl dG 
is protected using DMTr-Cl, as is the case for unmodified phosphoramidites used in 
automated DNA synthesis. The reaction mechanism involves the nucleophilic attack 
(SN1) of the 5′-hydroxyl group to the electrophilic tertiary carbon center of DMTr-Cl, 
resulting in the formation of the DMTr protected 5′-hydroxyl nucleoside and HCl. Since 
the nucleosides are sensitive to acid hydrolysis, the reaction is conducted in pyridine, a 
basic solvent, and in a presence of TEA to neutralize the acid generated and maximize the 
product yield. The reaction can be monitored by normal phase thin layer chromatography 
(TLC) with visualization by phosphomolybdic acid.  The reaction product appears as an 
orange spot, likely due to cleavage of the DMTr protecting group from the product as the 
DMTr group is very acid labile and gives DMTr-OH which is orange in color. Unlike the 
previous protection step, the DMTr protection product requires purification. Several 
chromatographic systems have been explored for purification of the DMTr protected 
nucleosides73. A silica gel stationary phase was first used and was shown to cause 
decomposition of the nucleoside due to the acidic nature of the stationary phase. In 
contrast, Alumina, a basic stationary phase, has been found to be a more suitable system 
and causes minimal product decomposition. A mixture of CH2Cl2 and methanol gradient 
(0-10%) is used as the mobile phase and, after chromatography, the product yield is 
usually in range between 40% and 60%. 
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The attachment of a 2-cyanoethoxydiisopropylaminophosphoramidite at the 3′-
hydroxyl position of the 8-aryl dG is the final step of the phosphoramidite synthesis. 2-
Cyanoethyldiisopropylchlorophosphoramidite is used as the phosphatidylating agent. The 
reaction also involves the nucleophilic substitution of the chlorine on phosphorous by a 
3′-hydroxyl of the 8-aryl dG. The reaction is conducted in CH2Cl2 in a presence of TEA 
to neutralize HCl that is generated during the course of the reaction. Due to high 
reactivity of the phosphatidylating agent, most nucleophiles, including water, can 
interfere with the reaction. Therefore, using dried, purified starting materials and solvent 
is necessary to achieve the desired product and optimize the yield, as is conducting the 
reaction under an inert atmosphere. The phosphoramidite is only partially purified by the 
precipitation of TEA hydrochloride salts out of the reaction by the addition of a mixture 
of benzene and THF. While further purification can be done by column chromatography, 
this step has been found to be unnecessary and tends to lead to the product degradation. 
After precipitation of salts, the solvents are removed in vacuo and the product dried over 
phosphorus pentoxide in vacuo.   
By following these synthesis protocols, the aryl adducts with different p-
substituents on phenyl ring can be introduced to the C8 position of dG. The 8-aryl dG 
phosphoramidites then were made and used for the modified CG decamer synthesis 
through the DNA synthesizer.  
 
2.2 Purification of CG Decamers Containing C8-Aryl Modified Guanine 
A number of factors, including low quality of the starting materials and reagents, 
degradation of the modified DNA during synthesis, machine malfunction, and other 
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technical issues, can affect the efficiency of the modified oligonucleotide synthesis. 
Although these unfavorable factors can be prevented or minimized, most of time they can 
not be completely eliminated. This will decrease the efficiency of the synthesis cycle and 
resulting in by-product generation. In order to get the sufficiently pure DNA that is pure 
enough for NMR and CD experiments, the crude modified oligonucleotides require 
purification. 
Several HPLC techniques including ion-exchange chromatography and reversed 
phase chromatography74 can be utilized to purify the modified oligonucleotides. The fast 
protein liquid chromatography (FPLC) method is one of the HPLC methods that has been 
widely used to isolate proteins in biochemistry and enzymology research and has also 
been used to purify the synthesized DNA. Because of the anion exchange matrix 
stationary phase that used in the preparation column, FPLC separates DNA mainly by the 
differences in negative charge of the DNA molecules. The oligonucleotide structures 
contain the phosphate backbones which carry negatively charges. Therefore, DNAs of 
various lengths will contain a different number of negatively charges and will bind to the 
anion exchange resin to a different degree. The longer DNA sequences that have more 
negative charge adsorb to the cationic stationary phase more strongly and require a more 
anionic mobile phase to elute them out of the column than shorter DNAs. In addition to 
the charge separation, there is some dependence of elution time on the hydrophopic 
nature of the DNAs with more hydrophobic sequences eluting more quickly. 
The anion exchange matrix, diethylaminoethyl (DEME) modified resin, is 
commonly used to isolate nucleic acids74 and have been successfully used to purify the 
modified CG decamer in this study. The quarternary ammonium ion functional groups on 
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DEME give them the anion exchanging capability. The counter ions, often OH-, maintain 
electroneutrality of the stationary matrices. Once the oligonucleotides are loaded on to 
the column, the multi-negatively charged molecules will replace the previous counter 
ions with stronger electrostatic forces. A mobile phase that contains anions, in this case 
Cl-, has been used extensively to elute the oligonucleotides and a gradient comprised of 
sodium chloride and sodium hydroxide can effectively be used to separate the modified 
oligonucleotides contained in the crude DNA synthesis mixture. Generally, the desired 
product, the longest sequence in the synthesis process, is the last one that is eluted off of 
the column since it bares the highest negative charge. The separation of the crude DNA 
can be monitored by using an ultraviolet (UV) light detector at 260 nm where nucleic 
acids generally have the highest absorbtivities.  
After isolation by FPLC, the oligonucleotides still need to be isolated from the 
sodium chloride and sodium hydroxide salts that were present in the eluant. Solid phase 
extraction (SPE) using reversed phase C18 cartridge can be used to desalt the DNA 
samples. Because of the partial hydrophobic parts of the DNA (the purine and pyrimidine 
rings) the oligonucleotides can bind to the lipophilic hydrocarbon chain in the stationary 
phase better than NaCl and NaOH. Therefore, the polar impurities can be eliminated by 
washing the cartridge with water after the DNA samples were loaded. The DNA can be 
eluted with an aqueous methanol mixture. After removing the solvent, the purity of the 
modified oligonucleotides can be confirmed by FPLC analysis. A single peak in the 
FPLC chromatogram is expected if the synthesized oligonucleotides are pure. 
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2.3 Mass Spectrometry of CG Decamers Containing C8-Aryl Modified Guanine 
Mass Spectrometry (MS) analysis has been commonly used to characterize 
organic compounds and study molecular interaction of a wide variety of chemicals. This 
method of analysis is based on the detection of weight to charge ratio of the ionized 
molecules by measuring the response of their trajectories to electronic or/and magnetic 
fields. Hence, in the process of detection, the analytes need to be ionized in vacuo and 
move through an electronic field to the mass analyzer which separates the ionized 
molecules by their mass to charge ratio (m/z). The detector will then detect the sorted 
ionized molecules and convert the signal into a mass spectrum that is generally distinct 
for each chemical.  
The classical MS methods usually use electron (EI) or chemical ionization (CI) as 
an ionization source75. The high energy electron beam used in EI to interact with the 
analytes and generate the molecular ions (M+·) and daughter ions. Unlike EI-MS in which 
electrons directly interact with the analyte molecules, CI-MS method uses an ionized 
reagent gas such as protonated methane (CH5+), isobutene cation ((CH3)3C+), or 
ammonium ion (NH4+) as the ionization reagent to generate protonated analytes (MH+). 
However, due to the limitations of conventional techniques, it is difficult to convert 
thermal labile and/or non-volatile macro molecules such as nucleic acids or proteins into 
the ionized gaseous state without decomposition.  
The development of soft ionization methods including electrospray ionization 
(ESI) and desorption ionization have provided the opportunity to use MS as an analytical 
tool for biological molecular research. ESI-MS analysis has been successfully used in for 
the characterization and sequencing of biological polymers and can be used to probe 
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molecular interaction76,77. Here, we have used ESI-MS to characterize the C8-aryl dG 
monomers and the C8-arylguanine modified CG decamers. 
The ESI-MS method produces the quasi-molecular ions78 by nebulizing a sample 
solution, in which analytes are already in the ionic form, into an aerosol through a high 
voltage chamber. The charged droplets containing the analytes that are generated are 
subjected to the counterflow of a drying gas, generally nitrogen gas. This process helps to 
accelerate solvent evaporation, decreases the size of the droplets, and increases the charge 
density on the droplet surfaces which ultimately causes the droplets to burst or undergo a 
“Coulomb explosion” due to their electrostatic repulsion. As a result, daughter droplets 
are produced and further break down until the preformed ions are generated (Figure 2.2). 
The preformed ions79 are the ionic analyte droplets that are small enough (ideally each 
droplet contains only one molecule of analyte) so they can be desorbed into the gas phase 
and pass through the capillary tube into the m/z analyzer. The ion adducts can be 
incorporated into the preformed ions in cases where the analyte molecules are not well 
dissociated or neutral. For instance, ammonium acetate buffer can be used as a source of 
the ammonium ion adducts which give positive charges to the preformed droplets. 
 
 
 
 
 
 
 
Figure 2.2 A diagram shows the ionization process in the positive ion mode ESI-MS to 
generate the preformed ions  
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Depending on the mode of detection, ESI-MS can be used to detect either 
negatively charged ions in a negative ion mode or positively charged ions in a positive 
ion mode. Fundamentally, the ionization state of the analyte molecule is mainly 
dependent on the solvent system and the pKa of the analyte molecule. Volatile aqueous 
organic solvent (methanol, ACN, isopropylalcohol, etc.) systems are commonly used in 
ESI-MS. In addition, a limited amount of volatile acids or bases, such as formic acid, 
acetic acid, trifluoroacetic acid, ammonium formate, ammonium acetate, ammonium 
hydroxide, and TEA, may be used as buffers to adjust the optimum pH of the solvent 
system. Non-volatile solvents or salts should be avoided since they may accumulate in 
the system and cause machine malfunction. In general, acidic molecules from negative 
ions in high pH solution while the basic molecules would be protonated and form positive 
ions in low pH solution. If the analyte is in a neutral form at the working pH, the ion 
adducts from buffer ions will largely determine the charge of the ions.  
Multiple charge states of the ions are commonly observed during the ionization 
process and depend on the structure of the analyte and the solvent system. This 
phenomenon is actually advantageous for the analysis of the biological macromolecules 
like peptides or oligonucleotides that have high molecular weight (MW). Because ESI-
MS detects m/z of the preformed ions, the higher charge state of the analyte the lower 
m/z ratio compared to a lower charge state of the same analyte. Unlike the conventional 
ionization methods, ESI can be used to analyze high MW compounds up to 100,000 mass 
units due to its ability to generate ions with multiple charged. The mass spectra of the 
biological molecules from ESI-MS are usually composed of a series of peaks from 
several charge states (Mn- or Mn+, n is a charge state of the molecule). The MW of the 
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analyte then can be determined from a mathematically approximation from the resulting 
mass spectrum. 
In the positive ion mode, the molecular mass (M) of the analyte can be 
calculated80 from a grouping of m/z ratios of the ion series and n as described by the 
following equations.  
 
From              m/z1 = (M + n)/n                                          Equation 2.1                         
and                                   m/z2 = (M + n + 1)/(n + 1)                            Equation 2.2 
Therefore                            n = (m/z2 -1)/(m/z1- m/z2)                            Equation 2.3 
 
By solving Equation 2.1 after calculating n from Equation 2.3, the molecular mass of the 
analyte can be estimated. Similar to a positive ion mode, M can also be calculated in a 
negative ion mode from the observe m/z and n as described below in the Equations 2.4 to 
2.6.  
 
From               m/z1 = (M - n)/n                                        Equation 2.4                        
and               m/z2 = (M - n - 1)/(n + 1)                            Equation 2.5 
Therefore               n = (m/z2 + 1)/(m/z1- m/z2)                            Equation 2.6 
 
The m/z ratios can be obtained from the mass spectrum of the analyte and used to 
calculate n from the Equation 2.6. After replacing the calculated n in Equation 2.4, M of 
the analyte then can be resolved. The calculation may need to be justified accordingly in 
case that the ion adducts are present. Alternatively, the series of m/z of multiple charge 
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states of the analyte, with or without the ion adducts, can be calculated based on the 
expected MW of the analyte and compared to the observed m/z in order to characterize 
the sample. 
The negative ion mode seems to be a suitable detection method for the 
oligonucleotides mass analysis because of the net negative charge of the DNA 
phosphodieater backbone (pKa ~ 1)77 which are usually dissociated in a sample solution 
at pH 7.4. Hence, without any buffer, an aqueous methanol solvent system for the 
modified CG decamers analysis and the negative ion mode ESI-MS has been successfully 
used to characterize the oligonucleotides. A series of charge states of the oligonucleotides 
were observed and compared to the calculated value to verify the identity of the 
synthesized oligonucleotides. 
 
2.4 Circular Dichroism Spectrophotometry of CG Decamers Containing C8-Aryl 
Modified Guanine  
2.4.1. CD of B and Z DNA 
CD spectroscopy is based on the fact that an optically active, asymmetrical 
molecule intereacts with the right and left handed circular polarized lights differently. 
When right and left circular polarized lights pass through absorbing optically active 
matter, not only do they travel at different speeds, they also absorbed to a dissimilar 
extent. The difference between the circular light absorptions (Δє = єL - єR) is called 
circular dichroism81 which is detected in the CD spectrometer. When two circular 
polarized light beams, with equal amplitudes and wavelengths, are superposed the result 
is a linear polarized wave. In case of CD, the superposition of the right and left polarized 
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light is no longer a linearly polarized wave. Instead, elliptically polarized light is 
generated. The ellipticity that is caused by CD can be mathematically determined and is 
usually presented in a CD spectrum. CD spectroscopy has been widely used to study 
molecular conformation of the chiral compounds including peptides and nucleic acids in 
several research areas due to the fact that different conformations of the same optically 
active substance can be distinguished by the unique patterns of their CD spectra.  
The structure of nucleic acids is composed of the aromatic purine/pyrimidine 
bases that are connected through the internucleotide sugar-phosphate backbone. The 
phosphate groups have high energy electronic transition at wavelengths shorter than 170 
nm. Close to the absorption band of phosphates, deoxyribose sugars absorb light begin at 
190 nm. The nucleotide bases, A, G, C, and T, are the chromophoric parts of DNA 
because of the aromatic system of purine and pyrimidine bases. Since the nucleotide base 
contains several π bonds, it is possible for them to have a large number of π→π* 
transitions which result in a lower electronic transition energy begining at 300 nm81. 
While the nucleotide bases are chromophoric, they are also symmetrical (plane of 
symmetry) and are not optically active which, in turn, makes them CD inactive. The 
deoxyribose sugar that attach to the base is chiral and gives the nucleoside molecule 
asymmetry and CD activity. However, since the absorbing moiety (pyrimidine or purine) 
is attached to the chiral component (deoxyribose) the effect of a chiral sugar on the CD is 
greatly attenuated and therefore, the CD intensity of a nucleoside base is relatively low. 
Several interactions including base-paring through hydrogen bonding, base stacking, 
hydrophobic and electronic interactions give rise to a super asymmetric species, the 
double helical structure of DNA which has high CD intensity. Due to the polymorphic 
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nature of nucleic acids and numerous secondary structures of DNA, other than the 
conventional B-DNA structure, can be adopted under specific conditions including the 
conformation of interest here, Z-DNA. Due to the differences in interstrand and 
intrastrand base-base interaction, B- and Z-DNA each have a unique ‘signature’ in the 
CD spectrum that can be used to distinguish the two structures. 
The B to Z transition of several oligonucleotides including unmodified and 
modified poly (dCdG) have been investigated by using CD spectrophotometry28,82-84 due 
to the fact that the repeated CG sequences can, relatively easily, assume the Z 
conformation. In general the CD spectrum of B-DNA shows the positive ellipticity at 
approximately 280 nm and 220 nm and a negative ellipticity at approximately 250 nm 
(Figure 2.3). In contrast, the CD spectrum of Z-DNA shows a sharp negative ellipticity at 
approximately 295 nm81. Based on the different CD patterns of B and Z-DNA, the 
conversion of B to Z-DNA can be monitored as demonstrated by Pohl, F.M. and Jovin, 
T.M. in 197282. The study has shown that the conformational change of poly (dCdG) 
from B to Z can be achieved by stabilizing the Z conformation by increasing sodium 
chloride concentration. The transition process is completely reversible since the Z-DNA 
converts back to B-DNA after salt removal. At physiological pH with low salt 
concentration, unmodified oligonucleotides preferentially adopt the B conformation.  Z-
DNA formation can be observed at high salt concentration (more than 2M sodium 
chloride for unmodified oligonucleotides). A reduction of the CD signal at approximately 
295 nm (trough formation) and an increase of CD at approximately 270 nm can be used 
to follow the transition of B to Z-DNA and to quantitate the conversion.   
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To evaluate the effect of the C8-arylguanine adduct on B-Z transition, a series of 
CD spectra of the unmodified and aryl modified CG decamers in pH 7.4 phosphate buffer 
solution with various concentrations of sodium chloride have been collected. The B to Z 
conversion of the oligonucleotides can be observed from the transition of CD spectra as 
explained previously. The CD spectra can be used to quantitate the amount of the Z and 
B forms and thereby the effect of the C8-arylguanine adducts on Z-DNA stabilization 
and/or B-DNA destabilization can be roughly estimated in response to increasing sodium 
chloride concentration that needed for Z-DNA formation. The lower the concentration of 
sodium chloride that is required to cause the B to Z transition of the modified 
oligonucleotides, then, can be related to the higher stabilization effect of the C8-
arylguanine adduct on a Z conformation or destabilization effect on B conformation of 
CG decamer. However, this method is only appropriate for preliminary comparison. A 
Figure 2.3 CD spectra of B-DNA (black) and Z-DNA (red) forms of the duplex CG 
decamer 
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more quantitative method that has been used to evaluate the effect of the aryl adduct on 
B-Z transition is discussed in the next section.        
 
2.4.2. Z-DNA Quantitation 
In order to compare the effect of the C8-arylguanine adduct on B- and Z-DNA 
stability in a more quantitative fashion, molar fractions of B, Z and ssDNA ( fB, fZ, and fss 
respectively) can be calculated from the CD spectra. By quantitating the amount of Z-
DNA in a sample, the Z-DNA stabilization effect of the aryl adducts can be inferred from 
the amount of Z-DNA that forms in the solution. The mathematical estimation of fB, fZ, 
and fss from CD spectra was reported previously by Xodo, L.E. et al.85 and was used in 
this study. The calculation was based on the assumption that there is an equilibrium 
amongst three conformations of the oligonucleotide under study (B, Z, and ss). Therefore, 
at any given wavelength, the total molar ellipticity (Δє) of the oligonucleotide is equal to 
the sum of the molar ellipticities of each conformation, weighted by the molar fraction of 
each species (Equation 2.7). The CD at 295 nm has being selected here to use in the 
calculation, mainly due to the strong CD intensity of the Z conformation relative to the B 
form. The total molar fraction of all conformations equals the summation of fB, fZ, and fss, 
and, therefore, equals 1 (Equation 2.8). 
 
At 295 nm                   Δє295 = ΔєB295*fB + ΔєZ295*fZ + Δєss295*fss                   Equation 2.7 
                                                          1 = fB + fZ + fss                                                     Equation 2.8 
 
However, in practice, the instrument provides the total ellipticity (є), not Δє. Therefore, 
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to make the calculation possible Equation 2.7 has been modified as shown in Equation 
2.9 as shown below. 
 
At 295 nm              CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*CZ)           Equation 2.9 
 
Where CD295 is the observed CD intensity at 295 nm and Css, CB, and Cz are the 
concentrations of ssDNA, B-DNA, and Z-DNA in solution, respectively. To simplify the 
calculation, the path length (b) which is constant at 1 mm for all experiments is left out of 
the equation. The Δє of each conformation can be estimated by assuming under selected 
conditions, most of the oligonucleotides can be driven into a single polymorphic form. At 
temperature as high as 90°C most of dsDNA will be denatured and is in the ssDNA form, 
thus the CD295 signal will be due to only the  ssDNA (CD295 = Δєss295 *Css). Then, Δєss295 
can be solved with the observed CD295 and Css which can be quantitated by UV. With low 
salt concentration at room temperature, B-DNA is expected to be a sole conformation 
present and ΔєB295 can be approximated from CD295 of the sample. By increasing a 
sodium chloride concentration to 2M-4M and cooling the sample to 10°C, the Δє of Z-
DNA can also be estimated the same way as done for the B and ssDNA. With the 
observed CD295 and the estimated molar ellipticities, Css, CB, and CZ are left to be solved. 
Note that Css, CB, and CZ are measurable by UV only when a single conformation exists 
in the sample under controlled conditions. Otherwise, they are considered as variables 
that need to be mathematically calculated. To get CZ, both Css and CB must be determined 
first. 
     The Css can be obtained by the following calculation. At the isosbestic point of 
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dsDNA, the molar absorptivities (Δε) of B and Z-DNA are equal (ΔεB = ΔεZ = Δεds). 
 
Therefore                                  ε270 = εds270*fds + εss270*fss                                   Equation 2.10 
And                                                       1 = fds + fss                                                  Equation 2.11 
 
Similar to CD, the observed UV absorbance (A) has being used in the calculation instead 
of Δε. Hence, Equation 2.10 has been modified to give Equation 2.12. 
 
At 270 nm                              A270 = (εss270*Css) + (εds270*Cds)                        Equation 2.12 
 
Where A270 is the observed UV absorbance at 270 nm and Cds is a concentration of 
dsDNA which equals to CB + CZ. The molar absorptivities of ss- and dsDNA can be 
obtained the same way as the molar ellipticities. At 90°C, εss270 can be estimated while 
εds270 is attained at low temperature. To further solve the calculation, the relationship 
between the concentrations of ssDNA and dsDNA in the sample is must be established. 
The equilibrium between ssDNA and dsDNA is varied based on a given condition, 
however the amount of total DNA is constant. Considering that at low temperature where 
DNA denaturation is minimized, we may assume the total concentration of 
oligonucleotide (Ctotal) as double helix based on the UV measurement. 
 
Therefore                                       Ctotal = (Css/2) + Cds                                                    Equation 2.13 
And                                                Cds = Ctotal – (Css/2)                                   Equation 2.14 
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By replacing Cds in Equation 2.12 with Ctotal – (Css/2) (Equation 2.14) Css can be solved 
from Equation 2.15 (derived below).  
 
                                     A270 = (εss270*Css) + (εds270*(Ctotal – (Css/2))) 
                                     A270 = (εss270*Css) + (εds270*Ctotal) – ((εds270/2)*Css) 
                                     A270 = ((εss270– (εds270/2))*Css) + (εds270*Ctotal)  
                                     A270 – (εds270*Ctotal) = (εss270– (εds270/2))*Css 
                                                   Css = A270 – (εds270*Ctotal)                              Equation 2.15 
                                                              εss270 – (εds270/2) 
 
Equation 2.9 can then be simplified to solve CB by replacing CZ with Cds-CB 
(because Cds = CZ + CB). As a result, CB can be calculated from Equation 2.16 which is 
derived as follows. 
 
                          CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*(Cds - CB)) 
                          CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*Cds) – (ΔєZ295*CB) 
                          CD295 = (Δєss295*Css) + (ΔєZ295*Cds) + (ΔєB295*CB) – (ΔєZ295*CB) 
                          CD295 = (Δєss295*Css) + (ΔєZ295*Cds) + ((ΔєB295 - ΔєZ295)*CB) 
                                       CB = CD295 – (Δєss295*Css) – (ΔєZ295*Cds)                         Equation 2.16 
                                                            ΔєB295 - ΔєZ295 
 
After CB is solved, CZ can then be estimated, and fB, fZ, ,and fss can be obtained 
accordingly. 
The molar fractions of the C8-arylguanine modified oligonucleotides in all three 
conformations have being calculated based on the described method. Measurements were 
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made on DNA samples with a wide range of salt concentrations and temperatures. The 
resulting data from the CD experiments were used to generate a series of conformational 
diagrams which are useful to evaluate and compare the Z-DNA stabilization and B-DNA 
destabilization effects among various C8-arylguanine adducts. Then, comparing under 
the same set of conditions, the molar fractions of Z form of the different synthetic 
modified oligonucleotides can be used to compare the Z-DNA stabilizing effect (or may 
be B-DNA destabilizing effect) of the DNA adducts, given that more stable Z-DNA 
would have higher fZ  which indicates a greater stabilization effect from the C8-
arylguanine adduct. CD spectroscopy has proven to be a useful technique to study the 
conformation and stability of the modified oligonucleotides.    
 
2.5 Nuclear Magnetic Resonance Spectrometry of CG Decamers Containing C8-
Aryl Modified Guanine 
Nuclear magnetic resonance (NMR) is one the most important tools available for 
obtaining structural information of molecules.  NMR has been used in this study to 
characterize synthetic nucleosides and also to determine the conformation of unmodified 
and modified oligonucleotides. Although CD can provide information about the overall 
conformation of an oligonucleotide, it cannot provide information regarding the local 
conformation.  To confirm the results from CD experiments and to obtain a better 
understanding of the B-Z interconversion, several NMR experiments have been 
conducted. The principles of the NMR experiment will be discussed briefly in this section 
along with the NMR methods that have been used to study the B-Z equilibrium of the 
modified oligonucleotides.   
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2.5.1. Basic Theory of NMR86-88 
All nuclei contain electrons that have the property of spin which may generate a 
magnetic dipole along the nuclear axis.  Fundamentally, NMR spectra of the nuclei that 
have a non-zero spin number (I) , can be measured , especially nuclei that have I = ½ 
(e.g. 1H and 13C) due to their uniform spherical charge distribution. Based on quantum 
mechanics, the spin number determines the number of possible orientations (2I +1) of 
nuclei when an external magnetic field is applied. In the case of a nucleus with I=½, there 
are two energy levels possible as shown in Figure 2.4. 
 
 
According to the Boltzmann distribution, the population of the lower energy state nuclei 
(Nα) is slightly greater than the higher energy state population (Nβ). The energy gap (ΔE) 
between the two states is determined by a magnetic field strength (B0) as shown in 
Equation 2.17,  
 
                                                 ΔE = (hγ/2π)B0                                               Equation 2.17 
 
Figure 2.4 Two energy levels of the nuclei with I = 1/2 in a magnetic field strength of B0 
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where h is Plank’s constant and γ is a gyromagnetic ratio which is constant for each 
atomic type of nuclei.  In a static magnetic field, the populations of two energy states are 
established and the application of RF can be used to cause a transition between the two 
states. Given ΔE = hv, the relationship between the applied radio frequency (v) and B0 
can be established as described in the Equation 2.18.  
 
                                                    v = (γ/2π)B0                                                  Equation 2.18    
 
By applying a matching RF at a particular magnetic field strength, nuclei in the lower 
energy state will absorb energy and rise to a higher energy level. The excited nuclei then 
relax back to the original state by radiating the absorbed energy which can be detected 
ultimately and recorded as the NMR spectrum.  
The potential of NMR for structure determination was not recognized until the 
chemical shift effect was discovered in 195387. The chemical shift effect arising from the 
electron cloud associated with nuclei plays a very important role in the observed NMR 
behaviour of other nearby nuclei.  The electron spin of each nucleus generates its own 
local magnetic field that alters the applied magnetic field (B0). Due to the shielding effect 
of the nuclei’s electron cloud that alters the local B0, the effective frequency (veff) is 
decreased as shown in Equation 2.19. A shielding constant (σ) is proportional to the 
degree of shielding by a nuclei electron cloud. The higher veff means less shielding effect 
from the electron cloud and the lower veff indicates more electron shielding effect. 
 
                                                    veff = (γ/2π)B0(1-σ)                                       Equation 2.19 
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Because the chemical environment can affect the electron density of nuclei, identical 
nuclei that are in different environments will have distinctive shielding constants that can 
be recorded by NMR instrumentation and used to differentiate them. As a result, a series 
of absorption peaks, which represent nuclei in different environments, are observed in the 
NMR spectrum. The chemical shifts that are assigned in NMR spectrum indicate the 
absorption position of the nuclei in dissimilar environments compared to the reference 
nuclei. For instance, a hydroxyl proton will have a different chemical shift as compared 
to the protons from tetramethylsilane (TMS). The unit of chemical shift is in Hz which 
can be converted to the ppm unit, typically used for reporting the NMR spectrum.  It is 
derived by dividing the observed frequency of nuclei by the operating frequency (MHz 
range) of the NMR spectrometer. Usually, a simple one dimension (1D) NMR spectrum 
shows a plot of the chemical shifts in ppm against the intensity of the absorption peaks of 
different nuclei. Furthermore, the peak area represents the relative number of each type of 
nuclei in a molecule.  
In addition to chemical shift, spin coupling is an important phenomenon that 
provides additional information regarding chemical structure. The coupling constant (J) 
and multiplicity of the absorption peaks results from spin-spin coupling that can be used 
to assist chemical shift assignment in order to characterize a molecular structure of 
chemical, especially in 1H NMR. An absorption peak of a certain proton can be affected 
by its magnetically active neighboring nuclei that typically are separated by two to three 
bonds. In a magnetic field, the energy states of nuclei are established based on their spin 
number. An NMR active nucleus can interact with nearby nuclei resulting in a 
multiplicity of absorption peaks for the nucleus under consideration. For example, as 
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shown in Figure 2.5, a triplet peak is observed for a proton that has two equivalent 
neighboring protons since the neighboring nuclei have three energy states that produce 
three different microfields. The coupling constant, which can be measured from the 
multiplet, is the separation between the two coupled NMR peaks and can be used to 
determine the relationship between protons (e.g., dihedral angle). 
  
 
 
 
 
 
 
 
 
 
 
A simple first order multiplicity can be used to predict the pattern of proton absorption 
peaks based on the formula n + 1, where n is the number of adjacent protons with the 
same coupling constant. A more general formula, 2nI +1, can be used to cover all nuclei 
(i.e., spin > ½). However, if the coupling is non-first order (non-first order coupling is 
observed when  then Δν/J < 10)  more complicated coupling patterns may be observed. 
Overall, by gathering all of the pieces of information available from the NMR spectrum 
of a compound, including the chemical shifts, coupling constants, and multiplicities of 
Figure 2.5 Triplet generated by neighbor CH2 microfields 
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the absorption peaks, one may use the observed 1H NMR spectrum (and perhaps 
additional spectra obtained on on nuclei other than protons) to assign both structure and 
conformation. 
Because many organic compounds are comprised mainly of a carbon skeleton, 13C 
NMR spectrometry has also been used to characterize the organic chemicals. The basic 
concept of 13C NMR is the same as 1H NMR.  In practice, however, since the spin 
couplings between 13C nuclei are very weak due to the low natural abundance of 13C 
(1.11%), and therefore the likelihood of having two adjacent 13C atoms, necessary to 
observe coupling, is low (12C (~98.89%) is NMR silent). Furthermore, 13C are typically 
obtained with proton decoupling and 13C NMR spectra appear as a series of 13C 
absorption singlets. 
Generally, simple 1D spectra of 1H and 13C NMR may be sufficient to identify a 
simple organic molecule. However, in the case of a more complicated molecule, 
additional NMR experiments may be necessary. Two dimensional (2D) NMR provides 
enhanced capability to elucidate the structure of organic compounds. The correlation 
NMR experiments including COSY (correlation spectroscopy) and HETCOR 
(heteronuclear correlation spectroscopy) have been used extensively in this study to 
characterize the synthesized nucleosides. In addition to COSY, NOESY (nuclear 
Overhauser effect correlation spectroscopy) has been used to study and assign the 
structure of the modified CG decamers and the B-Z DNA equilibrium.  
A proton-proton coupling correlation, 1H-1H COSY, is based on spin couplings 
among protons and therefore reveals connectivity. The diagonal of the correlated 
spectrum corresponds to the normal 1H NMR spectrum (typically displayed along both 
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the vertical and horizontal axes). The off-diagonal elements of a COSY spectrum indicate 
the couplings between protons.  Since the magnitude of coupling constants falls off 
rapidly, the appearance of COSY correlations typically indicates the protons are adjacent.  
Similar to 1H-1H COSY, the 1H -13C COSY or HETCOR shows the correlation between 
13C and 1H spectra. The cross peaks indicate the couplings between carbons and protons 
(and therefore attached protons) that may help identify unknown carbons or protons that 
can not be assigned from normal 1D NMR or assigned only with difficulty. With COSY 
and HETCOR, most protons and carbons of the nucleosides can be assigned. 
Unlike COSY, 2D 1H-1H NOESY experiment utilizes the nuclear Overhauser 
enhancement (nOe) to obtain spectra that are correlated based on a through space 
interaction. To explain nOe, we consider two nuclei that are close in space and involved 
in the relaxation process of each other. If a saturating RF were applied to equalize the 
population of the two energy levels (Nα = Nβ) of one nuclei, the energy state dynamics of 
another nuclei will be affected resulting in the enhancement of integrated signal of the 
nuclei89. The complete mathematical explanation of nOe has been described by Solomon, 
I, 195590. The nOe effect can be observed in 1D 13C NMR. As proton decoupling is 
typically used, the absorption peak intensity of 13C can be increased significantly (up to 
200 %)88. This is a major reason 13C spectra are acquired in the proton-decoupled mode.  
Another implication of nOe, the one that is useful for our conformational study, is that 
because of the nOe effect, NMR experiments can be designed and used to establish the 
spatial relationship between nuclei (e.g., protons) based on the change in absorption 
intensity. The nOe cross peaks in 2D NOESY spectra indicate the spatial separation 
between protons (nearer than approximately 4-5 Å give rise to nOe enhanced peaks) and 
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is due to spin polarization rather than spin coupling. Therefore, NOESY protons are near 
in space, but may also be separated by many intervening bonds. The intensity of the cross 
peak is dependent on the distance (r) between the interacting protons. In fact, the intensity 
enhancement is proportional to the inverse sixth power of the distance between the two 
nuclei (1/r-6)89. By using a combination of NMR experiments (1D, COSY, HETCOR, 
NOESY, etc) the solution structure and conformation of macromolecules, such as nucleic 
acids, can be determined.   
 
2.5.2. NMR Studies on B-Z Transition of DNA 
In 1979, Patel, D.J. et al.91  observed the conformational interconversion between 
two forms for poly(dG-dC) by using NMR. The 1D 1H NMR was used to assign the 
cluster of chemical shifts of H1′, H3′, H5′, H8 of dG, and H5, H6 of dC. The data showed 
that the chemical shift of H1′ of dG increased at high salt concentration, suggesting that 
the glycosidic torsion angle of the purine bases have changed dramatically. The 
observation made by NMR was correlated to the conformational transition that had been 
previously detected by CD. Considering that the chemical shift of H1′ of dG is sensitive 
to glycosidic torsion angle, the NMR data were consistent with a conformation change of 
B-DNA to “alternating B-DNA”, later has been identified as Z-DNA. Although the 
conformational change could be surmised from the simple 1D 1H NMR of the 
oligonucleotides, the structural details could not be determined from the 1D spectrum 
which made full determination of the DNA conformational interconversion difficult to 
investigate. Due to the fact that nucleic acids are composed of nucleotide monomers, they 
contain many protons which have relatively similar chemical environments and hence 
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similar chemical shifts. Therefore, 1D proton NMR of DNA contains a series of 
absorption peaks that are not well resolved from one another and it is nearly impossible 
to assign or distinguish each proton based solely on chemical shift. The 2D correlation 
experiments, including COSY and NOESY, provided the possibility to assign all protons 
of nucleic acids and resulted in a more complete picture of structure and conformation.  
Hence, the 2D NMR experiments can be used to study the tertiary structure of nucleic 
acids, B and Z-DNA in particular.  
For example, the sequential resonance assignment92 based on NOESY and COSY 
experiment has been applied to the non-exchangeable proton assignment of the right 
handed helix of d(TGAGCGG) : d(CCGCTCA). The J-correlated spectroscopy based 
COSY, was used first to assign the thymine H6 and 5-methyl, cytosine H6 and H5, 
deoxyribose H1′, H2′, and H2′′ resonances (see Figure 2.6 for structure of bases and 
nuclei number assignment). The off diagonal cross peaks in 2D nOe spectra link two 
types of protons that are near in space (less than 4 A°) and  have been used to help 
identify the remaining adenine H8, guanine H8,  H3′, H4′, H5′ and H5′′ protons. 
 
 
 
 
 
 
 
 
Figure 2.6 Structures of purine and pyrimidine deoxyribose nucleosides. 
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The nucleotides at 5′ or 3′-ends can serve as a starting point for the assignment due to 
distinctive chemical shift of the terminal bases compared to the same type of base in the 
middle of DNA strand (due to fraying of the ends). Then, the nearest neighbor 
nucleotides93 can be targeted and assigned accordingly. Basically, one can start with a 
terminal base assignment and then use nOe and/or J-correlated cross peaks to assign the 
protons, sequentially, of the remaining bases until the entire sequence has been assigned.  
The structural differences between Z-DNA and B-DNA stem from their distinct 
sugar backbone conformation. In B-DNA, all deoxyriboses are in anti conformation 
while Z-DNA has an alternating syn-anti backbone.  These differences give rise to unique 
NMR spectra, mainly,due to the effect of conformation on the chemical shifts of the H1’ 
protons and also the conformational requirements94-96. In the case of poly d(CG), the 
most notable observation is that the Z conformation displays strong nOe cross peak 
correlations between the guanine H8 and H1′95. This is due to the syn conformation of the 
purine nucleotides that brings the H8 of guanine into close proximity of H1′ of the 
intranucleoside deoxyribose residue (Figure 2.7). On the other hand, B-DNAs show only 
weak or no nOe cross peaks between the guanine H8 and its own H1′. This effect extends 
to C8 modified purines.  For example, C8 methyl guanine containing DNA20,21,97 displays 
strong nOe between methyl protons of the C8-methyl group and H1′. 
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By using a combination of NMR experiments as described above, the chemical 
shifts of protons of the unmodified CG and CG8Ph have been assigned for both the B and 
Z conformation22. The structural information obtained from NMR is in complete 
agreement with the CD data and has confirmed that the C8-phenyl adduct facilitate the B-
Z transition of CG decamers. The same NMR techniques have also been used in this 
research to study the B-Z transition of the rest of the aryl modified CG decamers.  
 
 
 
   
        
 
 
Figure 2.7 Shown are the syn and anti conformations of dG and how the H8 and H1′ 
are in close proximity in the syn conformation but not in the anti conformation. 
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CHAPTER 3 
EXPERIMENTAL PROCEDURES AND RESULTS PART I: SYNTHESIS OF CG 
DECAMERS CONTAINING C8-ARYL MODIFIED GUANINE 
 
Our approach to the study of the effects of the C8-arylguanine adducts on B/Z-
DNA equilibrium, was to prepare aryl modified CG decamers. Z-DNA formation 
generally requires an alternating purine-pyrimidine sequence.  Thus, the modification 
could be incorporated into either an alternating TG or CG sequence.  As it is well known, 
CG sequences are more prone to adopt the Z conformation98, we used this sequence here. 
The aryl adducts selected for incorporation into this sequence were p-substituted (-H, -
CH3, -COO-, -CH2OCH3, and -CH2OH) and were selected because of the availability of 
carcinogenic profiles of the arylhydrazines that lead to their formation. Each adduct was 
introduced in the middle of the CG decamer sequence at C8 position of G6 base and since 
the CG sequences are palindromes, duplexes contain two modified guanines. 
In our previous work22, the C8 phenyl or C8-tolyl adducts, which are needed for 
phosphoramidite synthesis and hence oligonucleotide synthesis, were prepared via a 
Suzuki cross coupling between 8-BrdG and the corresponding aryl boronic acid. The C8-
aryl modified dG phosphoramidites were then prepared by the successive protection of 
the N2 amine, the 5′-OH, and the 3′-OH groups. Finally, the unmodified CG, modified 
oligonucleotides CG8Ph, and CG8Tol were prepared by automated DNA synthesis, 
although the aryl modified bases were coupled by manual addition.   
In the present case, the same basic methods were applied to prepare the modified 
oligonucleotides CG8CPh, CG8MMPh, CG8HMPh as well as the synthesis of the corresponding 
modified phosphoramidites (Scheme 3.1) with one notable exception. The p-
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hydroxymethyl substituent was found to interfere with DNA synthesis. Therefore, the p-
hydroxymethyl was protected with TBS protecting group prior to Suzuki coupling to 
avoid potential side reactions during oligonucleotide synthesis. The TBS group was used 
to protect the hydroxymethyl group because it is stable toward all conditions used to 
prepare the phosphoramidite as well as conditions used for automated DNA synthesis and 
is removed under the same conditions used to remove all other protecting groups (i.e., 
concentrated ammonium hydroxide). Interestingly, although the p-carboxylate can be 
considered to be nucleophilic, the substituent did not interfere with DNA synthesis, hence 
no protection of the carboxyl group was necessary.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.1 Synthesis procedures of C8-arylguanine phosphoramidites a) Suzuki 
coupling, b) N2 protection, c) 5′-OH protection, and d) 3′-OH phosphoramidation 
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3.1 Synthesis of C8-Arylguanine Nucleosides and Phosphoramidites 
3.1.1 General   
All chemicals used were purchased from Aldrich (Milwaukee, WI) unless 
otherwise noted. Both 4-carboxyphenylboronic acid (4-CPBA) and 4-
methoxymethylphenylboronic acid (4-MMPBA) were purchased from Frontier Scientific 
(Logan, Utah). 
With exception for the Suzuki coupling reaction, all other reactions require 
anhydrous conditions. Therefore, organic solvents were dried and distilled prior to use as 
follows. Methanol was dried over molecular sieves (3Å). Methylene chloride was dried 
by distillation from phosphorus pentoxide. TEA, THF, and pyridine were dried and then 
distilled from LAH. Benzene and toluene were dried by distillation from calcium hydride. 
DMF was dried by distillation from barium oxide. 
To identify and characterize the chemical structure of the synthesized nucleosides 
(Structures are shown in Appendix B), NMR spectra were obtained on either Varian 300 
or 600 spectrometers (Palo Alto, CA). 1H NMR and COSY were obtained for proton 
assignment, while 13C NMR, HETCOR, and long range HETCOR were obtained to 
assign carbon nuclei. ESI-MS of the nucleosides, measured in positive ion mode, were 
recorded on a Finnigan LCQdeca (Waltham, MA). UV spectra were obtained on a 
Beckman DU640 spectrophotometer (Somerset, NJ). NMR, UV, and ESI-MS spectra of 
the modified nucleosides can be found in Appendix C. 
 
 
 
 57
3.1.2 Synthesis 
 
8-Bromo-2′-deoxyguanosine, C10H12O4N5Br (1): dG (2.86 g, 10.0 mmol) was 
suspended in the mixture of acetonitrile (100 ml) and water (25 ml) and N-
bromosuccinimide (freshly recrystallized, NBS, 2.67 g, 15.0 mmol) was then added to the 
suspension and the formation of light orange precipitate was then observed. The reaction 
mixture was allowed to stir for 30 min at room temperature. The precipitate was isolated 
by filtration and then suspended in acetone (50 ml). The suspension was stirred for an 
additional 2 h at room temperature, cooled at -20°C overnight, the precipitate collected 
by filtration, and then dried in vacuo to yield 8-BrdG (2.81 g, 8.1 mmole, 81.2% yield). 
 
1H NMR (600 MHz, dmso-d6): δ ppm 10.78 (1H, s, NH), 6.47 (2H, s, NH2), 6.16 (1H, t, 
J = 7.5 Hz, H-1′), 5.23 (1H, d, J = 4.2 Hz, 3′-OH), 4.83 (1H, t, J = 5.7 Hz, 5′-OH), 4.39 
(1H, m, H-3′), 3.80 (1H, m, H-4′), 3.62 and 3.50 (2H, m, H-5′/5″), 3.16 (1H, m, H-2″) 
and 2.10 (1H, m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 155.42, 153.31, 151.97, 
120.50, 117.49, 87.89, 85.06, 71.02, 62.04, and 36.47. 
 
4-(TBS-O-methyl)-phenyl bromide, C13H21OSiBr (2): 4-Bromobenzyl alcohol (756 
mg, 4.0 mmol), TBSCl (1.30 mg, 8.0 mmol), and imidazole (605 mg, 8.8 mmol) were 
dissolved in DMF (10 mL). The reaction mixture was allowed to stir at room temperature 
for 24 hr under argon.  The reaction mixture was then concentrated to dryness using 
rotavap (vacuum pump). The crude product was extracted with hexane (30 mL), washed 
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with water (3 x 30 mL), and the organic layer dried over sodium sulfate to yield 2 (1.08 
g, 3.58 mmol, 89.6%) was then collected by filtration and brought to dryness in vacuo.  
 
1H NMR (600 MHz, dmso-d6): δ ppm 7.46 (2H, d, J = 8.4 Hz, aryl), 7.20 (2H, d, J = 9.0 
Hz, aryl), 4.69 (2H, s, CH2), 0.95 (9H, s, t-butyl), and 0.11 (6H, s, dimethylsilyl). 13C 
NMR (150 MHz, dmso-d6): δ ppm 140.70, 131.49, 127.94, 120.80, 64.55, 26.14, 18.60, 
and -5.02. 
 
4-(TBS-O-methyl)-phenyl boronic acid, C13H23O3BSi (3): The synthesis protocol has 
been adapted based on the previous report by Zheng et al.70 Compound (2) (1 g, 3.3 
mmol) was dissolved in THF (10 mL), toluene (2 mL), and triisopropyl borate (1.1 mL, 
4.7 mmol). The mixture was sparged with nitrogen gas at -78°C (acetone/dry ice bath) for 
30 min and then n-butyl lithium (1.5 M in hexane, 4mL) was gradually added to the 
solution over 2 hr The reaction mixture was quenched with 2M HCl (3.5 mL) in an ice 
bath and stirred for 30 min. Ethyl acetate (5.5 mL) was then added to the reaction flask 
and mixed for an additional 30 min. The organic layer was collected, washed with the 
mixture of 5% sodium bicarbonate solution (5 mL) and sodium chloride (450 mg), and 
concentrated to dryness in vacuo. The crude product was suspended in ACN and the 
precipitate was collected by filtration to yield the aryl boronic acid (3) (300 mg, 1.13 
mmol, 33.7 %).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 8.22 (2H, d, J = 8.4 Hz, aryl), 7.48 (2H, d, J = 7.8 
Hz, aryl), 4.86 (2H, s, CH2), 0.99 (9H, s, t-butyl), and 0.15 (6H, s, dimethylsilyl). 13C 
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NMR (150 MHz, dmso-d6): δ ppm 146.52, 135.90, 133.67, 125.66, 65.19, 26.18, 18.66, 
and -4.98.   
 
8-(4-Carboxyphenyl)-2′-deoxyguanosine, C17H17O6N5 (4): 4-CPBA (183 mg, 1.10 
mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and Na2CO3 (292 mg, 
2.75 mmol) were placed in round bottom flask and purged with argon for 10 min. 
Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again purged with 
argon for an additional 5 min. A mixture of acetonitrile and water (1:2, 10 mL) (sparged 
with argon) was then added to the reaction flask and the reaction mixture then heated at 
80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1 water:methanol, UV 
detection) indicated complete consumption of 8-BrdG.  The reaction mixture was then 
diluted with water (5 mL) and the pH was adjusted to 6 by the dropwise addition of 10 % 
HCl. The precipitate was collected and dried in vacuo to yield the coupled product (320 
mg, 0.83 mmol, 82.6% yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 10.82 (1H, s, NH), 8.07 (2H, d, J = 7.8 Hz, aryl), 
7.80 (2H, d, J = 8.4 Hz, aryl), 6.48 (2H, s, NH2), 6.10 (1H, t, J = 7.2 Hz, H-1′), 5.14 (1H, 
brs, 3′-OH), 4.96 (1H, brs, 5′-OH), 4.34 (1H, m, H-3′), 3.80 (1H, m, H-4′), 3.66 and 3.55 
(2H, m, H-5′/5″), 3.11 (1H, m, H-2″) and 2.05 (1H, ddd, J = 3.0, 6.6, 13.2 Hz, H-2′).13C 
NMR (150 MHz, dmso-d6): δ ppm 166.88, 156.64, 153.20, 152.29, 146.11, 134.33, 
131.36, 129.48, 129.24, 117.42, 87.85, 84.45, 71.00, 61.93, and 36.66. UV: ε227 = 13,745 
cm-1M-1 and ε285 = 18,054 cm-1M-1. MS: m/z for MW 387.35, calculated MH+ 388.35, 
found 388, 410 (M+Na)+, 426 (M+K)+, 775 (2M+H)+,and 797 (2M+Na)+. 
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8-(4-Methoxymethylphenyl)-2′-deoxyguanosine, C18H21O5N5 (5): 4-MMPBA (183 
mg, 1.10 mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and Na2CO3 
(292 mg, 2.75 mmol) were placed in round bottom flask and purged with argon for 10 
min. Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again purged with 
argon for an additional 5 min. A mixture of acetonitrile and water (1:2, 10 mL) (sparged 
with argon) was then added to the reaction flask and the reaction mixture then heated at 
80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1 water:methanol, UV 
detection) indicated complete consumption of 8-BrdG.  The reaction mixture was then 
diluted with water (5 mL) and the pH was adjusted to 6 by the dropwise addition of 10 % 
HCl. The precipitate was collected and dried in vacuo to yield the coupled product (260 
mg, 0.67 mmol, 67.1% yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 10.76 (1H, s, NH), 7.63 (2H, d, J = 8.4 Hz, aryl), 
7.47 (2H, d, J = 7.8 Hz, aryl), 6.39 (2H, s, NH2), 6.07 (1H, dt, J = 1.8, 7.5 Hz, H-1′), 5.12 
(1H, d, J = 4.2 Hz, 3′-OH), 4.97 (1H, t, J = 5.7 Hz, 5′-OH), 4.49 (2H, s, CH2), 4.33 (1H, 
m, H-3′), 3.79 (1H, m, H-4′), 3.65 and 3.54 (2H, m, H-5′/5″), 3.34 (3H, s, OCH3 ), 3.15 
(1H, m, H-2″) and 2.02 (1H, m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 156.63, 
152.97, 151.95, 146.92, 139.69, 129.37, 129.05, 127.48, 117.13, 87.84, 84.58, 73.14, 
71.15, 62.07, 57.71, and 36.55. UV: ε221 = 9,377 cm-1M-1 and ε282 = 15,552 cm-1M-1. MS: 
m/z for MW 387.40, calculated MH+ 388.40, found 411 (M+Na)+ and 798 (2M+Na)+. 
 
8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine, C23H33O5N5Si  (6): Compound (3) 
(293 mg, 1.10 mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and 
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Na2CO3 (292 mg, 2.75 mmol) were placed in round bottom flask and purged, with argon, 
for 10 min. Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again 
purged with argon for an additional 5 min. A mixture of acetonitrile and water (1:1, 10 
mL) (sparged with argon) was then added to the reaction flask and the reaction mixture 
then heated at 80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1 
water:methanol, UV detection) indicated complete consumption of 8-BrdG.  The reaction 
mixture was then diluted with water (5 mL). Unlike the previous coupling reaction, the 
pH of reaction mixture was not adjusted. The precipitate was collected, washed with 
water and ethyl acetate respectively, and then dried in vacuo to yield the coupled product 
(350 mg, 0.72 mmol, 71.8% yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 10.78 (1H, s, NH), 7.62 (2H, d, J = 8.4 Hz, aryl), 
7.46 (2H, d, J = 8.4 Hz, aryl), 6.39 (2H, s, NH2), 6.06 (1H, t, J = 7.5 Hz, H-1′), 5.12 (1H, 
d, J = 3.6 Hz, 3′-OH), 4.96 (1H, m, 5′-OH), 4.80 (2H, s, CH2), 4.34 (1H, m, H-3′), 3.79 
(1H, m, H-4′), 3.65 and 3.55 (2H, m, H-5′/5″), 3.16 (1H, m, H-2″), 2.02 (1H, m, H-2′), 
0.93 (9H, s, t-butyl), and 0.11 (6H, s, dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ 
ppm 156.71, 153.00, 151.91, 147.00, 142.54, 129.00, 128.86, 125.99, 117.13, 87.87, 
84.65, 71.20, 63.90, 62.12, 36.56, 25.83, 18.01, and -5.33. UV: ε281 = 15,285 cm-1M-1. 
MS: m/z for MW 487.63, calculated MH+ 488.63, found 488, 510 (M+Na)+, 526 (M+K)+, 
975 (2M+H)+, and 997 (2M+Na)+. 
 
N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine, 
C20H22O6N6 (7): Compound (4) (387 mg, 1.00 mmol) was dissolved in methanol (10 
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mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and 
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature. 
The reaction mixture was then concentrated to dryness in vacuo to yield product (7) (423 
mg, 0.95 mmole, 95.7 % yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 8.53 (1H, s, HC=N), 8.02 (2H, d, J = 8.4 Hz, aryl), 
7.64 (2H, d, J = 8.4 Hz, aryl), 6.14 (1H, t, J = 7.2 Hz, H-1′), 4.45 (1H, m, H-3′), 3.82 (1H, 
m, H-4′), 3.68 and 3.58 (2H, m, H-5′/5″), 3.18 (1H, m, H-2″), 3.16 and 3.05 (3H each, s, 
N(CH3)2), and 2.10 (1H, ddd, J = 3.0, 6.6, 13.2 Hz, H-2′).13C NMR (150 MHz, dmso-d6): 
δ ppm 169.17, 158.12, 156.82, 150.75, 147.98, 138.74, 131.22, 129.13, 128.46, 120.21, 
87.67, 84.71, 70.95, 61.94, 40.79, 37.08, 34.58, and 34.13. UV: ε231 = 17,153 cm-1M-1 
and ε318 = 20,164 cm-1M-1. MS: m/z for MW 442.43, calculated MH+ 443.43, found 443, 
465 (M+Na)+, 488 (M+2Na)+, 885 (2M+H)+, and 907 (2M+Na)+. 
 
N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-deoxyguanosine, 
C21H26O5N6 (8): Compound (5) (387 mg, 1.00 mmol) was dissolved in methanol (10 
mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and 
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature. 
The reaction mixture was concentrated down close to dryness using a Rotavap follow by 
the addition of water (2 ml). After filtration, the precipitate was dried in vacuo to yield 
product (8) (388 mg, 0.88 mmole, 87.6 % yield). 
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1H NMR (600 MHz, dmso-d6): δ ppm 11.45 (1H, s, NH), 8.51 (1H, s, HC=N), 7.64 (2H, 
d, J = 8.4 Hz, aryl), 7.49 (2H, d, J = 7.8 Hz, aryl), 6.12 (1H, t, J = 7.2 Hz, H-1′), 5.21 
(1H, d, J = 4.2 Hz, 3′-OH), 4.88 (1H, dt, J = 1.8, 6.0 Hz, 5′-OH), 4.50 (2H, s, CH2), 4.44 
(1H, m, H-3′), 3.82 (1H, m, H-4′), 3.68 and 3.57 (2H, m, H-5′/5″), 3.34 (3H, s, OCH3 ), 
3.22 (1H, m, H-2″), 3.16 and 3.05 (3H each, s, N(CH3)2), and 2.08 (1H, m, H-2′).13C 
NMR (150 MHz, dmso-d6): δ ppm 158.10, 157.48, 156.81, 150.67, 147.92, 139.86, 
129.19, 129.08, 127.56, 120.17, 87.70, 84.81, 73.13, 71.03, 61.99, 57.72, 40.78, 37.03, 
and 34.57. UV: ε229 = 14,602 cm-1M-1 and ε314 = 20,834 cm-1M-1. MS: m/z for MW 
442.47, calculated MH+ 443.47, found 443, 466 (M+Na)+, and 908 (2M+Na)+. 
 
N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine, 
C26H38O5N6Si (9): Compound (6) (488 mg, 1.00 mmol) was dissolved in methanol (10 
mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and 
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature. 
The reaction mixture was concentrated to near dryness using Rotavap follow by the 
addition of water (2 ml). After filtration, the precipitate was dried in vacuo to yield 
product (9) (419 mg, 0.77 mmole, 77.3 % yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 11.42 (1H, s, NH), 8.51 (1H, s, HC=N), 7.63 (2H, 
d, J = 7.8 Hz, aryl), 7.48 (2H, d, J = 7.8 Hz, aryl), 6.11 (1H, t, J = 7.2 Hz, H-1′), 5.20 
(1H, d, J = 2.4 Hz, 3′-OH), 4.88 (1H, m, 5′-OH), 4.81 (2H, s, CH2), 4.44 (1H, m, H-3′), 
3.82 (1H, m, H-4′), 3.67 and 3.57 (2H, m, H-5′/5″), 3.22 (1H, m, H-2″), 3.16 and 3.05 
(3H each, s, N(CH3)2), 2.08 (1H, m, H-2′), 0.93 (9H, s, t-butyl), and 0.12 (6H, s, 
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dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ ppm 158.07, 157.46, 156.77, 150.62, 
148.01, 142.70, 129.02, 128.67, 126.03, 120.15, 87.70, 84.83, 71.04, 63.88, 62.01, 40.76, 
37.03, 34.56, 25.82, 18.00, and -5.35. UV: ε229 = 21,603 cm-1M-1 and ε313 = 28,129 cm-
1M-1. MS: m/z for MW 542.71, calculated MH+ 543.71, found 543, 565 (M+Na)+, 1085 
(2M)+, and 1107 (2M+Na)+. 
 
5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-carboxyphenyl)-2′-
deoxyguanosine, C41H40O8N6 (10): Compound (7) (442 mg, 1.00 mmol) and DMTr-Cl 
(1 g, 2.80 mmol) were dissolved in pyridine (10 mL) and then TEA (430 µL, 3.08 mmol) 
was added. The reaction mixture was stirred at room temperature, under argon, for 1 h. 
The reaction was quenched by the addition of methanol (10 mL) and solvents then 
removed in vacuo. The crude product was resuspended in methylene chloride (100 mL) 
and stored at -20°C for 24 hr. The precipitate was collected and dried again in vacuo to 
yield the DMTr protected product (10) (230 mg, 0.31 mmole, 30.9 % yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 8.32 (1H, s, HC=N), 8.05 (2H, d, J = 7.8, aryl), 
7.83 (2H, d, J = 8.4, aryl), 7.32-6.73 (13H, m, DMTr-H), 6.20 (1H, dd, J = 4.8, 7.8, H-1′), 
4.57 (1H, m, H-3′), 3.93 (1H, m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.30 and 3.15 
(2H, m, H-5′/5″), 3.21 (1H, m, H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), and 2.20 (1H, 
m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 157.93, 157.86, 157.59, 157.50, 156.44, 
150.54, 147.53, 144.92, 135.67, 135.58, 129.59, 129.41, 129.31, 128.95, 127.62, 127.56, 
126.48, 120.28, 112.93, 112.90, 85.71, 85.18, 84.05, 70.82, 63.99, 54.93, 54.89, 40.74, 
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37.44, 34.60, and 34.18. UV: ε233 = 43,258 cm-1M-1 and ε322 = 27,453 cm-1M-1. MS: m/z 
for MW 744.80, calculated MH+ 745.80, found 745, 767 (M+Na)+, and 1511 (2M+Na)+. 
 
5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-
deoxyguanosine C42H44O7N6 (11): Compound (8) (442 mg, 1.00 mmol) and DMTr-Cl 
(535 mg, 1.50 mmol) were dissolved in pyridine (10 mL) and then TEA (229 µL, 1.65 
mmol) was added. The reaction mixture was stirred at room temperature, under argon, 
and was monitored by normal phase TLC (aluminum oxide, 6 % methanol in methylene 
chloride) until the complete consumption of (8) was observed. In addition, an ethanolic 
solution of phosphomolybdic acid (10%) was used on the developed TLC plate to 
visualize the production of (11). Upon completion of the reaction or after 4 hr, the 
reaction was quenched by the addition of methanol (10 mL) and solvents removed in 
vacuo. The crude product was then purified by low pressure column chromatography 
(aluminum oxide, 0-10% methanol in methylene chloride) to yield the DMTr protected 
product (11) (406 mg, 0.55 mmole, 54.5 % yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 11.42 (1H, s, NH), 8.31 (1H, s, HC=N), 7.74 (2H, 
d, J = 8.4, aryl), 7.46 (2H, d, J = 8.4, aryl), 7.33-6.73 (13H, m, DMTr-H), 6.17 (1H, dt, J 
= 3.0, 6.6, H-1′), 5.28 (1H, d, J = 4.8 Hz, 3′-OH),  4.57 (1H, m, H-3′), 4.50 (2H, s, CH2), 
3.92 (1H, m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.35 (3H, s, CH3), 3.30 and 3.15 
(2H, m, H-5′/5″), 3.20 (1H, m, H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), and 2.18 (1H, 
m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 157.94, 157.87, 157.52, 156.31, 150.41, 
148.05, 144.94, 139.75, 135.70, 135.59, 129.61, 129.42, 129.12, 127.62, 127.57, 127.50, 
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126.48, 120.07, 112.94, 112.91, 85.72, 85.18, 84.02, 73.14, 70.87, 64.04, 57.68, 54.94, 
54.90, 40.72, 37.37, and 34.59. UV: ε231 = 35,034 cm-1M-1 and ε319 = 23,448 cm-1M-1. 
MS: m/z for MW 744.85, calculated MH+ 745.85, found 746, 768 (M+Na)+, 784 (M+K)+, 
and 1512 (2M+Na)+. 
 
5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-
deoxyguanosine, C47H56O7N6Si (12): Compound (9) (442 mg, 1.00 mmol) and DMTr-
Cl (535 mg, 1.50 mmol) were dissolved in pyridine (10 mL) and then TEA (229 µL, 1.65 
mmol) was added. The reaction mixture was stirred at room temperature, under argon, 
and was monitored by normal phase TLC (aluminum oxide, 6 % methanol in methylene 
chloride) until the complete consumption of (9) was observed. An ethanolic solution of 
phosphomolybdic acid (10%) was used on the developed TLC plate to visualize the 
production of (12). Upon completion of the reaction or after 4 hr, the reaction was 
quenched by the addition of methanol (10 mL) and solvents then removed in vacuo. The 
crude product was then purified by low pressure column chromatography (aluminum 
oxide, 0-10% methanol in methylene chloride) to yield the DMTr protected product (12) 
(350 mg, 0.41 mmole, 41.4 % yield).  
 
1H NMR (600 MHz, dmso-d6): δ ppm 11.41 (1H, s, NH), 8.31 (1H, s, HC=N), 7.74 (2H, 
d, J = 8.4, aryl), 7.46 (2H, d, J = 7.8, aryl), 7.33-6.73 (13H, m, DMTr-H), 6.17 (1H, m, 
H-1′), 5.28 (1H, d, J = 4.8 Hz, 3′-OH), 4.81 (2H, s, CH2), 4.57 (1H, m, H-3′),  3.93 (1H, 
m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.32 and 3.15 (2H, m, H-5′/5″), 3.21 (1H, m, 
H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), 2.18 (1H, m, H-2′), 0.94 (9H, s, t-butyl), and 
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0.12 (6H, s, dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ ppm 157.93, 157.86, 
157.51, 156.27, 150.38, 148.16, 144.94, 142.61, 135.68, 135.59, 129.61, 129.41, 129.07, 
128.93, 127.62, 127.56, 126.47, 125.97, 120.04, 113.09, 112.93, 112.89, 85.70, 85.17, 
84.00, 70.86, 64.03, 63.89, 54.92, 54.89, 40.72, 37.37, 34.58, 25.81, 17.99, and -5.36. 
UV: ε231 = 39,719 cm-1M-1 and ε316 = 22,703 cm-1M-1. MS: m/z for MW 845.08, 
calculated MH+ 846.08, found 845, 867 (M+Na)+, and 1712 (2M+Na)+. 
 
3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N 
dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine, C50H57O9N8P (13): 
Compound (10) (0.25 mmol) was dissolved in methylene chloride (2.5 mL) and then 
TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl 
diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction 
mixture for 30 min at room temperature, another portion of 2-cyanoethyl 
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture 
and then stirred for an additional 30 min. The crude reaction was dried in vacuo. The 
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered 
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite 
(13) that is ready to use for DNA synthesis. 
 
3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N 
dimethylformamidine)-8-(4-methoxymethylaryl)-2′-deoxyguanosine, C51H61O8N8P 
(14): Compound (11) (0.25 mmol) was dissolved in methylene chloride (2.5 mL) and 
then TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl 
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diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction 
mixture for 30 min at room temperature, another portion of 2-cyanoethyl 
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture 
and then stirred for an additional 30 min. The crude reaction was dried in vacuo. The 
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered 
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite 
(14) for DNA synthesis. 
 
3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N 
dimethylformamidine)-8-(4-(TBS-O-methyl)aryl)-2′-deoxyguanosine, 
C56H73O8N8SiP (15): Compound (12) (0.25 mmol) was dissolved in methylene chloride 
(2.5 mL) and then TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl 
diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction 
mixture for 30 min at room temperature, another portion of 2-cyanoethyl 
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture 
and then stirred an for additional 30 min. The crude reaction was dried in vacuo. The 
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered 
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite 
(15) that is ready to use for DNA synthesis. 
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3.2 Synthesis of CG Decamers Containing C8-Aryl Modified Guanine 
3.2.1 General 
The oligonucleotides CG8CPh, CG8MMPh, and CG8HMPh were made on ABI 394 
DNA synthesizer (Newark, CA). The reagents used for automated DNA synthesis, 
including phosphoramidites (dG CE-PA and dC CE-PA), phosphoramidite diluent 
(anhydrous ACN), activator (0.45M tetrazole in ACN), cap mix A (THF/pyridine/acetic 
anhydride), cap mix B (16% 1-methylimidazole in THF), oxidizing solution (0.02M I2 in 
THF/pyridine/water), deblocking mix (3% TCA in methelene chloride), and dG-CPG 
synthesis column (1 μmol, 500Å pore size), were purchased from Glen Research 
(Sterling, VA). In addition, the anhydrous acetonitrile used with the DNA synthesizer 
was purchased from VWR (West Chester, PA).  
To purify the synthesized oligonucleotides, the following FPLC system has been 
used. Anion exchange columns (DEAE-5PW) were purchased from Tosoh Bioscience 
(Montgomeryville, PA). Waters U6K loop injector, HPLC pump model 510 or 501, and 
Waters 486 tunable absorbance detector (Milford, MA) were used for the 
chromatography. Sep Pak C18 cartridges for solid phase extraction used to desalt the 
DNA sample were bought from VWR (West Chester, PA). The amount of DNA in 
synthesized samples were quantified by UV measurement at 260 nm on a Beckman 
DU640 spectrophotometer (Somerset, NJ) and assumed that a 1 mL solution with an 
absorbance of 1 OD at 260 nm contained 24 μg of oligonucleotide duplex. ESI-MS 
spectra of the purified oligonucleotides, obtained in negative ion mode, were recorded on 
a Finnigan LCQdeca (Waltham, MA).  
 
 70
3.2.2 Synthesis 
The modified oligonucleotides were made on an automated DNA synthesizer 
through solid phase synthesis on 1 µmol scale column. Fresh reagents were used to 
maximize the efficiency of the reactions. The base extensions started from the 3′ end 
through the 5′ end of 5′-CGCGCG*CGC-3′ sequences while the dG phosphoramidite 
from the dG-CPG synthesis column served as a first 3′-base. Generally, the synthesis 
utilized the standard protocol (1.0 µM CE cycle) for automated DNA synthesis which 
includes detritylation, coupling, capping and oxidation. The efficiency of each base 
extension can be monitored from the trityl group (as the alcohol) that is cleaved just 
before the addition of the next base. In order to make the aryl modified oligonucleotides, 
the G6 coupling was performed manually with the C8-aryl modified guanine 
phosphoramidites (compounds (13), (14), or (15) to yield CG8CPh, CG8MMPh, or CG8HMPh 
respectively).  Manual addition of the modified bases was required because these 
phosphoramidites form gels in acetonitrile within minutes of initial dissolution. After 
detritylation of C7 (the 3rd base from 3′end) the automated synthesis was stopped and the 
synthesis column, sealed at both ends to minimize air and moisture exposure, was 
removed from the DNA synthesizer. The C8-aryl modified dG phosphoramidite (25-30 
mg or approximately 25 µmol) was dissolved immediately prior to use in anhydrous 
ACN (100 µL) and transferred to the synthesis column through a 1 mL syringe. The 
activator solution (100 µL) was then added to the synthesis column through another 1 mL 
syringe. Both phosphoramidite solution and activator solution were mixed through the 
synthesis column and the reaction mixture was allowed to stay in the column for 15 min. 
After that, the reaction mixture was removed from the column and a fresh solution of the 
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coupling reaction mixture was then added and allowed to stay in the column for an 
additional 15 min to maximize the efficiency of modified base extension. After removing 
the reaction mixture, the synthesis column was reattached to the DNA synthesizer. The 
automated synthesis cycle was then resumed after programming to skip the G6 coupling 
and pass to the capping step. The DNA synthesis was continued normally after the 
manual coupling of C8-aryl G6 until the CG decamer sequence has been completely 
extended.  
Following the completion of DNA synthesis, the oligonucleotides were cleaved 
off the synthesis column. Ammonium hydroxide (30%, 0.3 mL) was transferred by using 
a syringe and allowed to stay on the column for 20 min. Two additional fresh fractions of 
ammonium hydroxide were added to the synthesis column in the same fashion as the first 
one to ensure complete removal of the oligonucleotides from the column. The 
synthesized oligonucleotides, in ammonium hydroxide, were then collected from the 
column, transferred to a centrifuge tube, and deprotected by heating at 55°C overnight. 
After cooling to room temperature, the solution was brought to dryness in SpeedVac to 
yield the crude C8-arylguanine modified CG decamer. 
 
3.2.3 FPLC Purification 
Generally, the crude oligonucleotide sample contains unwanted products, 
including incomplete extended sequences and residual protecting groups. Therefore, 
purification by FPLC is necessary to get a pure oligonucleotide for further experiments. 
The crude oligonucleotides (0.3-0.4 µmol) were dissolved in deionized (DI) water (250 
µL) and were purified by FPLC using a gradient of 70-30% buffer A (10 mM NaOH) and 
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buffer B (30-70% 10 mM NaOH and 1 M NaCl) at a flow rate 6 mL/min on a Biorad 
TSK gel DEAE-5PW preparative column (21.5 mm ID x 15 cm). The separation of the 
oligonucleotides was monitored by UV detector at 260 nm and the mobile phase fractions 
from the major peaks on the chromatogram were collected due to the likelihood that the 
desirable DNA sequence is often the major product which gives the highest absorbance.    
The fractions collected from FPLC have high salt concentration. Thus, a C18 Sep 
Pak was used to desalt the oligonucleotide sample. A solid phase extraction started by 
using a syringe to purge methanol (3 x 2ml) and water (3 x 2 ml) through the C18 
cartridge respectively. The product fraction from FPLC was then slowly infused through 
the cartridge. At this point, the oligonucleotide would adsorb to the C18 matrices while 
the salt will pass through with solvent. Water (4 x 2mL) was later used to wash the 
remaining salts out of the cartridge. The oligonucleotide was collected from the cartridge 
after eluting with aqueous methanol (60% methanol, 4 x 1.5 mL). The solvent was 
removed in a SpeedVac to yield a pure oligonucleotide sample. 
To confirm that the purity of oligonucleotide after chromatography and desalting, 
the sample has been analyzed using FPLC. The oligonucleotides sample (approximately 
10 µM in DI water) was run with FPLC using a gradient of 70-30% buffer A (10 mM 
NaOH) and buffer B (30-70% 10 mM NaOH and 1 M NaCl) at a flow rate 1 mL/min on a 
Biorad TSK gel DEAE-5PW analytical column (5.0 mm ID x 5 cm). To eliminate the 
false result that a single peak is composed of more than one product, which may occur 
due to the binding of single-stranded oligonucleotides, the sample was heated at 90°C for 
30 min to denature all DNA into single strand. The chromatogram obtained at 260 nm, 
that displayed a single peak, indicates that the sample contained only one oligonucleotide 
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which was successfully purified. The observed retention time of CG8CPh, CG8MMPh, and 
CG8HMPh is 21.9, 17.7, and 25.3 min respectively as shown in the chromatograms in 
Figure 3.1, 3.2, and 3.3. 
 
 
 
Figure 3.1 FPLC chromatogram of CG8CPh 
Figure 3.2 FPLC chromatogram of CG8MMPh
Figure 3.3 FPLC chromatogram of CG8HMPh
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3.2.4 ESI-MS Analysis  
The purified CG decamers were examined by ESI-MS in negative ion mode to 
confirm that we have obtained the desired modified oligonucleotides based on their MW. 
The oligonucleotide sample (10 µM in DI water) was analyzed on a Finnigan LCQ deca 
using direct injection through a syringe pump. Due to the nature of oligonucleotides that 
have negatively charged phosphate backbones at physiological pH, the m/z of 
oligonucleotides are best detected when operating in the negative ion mode. The series of 
m/z peaks, based on charge state (e.g., M6-, M5-, M4-, and M3-) of the oligonucleotides 
with different number of sodium adducts are, generally observed. The observed m/z of 
CG8CPh, CG8MMPh, and CG8HMPh were in agreement with the calculated m/z of the DNA as 
shown in Table 3.1. The result from ESI-MS indicates that the synthesized DNA have 
been successfully made and ready for structural and conformational analysis. The mass 
spectra of CG8CPh, CG8MMPh, and CG8HMPh can be found in Appendix C. 
 
 
Table 3.1 ESI-MS analysis for the synthesized oligonucleotides  
 
DNA MW (g/mol) Calculated m/z Found m/z 
CG8CPh 3150 524.0a, 629.0b, 786.5c, 1049.0d 524.7, 629.8, 786.9, 1049.3
CG8MMPh 3150 524.0, 629.0, 786.5, 1049.0 524.0, 629.2, 786.8, 1049.1
CG8HMPh 3136 521.7, 626.2, 783.0, 1044.3 626.5, 783.4, 1044.5 
    
   a Charge state M6- 
   b Charge state M5- 
   c Charge state M4- 
   d Charge state M3- 
 
The C8-carboxyphenyl, methoxymethylphenyl, and TBS protected 
hydroxymethylphenyl dG phosphoramidites have been made and characterized by NMR, 
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ESI-MS, and UV analysis. The Suzuki cross coupling was proven to be a convenient and 
efficient method to make C8-arylguanine adducts. The general protocol for making 
phosphoramidites that was developed for preparing the C8-phenyl and C8-tolyl modified 
dG seems to be generally applicable for other derivatives with minor alterations due to 
the small distinctions in physicochemical properties of the modified dG when different 
para-substituents were presented. For instance, the coupling between 8-BrdG and a 
relatively hydrophobic TBS protected 4-HMPBA required more content of ACN in 
Suzuki coupling solvent system compares to the syntheses of other aryl modified dG in 
this study. Use lower ACN content results in a precipitation of (3) and a very low 
production of the coupling product.       
The N2 protection has been shown to be a straight forward step and gives 
excellent yields (70-90%) for all derivatives without the need for further purification, The 
5′-OH protection step has usually resulted in lower yields and requires a purification step. 
Normal phase column chromatography (Al2O3, gradient 0-7% methanol in 
dichloromethane) were used to separate 5′-OH protection products with the exception of 
the C8-carboxyphenyl derivative, compound (10), which was found to be difficult to 
separate with the chromatographic conditions successfully used with compounds (11) and 
(12). Crystallization in dichloromethane seems to be a more practical alternative to purify 
compound (10), although the product yield was low.     
The phosphoramidites were made successfully and the modified DNA, CG8CPh, 
CG8MMPh, and CG8HMPh, have been synthesized. As with phosphoramidites of the C8-
phenyl and tolyl, the phosphoramidites prepared here form gels shortly after dissolving in 
ACN. This property necessitates manual addition of the modified base. We do not know 
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the exact nature of the gels formed though G-quartet formation is a reasonable 
possibilitity. After FPLC purification, ESI-MS was used to identify the oligonucleotides 
based on their MW. The result from ESI-MS indicates the success of CG8CPh, CG8MMPh, 
and CG8HMPh syntheses. 
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CHAPTER 4 
EXPERIMENTAL PROCEDURES AND RESULTS PART II: CD AND NMR 
ANALYSES OF CG DECAMERS CONTAINING C8-ARYL MODIFIED 
GUANINE 
 
In previous work we demonstrated that the incorporation of a C8-phenylguanine 
adduct in a CG sequence stabilizes the Z DNA form and/or destabilizes the B-DNA 
form22.  Additional C8-arylguanine adducts had also been examined by molecular 
modeling and free energy calculations99. The results of the computational methods were 
in agreement with the experimental results that were available (e.g., unmodified and C8-
phenyl adduct). However, the computational results and predictions for some aryl 
hydrazine related C8-adducts were not consistent with the proposed theory that Z DNA is 
involved in aryl hydrazine carcinogenesis (e.g., C8-hydroxymethylphenyl adduct). 
Therefore, to determine whether the results from prior computational studies, were 
correct, the CG decamers, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh, were prepared and 
analyzed by CD and NMR  
Circular dichroism is a useful tool for the study of B and Z DNA as the spectra 
can be used to demonstrate the presence of these forms of DNA both qualitatively and 
quantitatively. Here, we have used CD data to determine the molar fractions of B-DNA, 
Z-DNA, and ssDNA of C8-arylguanine modified oligonucleotides as a function of 
temperature and salt concentration. These data permit the comparison of the effects of the 
selected aryl adducts on Z-DNA stabilization/B-DNA destabilization in a quantitative 
fashion and provides insight in the nature and extent of the Z-DNA stabilization/B-DNA 
destabilization aryl adducts produce. Ultimately, the goal is to determine, how the aryl 
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adducts facilitate B-Z conversion, how they stabilize the Z DNA form and/or how they 
destabilize the B form.  In addition, the carcinogenic profiles and B-Z-DNA transition 
effects of the selected aryl hydrazines can be correlated and evaluated, hence the potential 
role of the Z form in carcinogenesis can be assessed. 
All CG sequences used in this study have been examined with CD and NMR 
analysis. The conformation of CG decamers can be assumed from CD spectra, while the 
B-Z conversion can be observed by the change in pattern of the spectra. The proton NMR 
experiments provide useful pieces of information regarding DNA conformation that have 
proven to be useful to identify DNA conformation and support CD data.  
 
4.1 CD Analysis and Molar Fraction Calculation of CG Decamers Containing C8-
Aryl Modified Guanine 
4.1.1 General 
The oligonucleotide samples (50 µM of CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh or 
CG8HMPh in 10 mM phosphate buffer, pH 7.4, 300 µL) with various sodium chloride 
concentrations (0, 25, 50, 100, 200, 500, 1000, 2000, and 4000 mM) were prepared in a 
centrifuge tube. Prior to acquiring CD spectra, oligonucleotide samples were annealed by 
heating at 90°C for 30 min, slowly cooling down to room temperature, and then further 
cooled to 4°C for and additional 15 min. A sample was transferred to cuvette and CD 
spectra were obtained using a Jasco J-810 spectropolarimeter (Easton, MD). 
From the CD results, the molar fractions of B, Z and ssDNA, over the temperature 
range 10-90°C and with NaCl concentrations from 0-4000 mM, were calculated as 
described previously in Section 2.4.2 
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4.1.2 CD Measurment 
The CD spectra of each modified CG decamer sample was recorded from 220 to 
350 nm at 10, 20, 30, 37, 50, 60, 70, 80, and 90°C using the instruments 
temperature/wavelength scan mode with the temperature ramp rate of 1°C/min and a scan 
rate of 50 nm/min. The data reported are the averages of two duplicate experiments. 
 The tertiary structure of DNA such as B and Z-DNA can be distinguished by CD. 
The CD signal of B DNA shows positive ellipticity at approximately 280 nm and 220 nm 
and a negative ellipticity at approximately 250 nm. In contrast, the CD spectrum Z-DNA 
shows negative ellipticity at approximately 295 nm. The CD spectra of CG and aryl 
modified CG, as a function of NaCl concentrations from 0-4000 mM at 37°C, are shown 
in Figure 4.1-4.6. Generally, at low salt concentration, the alternating CG sequences 
adopt a B-DNA conformation, while under high salt conditions a conformational 
conversion for B to Z can be observed. The conversion of B to Z-DNA can be monitored 
by the change in CD spectra. The negative ellipticipy observed at 295 nm increases in 
intensity while, simultaneously, the negative ellipticity at 250 nm decreases in intensity 
as the B-DNA converts to Z-DNA.  
 In agreement with previous studies of CG oligomers82, the unmodified CG 
decamer predominantly adopts the B conformation at salt concentrations below 2 M, as 
indicated by the positive ellipticity at 280 nm and negative ellipticity at approximately 
250 nm (Figure 4.1). At 2 M NaCl, there is only a small amount of the Z form observed 
and as the salt concentration is further increase to 4 M, the Z-DNA becomes predominant 
(i.e., the positive ellipticity at 280 nm is replaced by negative ellipticity peak at 295 nm). 
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Figure 4.1 CD spectra of CG with NaCl 0-4000 mM at 37°C 
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Figure 4.2 CD spectra of CG8Ph with NaCl 0-4000 mM at 37°C 
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 Figure 4.3 CD spectra of CG
8Tol with NaCl 0-4000 mM at 37°C 
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 Figure 4.4 CD spectra of CG8CPh with NaCl 0-4000 mM at 37°C 
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Figure 4.5 CD spectra of CG8MMPh with NaCl 0-4000 mM at 37°C 
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Figure 4.6 CD spectra of CG8HMPh with NaCl 0-4000 mM at 37°C 
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The CD spectra of CG8Ph (Figure 4.2), CG8MMPh (Figure 4.5), and CG8HMPh (Figure 4.6), 
show that the Z form is predominant (B-Z conversion greater than 50%) in samples that 
have salt concentration of approximately 500 mM, considerably less than the 2 M salt 
concentration required for the unmodified oligonucleotide. The modified CG decamers 
are approximately 100% in the Z conformation at 1 M salt concentrations as indicated by 
CD spectra. Based on the lower concentration of sodium chloride needed to stabilize the 
Z comformation of CG8Ph, CG8MMPh, and CG8HMPh as compared to the unmodified CG, 
indicates Z-DNA stabilization and/or B-DNA destabilization effects of C8-phenyl, 
methoxymethylphenyl, hydroxymethylphenyl guanine adducts. 
 The effect of C8-tolyl guanine adduct on Z-DNA formation seem to be lower 
since CG8Tol (Figure 4.3) requires 500 mM to 1 M salt to facilitate B-Z conversion and 
requires approximately 2 M NaCl to make the Z-DNA form predominant. On the other 
hand, the C8-carboxyphenyl guanine adduct seems to have the greatest effect on Z-DNA 
formation, due to the fact that the B-Z conversion of CG8CPh (Figure 4.4) is observed at 
very low salt concentration (25- 50 mM) and the oligonucleotide requires only 200 mM 
salt to entirely adopt in Z conformation. 
 Generally, the C8-arylguanine modified CG decamers principally adopt the Z 
form at salt concentrations below 1 M, much lower that what is needed for the 
unmodified CG, indicating the Z-DNA stabilization and/or B-DNA destabilization effects 
of the aryl adducts on CG decamer sequences. Among the aryl adducts, p-carboxyphenyl 
has the greatest effect while tolyl has the lowest compare with phenyl, p-
methoxymethylphenyl, and p-hydroxymethylphenyl which have comparable effects on Z-
DNA stabilization. To compare the effect of each aryl adduct on Z-DNA formation, the 
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molar fraction of Z-DNA in each sample has been determined as described in the next 
part. 
 
4.1.3 Molar Fraction Calculation 
 CD spectra were analyzed assuming that there is equilibrium among three 
conformation of DNA (B, Z, and ssDNA) in solution. Therefore, at each temperature 
 
                               Δє295 = ΔєB295*fB + ΔєZ295*fZ + Δєss295*fss                               Equation 3.1 
                                                     1 = fB + fZ + fss                                                                Equation 3.2 
 
 While f is the molar fraction of each DNA conformation, Δє of each conformation 
was estimated from CD at 295 nm. At 270 nm, the isosbestic point of dsDNA forms and 
where Δε of B and Z are equal, fss was determined from the Equations 3.3 and 3.4. The fB 
and fZ then were solved from the calculated fss, Equation 3.1, and 3.2.  
 
                                          Δε270 = Δεds270*fds + Δεss270*fss                                           Equation 3.3 
                                                         1 = fds + fss                                                                    Equation 3.4 
 
 Generally, for each oligonucleotide, Δεds270 was obtained and averaged from UV 
absorbance at 270 nm from all samples at 10°C where DNA denaturation is minimized, 
while Δεss270 was obtained the same way but at 90°C assuming that all DNA are in single 
strand form. Molar ellipticities of B-DNA, Z-DNA and ssDNA are estimated from CD at 
295 nm under conditions such that only one conformation of DNA is predominant. At 
30°C, without or with low salt ΔєB295, was obtained, while at 10°C with high salt 
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concentration ΔєZ295 was calculated. The Δєss295 was estimated from CD295 of the DNA 
samples at 90°C. 
 The fB, fZ, and fss of CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh were 
approximated and are shown in Tables 4.1 through 4.6, respectively. From the calculated 
data, the conformation diagrams, that represent the molar fractions of each DNA 
conformation as a function of temperatures and sodium chloride concentration, have been 
plotted and are shown in Figures 4.7- 4.12 for CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh and 
CG8HMPh, respectively. The diagrams are consistent with the known behavior of DNA 
where B-DNA predominates at low salt concentration or higher temperatures and Z-DNA 
formation is favored at lower temperatures and higher salt concentrations.  Raising the 
temperature too high, of course, causes DNA denaturation and results in the formation of 
ssDNA. 
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Table 4.1 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG with salt 0-4000 mM at 
temperature 10-90°C  
 
fB at Temperature (°C) NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.99 0.96 0.93 0.90 0.74 0.52 0.24 0.12 0.00 
25 0.98 0.99 0.99 0.98 0.92 0.78 0.44 0.16 0.00 
50 0.98 0.98 0.98 0.96 0.92 0.83 0.54 0.20 0.00 
100 0.99 0.97 0.95 0.94 0.90 0.83 0.60 0.22 0.00 
200 0.98 0.99 0.99 0.98 0.96 0.90 0.69 0.28 0.00 
500 0.97 0.98 0.99 0.99 0.96 0.91 0.73 0.34 0.00 
1000 0.96 0.96 0.96 0.95 0.91 0.84 0.67 0.31 0.00 
2000 0.72 0.80 0.86 0.88 0.88 0.79 0.64 0.24 0.00 
4000 0.00 0.07 0.16 0.22 0.34 0.40 0.34 0.13 0.00 
          
fZ at Temperature (°C) NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
200 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
1000 0.04 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.00 
2000 0.28 0.18 0.12 0.09 0.05 0.01 0.00 0.00 0.00 
4000 1.00 0.89 0.77 0.68 0.51 0.36 0.17 0.03 0.00 
          
fss at Temperature (°C) NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0  0.04 0.07 0.10 0.26 0.48 0.76 0.88 1.00 
25 0.00 0.00 0.01 0.02 0.08 0.22 0.56 0.84 1.00 
50 0.00 0.00 0.02 0.04 0.08 0.17 0.46 0.80 1.00 
100 0.00 0.03 0.05 0.06 0.10 0.17 0.40 0.78 1.00 
200 0.00 0.00 0.01 0.02 0.04 0.10 0.31 0.72 1.00 
500 0.00 0.00 0.00 0.01 0.04 0.09 0.27 0.66 1.00 
1000 0.00 0.01 0.03 0.04 0.09 0.16 0.33 0.69 1.00 
2000 0.00 0.02 0.02 0.03 0.08 0.20 0.36 0.76 1.00 
4000 0.00 0.04 0.07 0.10 0.15 0.24 0.49 0.84 1.00 
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Figure 4.7 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG over 
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium 
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM 
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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Table 4.2 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Ph with salt 0-4000 
mM at temperature 10-90°C  
 
fB at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.98 0.96 0.96 0.96 0.92 0.79 0.54 0.25 0.00 
25 0.77 0.85 0.89 0.88 0.85 0.75 0.54 0.27 0.00 
50 0.85 0.90 0.97 0.96 0.94 0.84 0.61 0.30 0.00 
100 0.65 0.68 0.85 0.88 0.83 0.73 0.53 0.25 0.00 
200 0.32 0.36 0.65 0.77 0.76 0.69 0.48 0.23 0.00 
500 0.01 0.06 0.24 0.38 0.59 0.58 0.42 0.21 0.00 
1000 0.00 0.01 0.10 0.19 0.41 0.49 0.38 0.17 0.00 
2000 0.00 0.04 0.09 0.14 0.25 0.35 0.29 0.12 0.00 
4000 0.04 0.11 0.16 0.19 0.24 0.26 0.20 0.08 0.00 
          
fZ at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.23 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.15 0.10 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.35 0.32 0.05 0.00 0.00 0.00 0.00 0.00 0.00 
200 0.68 0.64 0.24 0.08 0.00 0.00 0.00 0.00 0.00 
500 0.99 0.89 0.63 0.42 0.07 0.00 0.00 0.00 0.00 
1000 1.00 0.98 0.85 0.72 0.35 0.09 0.00 0.00 0.00 
2000 1.00 0.96 0.90 0.84 0.65 0.38 0.10 0.02 0.00 
4000 0.96 0.89 0.83 0.79 0.69 0.54 0.27 0.06 0.00 
          
 fss at Temperature (°C) NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.04 0.04 0.04 0.08 0.21 0.46 0.75 1.00 
25 0.00 0.10 0.11 0.12 0.15 0.25 0.46 0.73 1.00 
50 0.00 0.00 0.02 0.04 0.06 0.16 0.39 0.69 1.00 
100 0.00 0.01 0.11 0.12 0.17 0.27 0.47 0.75 1.00 
200 0.00 0.00 0.10 0.15 0.24 0.31 0.52 0.77 1.00 
500 0.00 0.05 0.13 0.20 0.33 0.42 0.58 0.79 1.00 
1000 0.00 0.01 0.04 0.08 0.24 0.42 0.62 0.82 1.00 
2000 0.00 0.00 0.01 0.02 0.11 0.27 0.61 0.86 1.00 
4000 0.00 0.00 0.02 0.02 0.07 0.20 0.53 0.86 1.00 
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Figure 4.8 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Ph over 
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium 
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM 
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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Table 4.3 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Tol with salt 0-4000 
mM at temperature 10-90°C 
 
fB at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.98 0.95 0.94 0.93 0.81 0.67 0.42 0.22 0.00 
25 0.94 0.97 0.92 0.81 0.62 0.43 0.34 0.24 0.00 
50 0.71 0.84 0.87 0.89 0.86 0.78 0.58 0.30 0.00 
100 0.37 0.67 0.76 0.75 0.66 0.70 0.53 0.27 0.00 
200 0.16 0.46 0.71 0.75 0.75 0.68 0.53 0.26 0.00 
500 0.04 0.18 0.44 0.59 0.67 0.61 0.46 0.22 0.00 
1000 0.00 0.03 0.20 0.34 0.55 0.56 0.42 0.20 0.00 
2000 0.00 0.02 0.09 0.16 0.33 0.41 0.33 0.15 0.00 
4000 0.00 0.04 0.10 0.14 0.20 0.24 0.20 0.09 0.00 
          
fZ at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.06 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.29 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.63 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
200 0.84 0.38 0.04 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.96 0.75 0.36 0.14 0.00 0.00 0.00 0.00 0.00 
1000 1.00 0.93 0.70 0.49 0.12 0.00 0.00 0.00 0.00 
2000 1.00 0.96 0.86 0.76 0.47 0.19 0.03 0.02 0.00 
4000 1.00 0.94 0.87 0.82 0.67 0.46 0.18 0.05 0.00 
          
 fss at Temperature (°C) NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.05 0.06 0.07 0.19 0.33 0.58 0.78 1.00 
25 0.00 0.01 0.08 0.19 0.38 0.57 0.66 0.76 1.00 
50 0.00 0.12 0.13 0.11 0.14 0.22 0.42 0.70 1.00 
100 0.00 0.17 0.24 0.25 0.34 0.30 0.47 0.73 1.00 
200 0.00 0.16 0.26 0.25 0.25 0.32 0.47 0.74 1.00 
500 0.00 0.07 0.20 0.27 0.33 0.39 0.54 0.78 1.00 
1000 0.00 0.04 0.10 0.17 0.33 0.44 0.58 0.80 1.00 
2000 0.00 0.03 0.05 0.08 0.20 0.41 0.64 0.83 1.00 
4000 0.00 0.02 0.02 0.04 0.13 0.30 0.62 0.86 1.00 
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Figure 4.9 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Tol over 
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium 
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM 
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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Table 4.4 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8CPh with salt 0-4000 
mM at temperature 10-90°C 
 
 fB at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.32 0.45 0.71 0.71 0.61 0.44 0.23 0.08 0.00 
25 0.24 0.31 0.62 0.70 0.61 0.47 0.25 0.09 0.00 
50 0.11 0.16 0.39 0.53 0.56 0.44 0.26 0.11 0.00 
100 0.00 0.05 0.21 0.35 0.51 0.42 0.25 0.11 0.00 
200 0.01 0.04 0.12 0.20 0.40 0.44 0.30 0.13 0.00 
500 0.00 0.02 0.06 0.10 0.22 0.31 0.27 0.13 0.00 
1000 0.00 0.02 0.05 0.08 0.14 0.21 0.21 0.12 0.00 
2000 0.06 0.07 0.09 0.11 0.15 0.17 0.16 0.09 0.00 
4000 0.09 0.12 0.14 0.16 0.18 0.19 0.16 0.07 0.00 
          
 fZ at Temperature (°C)   NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.68 0.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.76 0.69 0.22 0.05 0.00 0.00 0.00 0.01 0.00 
50 0.89 0.79 0.39 0.16 0.00 0.00 0.00 0.00 0.00 
100 1.00 0.89 0.61 0.39 0.04 0.00 0.00 0.00 0.00 
200 0.99 0.92 0.77 0.63 0.24 0.03 0.00 0.00 0.00 
500 1.00 0.94 0.85 0.79 0.54 0.25 0.04 0.01 0.00 
1000 1.00 0.94 0.86 0.81 0.65 0.42 0.14 0.03 0.00 
2000 0.94 0.87 0.81 0.77 0.66 0.51 0.25 0.05 0.00 
4000 0.91 0.83 0.76 0.71 0.63 0.54 0.35 0.10 0.00 
          
  fss at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.12 0.29 0.29 0.39 0.56 0.77 0.92 1.00 
25 0.00 0.00 0.16 0.25 0.39 0.53 0.75 0.90 1.00 
50 0.00 0.06 0.22 0.31 0.44 0.56 0.74 0.89 1.00 
100 0.00 0.07 0.18 0.27 0.46 0.58 0.75 0.89 1.00 
200 0.00 0.04 0.11 0.17 0.35 0.53 0.70 0.86 1.00 
500 0.00 0.04 0.09 0.12 0.24 0.45 0.69 0.85 1.00 
1000 0.00 0.05 0.09 0.11 0.20 0.37 0.65 0.85 1.00 
2000 0.00 0.06 0.11 0.12 0.19 0.32 0.59 0.86 1.00 
4000 0.00 0.05 0.10 0.12 0.19 0.27 0.49 0.82 1.00 
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Figure 4.10 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8CPh 
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM 
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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Table 4.5 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8MMPh with salt 0-4000 
mM at temperature 10-90°C 
 
 fB at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.96 0.93 0.94 0.95 0.92 0.80 0.56 0.25 0.00 
25 0.96 0.93 0.91 0.97 0.95 0.84 0.61 0.29 0.00 
50 0.78 0.86 0.91 0.92 0.90 0.81 0.60 0.30 0.00 
100 0.31 0.55 0.77 0.79 0.77 0.66 0.50 0.24 0.00 
200 0.24 0.37 0.65 0.74 0.75 0.67 0.49 0.25 0.00 
500 0.04 0.10 0.30 0.45 0.64 0.62 0.45 0.22 0.00 
1000 0.00 0.01 0.11 0.21 0.45 0.50 0.39 0.18 0.00 
2000 0.00 0.03 0.08 0.12 0.25 0.32 0.30 0.14 0.00 
4000 0.01 0.07 0.11 0.14 0.17 0.20 0.17 0.07 0.00 
          
  fZ at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.22 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.69 0.33 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
200 0.76 0.58 0.17 0.04 0.00 0.00 0.00 0.00 0.00 
500 0.96 0.87 0.58 0.36 0.05 0.00 0.00 0.00 0.00 
1000 1.00 0.96 0.81 0.67 0.31 0.07 0.00 0.00 0.00 
2000 1.00 0.95 0.88 0.80 0.60 0.33 0.09 0.03 0.00 
4000 0.99 0.90 0.83 0.77 0.66 0.51 0.26 0.07 0.00 
          
  fss at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.07 0.06 0.05 0.08 0.20 0.44 0.75 1.00 
25 0.00 0.05 0.09 0.03 0.05 0.16 0.39 0.71 1.00 
50 0.00 0.05 0.09 0.08 0.10 0.19 0.40 0.70 1.00 
100 0.00 0.11 0.21 0.21 0.23 0.34 0.50 0.76 1.00 
200 0.00 0.06 0.18 0.22 0.25 0.33 0.51 0.75 1.00 
500 0.00 0.03 0.12 0.18 0.31 0.38 0.55 0.78 1.00 
1000 0.00 0.03 0.08 0.12 0.24 0.43 0.61 0.82 1.00 
2000 0.00 0.02 0.04 0.07 0.16 0.36 0.61 0.84 1.00 
4000 0.00 0.03 0.05 0.09 0.17 0.29 0.57 0.86 1.00 
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Figure 4.11 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8MMPh 
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM 
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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Table 4.6 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8HMPh with salt 0-4000 
mM at temperature 10-90°C 
 
fB at Temperature (°C)   NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 1.00 0.97 0.96 0.94 0.85 0.74 0.51 0.23 0.00 
25 0.94 0.94 0.94 0.93 0.85 0.70 0.48 0.20 0.00 
50 0.91 0.92 0.91 0.91 0.83 0.71 0.47 0.23 0.00 
100 0.65 0.71 0.82 0.86 0.72 0.58 0.37 0.12 0.00 
200 0.28 0.35 0.59 0.61 0.56 0.49 0.36 0.15 0.00 
500 0.02 0.09 0.30 0.41 0.49 0.41 0.38 0.21 0.00 
1000 0.00 0.02 0.13 0.23 0.47 0.48 0.36 0.18 0.00 
2000 0.00 0.02 0.05 0.11 0.21 0.31 0.28 0.12 0.00 
4000 0.04 0.10 0.15 0.18 0.23 0.24 0.21 0.08 0.00 
          
fZ at Temperature (°C)   NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.06 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.09 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.35 0.25 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
200 0.72 0.55 0.12 0.02 0.00 0.00 0.00 0.00 0.00 
500 0.98 0.90 0.58 0.34 0.03 0.00 0.00 0.00 0.00 
1000 1.00 0.97 0.82 0.67 0.27 0.06 0.00 0.00 0.00 
2000 1.00 0.95 0.88 0.80 0.60 0.33 0.09 0.02 0.00 
4000 0.96 0.90 0.84 0.80 0.68 0.52 0.24 0.06 0.00 
          
 fss at Temperature (°C)  NaCl 
(mM) 10 20 30 37 50 60 70 80 90 
0 0.00 0.03 0.04 0.06 0.15 0.26 0.49 0.77 1.00 
25 0.00 0.03 0.06 0.07 0.15 0.30 0.52 0.80 1.00 
50 0.00 0.03 0.09 0.09 0.17 0.29 0.53 0.77 1.00 
100 0.00 0.04 0.15 0.14 0.28 0.42 0.63 0.88 1.00 
200 0.00 0.10 0.29 0.37 0.44 0.51 0.64 0.85 1.00 
500 0.00 0.01 0.12 0.26 0.48 0.59 0.62 0.79 1.00 
1000 0.00 0.00 0.05 0.10 0.25 0.45 0.64 0.82 1.00 
2000 0.00 0.03 0.07 0.09 0.19 0.36 0.63 0.85 1.00 
4000 0.00 0.00 0.01 0.02 0.08 0.24 0.55 0.86 1.00 
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Figure 4.12 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8HMPh 
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM 
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl. 
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 The CD spectra of the unmodified and modified CG decamers indicate that the 
aryl adducts formed from carcinogenic aryl hydrazines stabilize Z-DNA conformation 
and/or destabilize B-DNA relative to the unmodified oligonucleotide.   
 To quantitatively compare the B-Z transition effect among aryl adducts, the molar 
fraction of Z-DNA in various salt concentrations at different temperatures have been 
calculated from the CD data and are plotted in Figure 4.13, fZ of CG, CG8Ph, CG8Tol, 
CG8CPh, CG8MMPh and CG8HMPh as a function of salt concentration at 37°C.  By 
extrapolating from the plot, to obtain 50% Z-DNA, the unmodified CG needs 3400 mM 
salt while CG8Ph, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh require 606 mM, 1000 mM, 131 
mM, 669 mM, and 694 mM sodium chloride respectively. Based on these data, the B-Z 
transition effect of aryl adduct is ranked in the order of p-carboxyphenyl >> phenyl > p-
methoxymethylphenyl > p-hydroxymethylphenyl >> p-tolyl >> unmodified 
 As can be seen, the mole fractions of B forms (Figure 4.14) roughly mirror the Z 
forms. B-DNA is predominant at lower salt concentration, while the main conformation 
in high salt sample is Z-DNA.  Interestingly, at lower salt concentrations spikes of 
ssDNA formation (Figure 4.15) are seen for the modified oligonucleotides. The intensity 
of spikes is varied depending on the substituents on aryl adduct. This suggests that, in 
addition to stabilizing Z-DNA at higher salt concentration, the aryl adduct destabilizes 
the B form at salt concentrations less than that at which the spike occurs. This study 
indicates the dual effect of aryl adduct on B and Z-DNA which drives B-Z conversion. 
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Figure 4.13 Molar fractions of Z-DNA of the unmodified and aryl modified CG 
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM 
Figure 4.14 Molar fractions of B-DNA of the unmodified and aryl modified CG 
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM 
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4.2 NMR Analysis of CG Decamers Containing C8-Aryl Modified Guanine 
CD is a powerful method for determining and monitoring the global 
conformational of DNA but can not provide information regarding the finer details of 
local conformation (e.g., of base-pairs).  Information regarding local conformation can be 
obtained from NMR studies.  NMR has been extensively used to study and determine the 
conformation(s) of nucleic acids and has relied upon two-dimensional correlation 
spectroscopic techniques.  Overall, the technique requires the assignment of non-
exchangeable proton of the synthesized oligonucleotides which is possible with the 
combined data from COSY and NOESY experiments as described by Scheek R.M. et al. 
and Orbons L.P.M. et al.  In prior studies, we successfully used the assignment procedure 
to assign the non-exchangeable protons of CG in B form and CG8Ph in Z form22.  Though 
Figure 4.15 Molar fractions of ssDNA of the unmodified and aryl modified CG  
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM 
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there are potential difficulties - suitable spectra of the Z form of CG cannot not be 
obtained due to line-broadening cause by the high salt concentration or due to spectral 
complexity caused by the presence of multiple forms of DNA - the method has been 
shown to be sufficient to characterize the B and Z conformations of nucleic acids and we 
have applied it to determine the conformation of CG8CPh, CG8HMPh, and CG8MMPh. 
 
4.2.1 General 
Deuterated phosphate buffer for NMR was prepared by drying down a known 
volume of phosphate buffer (10 mM, pH 7.4, 500 µL) in vacuo (SpeedVac) and then 
adding back an equal volume of deuterium oxide (D2O, 99.996%, 500 µL).  The resulting 
solution was then evaporated and this process repeated three times.  The solid deuterated 
buffer salt was kept dry in cool place and was reconstituted in D2O just prior to use. 
The oligonucleotide sample (0.8 mM of CG8CPh, CG8MMPh or CG8HMPh) was 
prepared in deuterated phosphate buffer (10 mM, pD 7.4, 500 µL) with or without NaCl 
(500 mM) and the sample solution was transferred into Shigemi NMR tube. High salt 
concentration was used to ensure that the Z conformation of the CG decamer was 
predominant in a sample. From CD data of CG8CPh, CG8MMPh or CG8HMPh with 500 mM 
NaCl recorded at 30°C, the amount of Z conformation of each oligonucleotide was more 
than 60% which would greatly simplify the proton assignment of Z-DNA. Without NaCl, 
oligonucleotides are generally in B form. 
All NMR spectra were measured on a Varian Unity 600 MHz spectrometer at 
28°C. The 1H NMR spectra of the oligonucleotides were obtained with solvent (D2O) 
suppression.  Sample concentrations were approximately 0.8 mM (10 mM, pD 7.4, 500 
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µL, Shigemi NMR tube was used to improve S/N) and required approximately 16 
transients to obtain spectra with sufficiently high signal-to-noise. The 1H-1H COSY 
spectra were collected with 512 t1 increments and 2048 t2 complex points, each the sum of 
16 transients. The proton nOe correlation spectra (NOESY) of the non-exchangeable 
protons were collected with a mixing time of 600 ms. The data were collected with 512 t1 
increments and 2048 t2 complex points, each with the sum of 16 transients. Spectral 
assignments were made as described in the following sections for the B and Z DNA 
forms of CG8CPh, CG8MMPh or CG8HMPh. 
        
4.2.2 B-DNA Non-exchangeable Proton Assignment 
In order to assign the non-exchangeable protons of the modified CG decamer 
duplexes in the B form, several types of NMR experiments are required including 1H 
NMR, COSY, and NOESY. Basically, the 1-D proton spectrum gives a general idea of 
whether ss or ds DNA is present and may also provide some information regarding the 
DNA form (i.e., B or Z DNA). The non-exchangeable protons of DNA are typically 
observed in the range of 0-9 ppm. The downfield region contains base protons including 
H8 (δ 8.0-8.3 ppm) of guanines, H6 (δ 7.4-7.6 ppm), and H5 (δ 5.5-6.0 ppm) of cytosines 
are usually seperate well for CG at low salt concentration.  In the present case, the aryl 
adduct protons (δ 6.3-7.3 ppm) are also included in this region.  The sugar protons are 
upfield of the base protons and, for a given type of sugar proton, generally exhibit poor 
dispersion resulting in several clusters of unresolved peaks. Thus, to make specific 
assignments requires 2-D NMR techniques. 
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COSY data is used for the assignment of both base and sugar protons.  In the case 
of the base protons, only the cytosine H5/H6 protons can be assigned as no other base 
bears protons that are adjacent to one another. Here, the COSY spectra also can be used 
to assign the protons of the C8-aryl group (the protons that are ortho- and meta- to the 
carbon attached to the modified guanine G6). In addition, the H-1′/H-2′/2′′ cross peaks 
are fairly easy to assign by COSY, mainly because they often have a relatively broad 
chemical shift range.  However, the assignment of the base or sugar protons to specific 
residues in an oligonucleotide can not be achieved using 1-D or COSY data alone and 
requires inclusion of NOESY spectra. 
The connection between base protons and sugar protons in the same nucleoside 
residue can be determined from NOESY spectra due to close spatial proximities between 
the proton nuclei. The nOe cross peaks of Aryl/H-1′, Aryl/H-2′/2′′, H8/H-1′, H8/H-2′/2′′, 
H6/H5, H6/H-1′, and H6/H-2′/2′′ in the same nucleotide subunit are usually observed in 
the spectra. To assign protons in and to successive bases, the connections between 
adjacent bases are first located. As described in the proton assignment for d(CGC)2 in the 
B form by Orbons L.P.M. et al.95, nOe cross peaks between H8 of G(n) and H6, H-1′, or 
H2′/2′′ of C(n-1) were observed as well as nOes between H8, H-1′, or H2′/2′′ of G(n) and 
H6 or H5 of C(n+1). Thus, by locating these nOe correlations they can be used as 
connecting points and, in turn, for assignment of protons to specific bases.   
Figure 4.16 shows a diagram that schematically shows the nOe correlations that 
are generally used for protons assignment for oligonucleotides in the B-DNA 
conformation and, in particular, for a B-DNA of CG decamer. The C1 residue can often 
be used as the starting point because of its distinct H6 chemical shift that is the furthest 
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downfield as compared to the remaining cytosines (due to base-pair fraying). Then, given 
this assignment, the NOESY spectrum is used to identify H8 of G2 (C1-H-1′ and/or H-
2′/2′′ correlation with G2-H8) and, in turn, G2-H-2′/H2′′ (G2-H8 correlation with G2-H-
1′/2′/2′′). With G2-H-1′/2′/2′′ assigned, C3-H6, and in turn C3-H-1′/2′/2′′ can be assigned. 
Continuing this process leads to assignment of all G-H8 and C-H6 protons and the H-
1′/2′/2′′ of the attached deoxyribose. The protons of modified G6 are also quite easy to 
assign due to correlations with the unique aryl protons present in the DNA adduct. 
Finally, the H-3′, H-4′, and H5′/5′′ assignments of each base are possible by following the 
nOes and J-correlation cross peaks in NOESY and COSY spectra from the H-2′/2′′ 
protons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 Diagram shows proton assignment strategy for B-form of CG decamers 
based on nOe correlations observed in NOESY spectra 
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To demonstrate the assignment procedure, the assignment of the non-
exchangeable protons of CG8HMPh will be described.  The analysis begins with 
examination of 1H NMR spectrum from δ5.4-8.3 ppm, shown in Figure 4.17. The four 
furthest downfield singlets were assigned to the H8 protons of the four unique guanines 
(δ8.33, 8.093, 8.089, and 8.05 ppm). Next, the cluster of neighboring upfield doublets 
should be the proton resonances for the five unique cytosine H6 protons (δ7.75, 7.62, 
7.52, 7.50, and 6.53 ppm). The doublets at 7.09 and 6.37 were assigned to the aryl 
protons of G6 adduct based on their chemical shifts, and integration of about two protons 
which distinguishes these doublets from H6 of cytosine. 
 
 
 
 
 
 
 
 
 
The COSY spectra support our assignment on the chemical shifts of H8, H6, and 
aryl protons. The 8.33, 8.093, 8.089, and 8.05 ppm peaks (Figure 4.18a) do not have any 
cross peaks with any other protons, confirming that these peaks were G-H8 protons. The 
peaks at 7.75, 7.62, 7.52, 7.50, and 6.53 ppm correlated to peaks at 6.03, 5.56, 5.50, 5.54, 
and 5.58 ppm, respectively, and arise from the J correlations between H6 and H5 (Figure 
Figure 4.17 1H NMR spectrum of B-CG8HMPh (downfield region).  The resonances 
corresponding to H8, H6, and aryl adduct protons are noted below the frequency axis. 
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4.18b). As expected, the doublet at 7.09 ppm has a correltion with the peak at 6.37 ppm 
(Figure 4.18c) verifying that they are adjacent protons on the aryl adduct. In addition, H-
1′/H-2′/2′′ correlations were observed as shown in Figure 4.18d. Between 5.6 and 6.5 
ppm, ten H-1′ peaks (δ5.72, 5.89, 5.91, 5.97, 6.03, 6.13, 6.19, 6.26, 6.27, and 6.43 ppm) 
were identified based on the criteria that these peaks had at least one correlation with 
peak in the region below 3 ppm which usually is the region of H-2′/2′′. Most chemical 
shifts of H-2′/2′′ were identified from H-1′/H-2′/2′′ cross peaks. Next step were to assign 
H-1′/2′/2′′ to their corresponding H8, H6/H5, or aryl protons in sequential order. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 COSY of B-CG8HMPh The boxed areas show a) H8, b) H6/H5, c) Ar/Ar, 
and d) H-1′/H-2′/2′′ cross peaks. 
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Due to the close spatial proximity (generally from 3-5 Å based on molecular 
modeling) between H-1′ and H8, H6, or aryl protons in the same nucleotide residue, the 
nOe cross peaks of H8/H-1′, H6/H-1′, and aryl/H-1′ can be observed in NOESY spectra. 
Therefore, H-1′ chemical shifts can be matched up with H8 or H6 from the same bases in 
NOESY as shown in Figure 4.19. The assignment of H-2′/2′′ from COSY can be 
confirmed using NOESY in similar way to H-1′ since these protons usually are close 
enough to have nOes with H8 or H6 in the same residue. As a result, the correlations of 
H8, H6, or aryl Æ H-1′ Æ H-2′/2′′ were obtained including 6.53 Æ 5.97 Æ 2.20, 0.57 
ppm, 7.09/6.37 Æ 5.72 Æ 3.68, 2.40 ppm, 7.50 Æ 5.89 Æ 2.43, 2.07 ppm, 7.52 Æ 6.43 
Æ 2.25, 1.59 ppm, 7.62 Æ 6.27 Æ 2.69 ppm, 7.75 Æ 5.91 Æ 2.53, 2.11 ppm, 8.05 Æ 
6.26 Æ 2.72, 2.46 ppm, 8.089 Æ 6.19 Æ 2.73 ppm, 8.093 Æ 6.13 Æ 2.95, 2.78 ppm, and 
8.33 Æ 6.03 Æ 2.88, 2.75 ppm. 
 
 
 
 
 
 
 
 
 
 
      Figure 4.19 NOESY of B-CG8HMPh.  The areas shows a) H8/H-1′, b) H6/H-1′, c) and 
Ar/H-1′ correlations. 
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To assign the chemical shifts in sequential order, we began with the peak at 7.75 
ppm which was assigned to C1-H6 due to its most downfield position among H6. The 
C1-H-2′/2′′ (2.53, 2.11 ppm) were then used to assign G2-H8 (8.093 ppm) based on the 
observed nOe correlations. Likewise, G2-H-2′/2′′ (2.95, 2.78 ppm) were correlated with 
C3-H6 (7.62 ppm). In addition, G2-H-1′ (6.13 ppm) was also correlated with C3-H6. 
Although C3-H-2′/2′′ (2.69 ppm) was not correlated with any H8, C3 can be linked to G4 
with a weak nOe from C3-H5 and G4-H8 (8.089 ppm) which allowed the further 
assignments of C5-H6 (6.52 ppm) through nOe with G4-H-1′/H-2′/2′′ (6.19 and 2.73 
ppm). The C5-H5 (5.50 ppm) has found to be correlated with aryl protons (6.37 ppm) of 
G6 adduct. Both G6-Ar and G6-H-1′ then correlated with C7-H6 (7.52 ppm). The nOe 
correlations between base(n)-H2′/2′′ and base(n-1)-H8 or H6 simply allowed the 
assignments of G8-H8 (8.33 ppm), C9-H6 (7.50 ppm), G10-H8 (8.05 ppm) and their 
corresponding H-1′ and H-2′/H-2′′. The uninterrupted assignment validated a previous 
assumption that the chemical shift of C1-H6 was 7.75 ppm.  If the assignment was 
incorrect, an uninterrupted path would not have been observed. The NOESY in Figure 
4.20 (left) shows nOe cross peaks that used for the proton assignment which are 
schematically shown in the diagram on the right.  
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Because H-2′/2′′ of each base has been identified, the H-3′ protons can be 
assigned based mainly on the COSY data and with a little help from the NOESY data. 
Due to their three bond separation, J-correlation between H-2′/2′′ and H-3′ were observed 
in the COSY spectrum (Figure 4.21) and used to assign H-3′ of C1 through G10 (4.81, 
5.11, 5.08, 5.27, 4.73, 4.94, 5.01, 5.10, 4.95, and 4.78 ppm, respectively).  
 
 
 
 
Figure 4.20 NOESY (left) of B-CG8HMPh shows nOe correlations (right, a-q) that used 
in sequential proton assignment.  
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Once H-3′ were assigned, H-4′ and H-5′/5′′ can be obtained by simultaneous use 
of the NOESY and COSY spectra in the spectral regions shown in Figure 4.22. Based on 
the NOESY data, H-4′ and H-5′/5′′ were determined from their intra-nucleotide cross 
peaks with H-3′, Note that nOes between H-4′ or H-5′/5′′ and H-3′ of a neighboring base 
is insignificant or can be ruled out because of their weaker cross peak intensities (more 
spatial separation between nuclei) compared to the nOes of H-4′ and H-5′/5′′ to H-3′ in 
the same base. The cross peaks found in COSY were only from H-3′/H-4′ but not from 
Figure 4.21 COSY of B-CG8HMPh. The cross peaks between H-3′ and H-2′/2′′ of C1 
through G10 are marked. 
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H-3′/H-5′/5′′, therefore, one can distinguish H-4′ and H5′/5′′ found in NOESY spectra. By 
following this procedure H-4′ of C1, G2, C3, C5, G8, C9, and G10 (4.16, 4.46, 4.25, 
4.11, 4.58, 4.22, and 4.26 ppm) were assigned. An alternate method was used to assign 
G6-H-4′ and C7-H-4′, since their H-3′/H-4′ cross peaks could not be indentified in COSY 
spectrum. Because H-4′ is close enough to have nOe with H8 or H6, G6-H-4′ (4.55 ppm) 
and C7-H-4′ (4.40 ppm) were identified based on the appearance of their H-4′/H8 and H-
4′/H6 nOe cross peaks. G4-H-4′ and H-5′/5′′ could not be unequivocally assigned. 
 
 
 
 
 
 
 
 
 
 
 
 
By following the assignment strategy, the non-exchangeable protons of B-
CG8HMPh were assigned (see Table 4.7 for full chemical shift assignment). According to 
1H NMR, COSY, and NOESY, the patterns of spectra have verified that CG8HMPh was in 
B conformation which is in agreement with the data from CD experiment. The non-
exchangeable proton assignment of B-CG8MMPh was conducted in the same way as B-
Figure 4.22 NOESY (left) of B-CG8HMPh displays nOe correlation between H-3′ and 
H-4′/5′/5′′ of all bases. On the right, COSY shows H-3′/H-4′ cross peaks of C1, G2, 
C3, C5, G8, C9, and G10. 
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CG8HMPh and is reported in Table 4.8. Unfortunately, the assignment of B-CG8CPh protons 
was problematic due to a fairly high content of Z-CG8CPh even in low salt concentration 
as supported by the CD data. The inability to obtain mainly B-DNA in the NMR sample 
significantly increases the difficulty of the NMR analysis and prevents us from 
successfully assigning the non-exchangeable protons for B-CG8CPh. Full 1H NMR, 
COSY, and NOESY spectra of B-CG8CPh, B-CG8HMPh, and B-CG8MMPh can be found in 
Appendix C. 
 
Table 4.7 Non-exchangeable protons assignment of B-CG8HMPh 
 
Non-exchangeable 1H Chemical Shifts (ppm) of CG8HMPh in B Conformationa Base 
H6/H8/Ar H5 H1' H2' H2'' H3' H4' H5'/H5'' 
C1 7.75 6.03 5.91 2.53 2.11 4.81 4.16 3.81 
G2 8.09 N/A 6.13 2.95 2.78 5.11 4.46 4.20, 4.09 
C3 7.62 5.56 6.27 2.69  N/D 5.08 4.25 4.37, 4.30 
G4 8.09 N/A 6.19 2.73  N/D 5.27 4.54 4.28, 4.20 
C5 6.53 5.50 5.97 2.20 0.57 4.73 4.11 4.19 
G6b 7.09, 6.37 N/A 5.72 3.68 2.40 4.94 4.55 4.30, 4.09 
C7 7.52 5.54 6.43 2.25 1.59 5.01 4.40 4.17 
G8 8.33 N/A 6.03 2.88 2.75 5.10 4.58 4.28, 4.20 
C9 7.50 5.58 5.89 2.43 2.07 4.95 4.22 4.18 
G10 8.05 N/A 6.26 2.72 2.46 4.78 4.26 4.15 
  aN/A – not applicable, N/D – not determined. 
   bChemical shift of p-substituent on the aryl adduct; 4.58 (–CH2) 
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Table 4.8 Non-exchangeable protons assignment of B-CG8MMPh 
 
Non-exchangeable 1H Chemical Shifts (ppm) of CG8MMPh in B Conformation Base 
H6/H8/Ar H5 H1' H2' H2'' H3' H4' H5'/H5'' 
C1 7.75 6.04 5.91 2.54 2.10 4.82 4.16 3.82 
G2 8.10 N/A 6.13 2.95 2.81 5.11 4.47 4.20 
C3 7.62 5.56 6.28 2.69  N/D 5.08 4.26 4.38, 4.31 
G4 8.09 N/A 6.19 2.72  N/D 5.27 4.54 4.28, 4.21 
C5 6.52 5.49 5.96 2.19 0.58 4.73 4.11 4.19 
G6b 7.08, 6.38  N/A 5.72 3.70 2.42 4.94 4.54 4.30, 4.10 
C7 7.48 5.49 6.44 2.24 1.63 5.03 4.40 4.48, 4.17 
G8 8.33 N/A 6.03 2.88 2.74 5.11 4.58 4.20 
C9 7.50 5.57 5.88 2.44 2.08 4.95 4.21 4.48, 4.16 
G10 8.05 N/A 6.27 2.71 2.48 4.77 4.28 4.16 
   aN/A – not applicable, N/D – not determined. 
   bChemical shift of p-substituent on the aryl adduct; 4.59 (–CH2) and 3.41 (–OCH3) 
 
4.2.3 Z-DNA Non-exchangeable Proton Assignment 
The same basic approach as used to assign the proton resonances for the B forms 
of the C8-arylguanine modified oligonucleotides is used to assign resonances in the Z 
form.  Thus, the same data set needs to be acquired, including 1H NMR, COSY, and 
NOESY. As in the case of the B form, the 1D proton spectrum gives provides 
information as to whether B, Z or single-stranded DNA is present.  The chemical shift 
ranges for the base and sugar protons are roughly the same and the peaks for H8 (δ 7.8-
7.9 ppm) of guanines, aryl adduct protons (δ 7.7-8.1 ppm), H6 (δ 7.4-7.5 ppm) and H5 (δ 
5.2-5.3 ppm) of cytosines can be seen.  However, as can be seen, the resolution is not as 
good as for the B DNA spectra.  This is due to the line broadening caused by higher salt 
concentration, required for the oligonucleotide to adopt the Z conformation. The J 
correlations of H6/H5 can be observed from COSY spectra as well as the correlation 
between the aryl protons that are ortho- and meta- to the guanine C8 carbon of the aryl 
adduct on G6. In addition, the correlation peaks between H-1′ and H-2′/2′′ are also shown 
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in COSY. Based on the well defined regions on 1D 1H NMR and 2D COSY spectra, the 
chemical shifts of aryl, H8, H5, H6, H-1′, H-2′, and H-2′′ protons can be obtained. To 
proceed on the proton assignment, the connection between base protons and sugar 
protons in the same nucleoside residue are observed from NOESY spectra due to close 
spatial proximities between the proton nuclei. The nOe cross peaks of Aryl/H-1′, Aryl/H-
2′/2′′, H8/H-1′, H8/H-2′/2′′, H8/H-3′, H8/H-4′, H8/H-5′/5′′, H6/H5, H6/H-1′, and H6/H-
2′/2′′ in the same nucleotide subunit are generally observed in the spectra and can be used 
to assign some of sugar protons for each base. Strong nOes cross peaks of H8/H-1′ 
indicate that dG are in syn conformation which associate with structural feature of Z-
DNA20,97. To sequentially assign protons, the connections between adjacent bases are 
required. Instead of weak nOe correlations between H8 of G(n) and both H6 of C(n-1) 
and C(n+1) observed in B form, NOESY of Z form shows relatively strong nOe cross 
peaks only between H8 of G(n) and H6 of C(n-1) which would quickly help lining up 
G(n) and C(n-1). To completely assign the base positions in CG decamer sequence, 
C(n+1) can be linked to G(n) through nOes cross peaks between H-4′ or H-5′/5′′ of C(n-
1) and H8 of G(n) as described in a Z-DNA protons assignment reported by Orbons 
L.P.M. et al95.  
As was the case for the assignment of protons for the oligonucleotides in the B 
form, the C1 base serves as the starting point because of its distinct H5 and H6 chemical 
shifts that are most downfield compares to the rest of cytosines due to C1 position in the 
sequence. Figure 4.23 shows a diagram described nOe correlations that generally used for 
Z-DNA assignment of CG decamer. The protons of modified G6 are also quite simple to 
assign due to its correlation with unique aryl protons from the DNA adduct. The H-3′, H-
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4′, and H5′/5′′ assignments of each base are possible by following nOes and J-correlation 
cross peaks in NOESY and COSY spectra. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
To demonstrate the assignment of the non-exchangeable protons of the modified 
CG decamer in Z conformation, the proton assignment of Z-CG8CPh will be used as an 
example. The NMR spectra analysis was started on an expansion of 1H NMR spectrum 
from δ7.0-8.3 ppm (Figure 4.24) where peaks of H8, H6, and aryl protons generally 
locate. The two doublets at 8.16 and 7.81 ppm were expected to be aryl protons of G6 
adduct based on their chemical shifts, and integration of about two protons. The next four 
singlet peaks were suggested to be H8 of guanines (δ7.91, 7.88, 7.87, and 7.85 ppm), 
Figure 4.23 Diagram shows proton assignment strategy for Z-form of CG decamers 
based on nOe correlations observed in NOESY spectra 
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while the cluster of peaks around 7.4-7.5 ppm are assigned to the cytosine H6 protons. 
Because the resolution of spectrum was fairly poor due to the high salt concentration in 
NMR sample, the H6 cytosine protons could not be clearly assigned at this point.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
The COSY spectra (Figure 4.25a) support our suggestion on the chemical shifts of 
H8 (Figure 4.25a) and aryl protons (Figure 4.25c). The peaks at 7.91, 7.88, 7.87, and 7.85 
ppm did not have cross peaks with any others which suggests that these peaks are the of 
H8 protons. As expected, the doublet at 8.16 ppm is correlated with the doublet at 7.81 
ppm (Figure 4.25b) verifying that they were protons of the aryl group. Because of 
mesomeric effect, the downfield doublet at 8.16 ppm was assigned to the aryl protons 
located ortho to the electron withdrawing p-carboxy substituent, while the upfield doublet 
at 7.81 ppm was assigned to the protons ortho to the guanine C-8 carbon. Five pairs of 
H6/H5 correlations (δ7.51/5.29, 7.50/5.83, 7.49/5.29, 7.46/5.19, and 7.44/5.20 ppm) were 
Figure 4.24 1H NMR spectrum of Z-CG8CPh. The peaks corresponding to H8, H6, and 
aryl adduct protons are indicated below the frequency axis. 
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seen in the COSY (Figure 4.25b) spectrum and were used to assign H6 and H5 of 
cytosines.  In addition, several H-1′/H-2′/2′′ correlations can be observed in COSY as 
shown in Figure 4.25d. Between 5.7 and 6.4 ppm, six H-1′ peaks (δ5.81, 5.87, 5.94, 6.30, 
6.33, and 6.34 ppm) were identified based on the criteria that these peaks had at least one 
correlation with peak in the region upfield of 3 ppm which usually is the region where the 
H-2′/2′′ (Z DNA) protons are observed. Some of the chemical shifts for H-2′/2′′ were 
identified from H-1′/H-2′/2′′ cross peaks. The assignment of H-1′/2′/2′′ to their 
corresponding H8, H6/H5, or aryl protons were conducted in the next step followed by 
sorting protons in CG decamer sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
Figure 4.25 COSY of Z-CG8CPh. The boxed regions show the a) H8, b) H6/H5, c) 
Ar/Ar, and d) H-1′/H-2′/2′′ crosspeaks. 
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Due to the close spatial proximity between H-1′ and H8, H6, or aryl protons in the 
same nucleotide residue, nOes cross peaks of Ar/H-1′ (Figure 4.26a), H8/H-1′ (Figure 
4.26b), and H6/H-1′ (Figure 4.26c) can be observed in NOESY spectra. It should be 
noted that H8/H-1′ nOes have relatively intense cross peaks because G residues were in 
syn-conformation which make H8 closer to H-1′ (2-3 Å) relative to the anti-conformation 
that all bases adopt in B form. The intense H8/H-1′ nOe was the strongest evidence 
indicating that the CG8CPh oligonucleotide was in Z form. From COSY (Figure 4.25d) 
and NOESY (Figure 4.26d) spectra, H8, H6, or the aryl adduct protons were matched 
with their corresponding H-1′ and H2′/2′′ (H8, H6, or aryl Æ H-1′ Æ H-2′/2′′: 7.44 Æ 
5.81 Æ 2.69, 1.77 ppm, 7.46 Æ5.81 Æ 2.69, 1.77 ppm, 7.49 Æ 5.81 Æ 2.69, 1.77 ppm, 
7.50 Æ 5.87 Æ 2.51, 1.71 ppm, 7.51 Æ 5.94 Æ 2.73, 1.82 ppm, 7.85 Æ 6.30 Æ 2.83, 
2.66 ppm, 7.87 Æ 6.33 Æ 3.28, 2.51 ppm, 7.88 Æ 6.30 Æ 2.81, 2.67 ppm, 7.91 Æ 6.34 
Æ 2.88, 2.66 ppm, 8.16/7.81 Æ 6.33 Æ 2.94, 2.77 ppm).                         
Based on the computational model of Z-CG8CPh, the distances between C(n-1)-H6 
and G(n)-H8 are generally greater than 6 Å while the distances between C(n+1)-H6 and 
G(n)-H8 are below 6 Å.  Therefore, only nOes of C(n+1)-H6 and G(n)-H8 are observed 
in the NOESY spectrum while none of C(n-1)-H6/G(n)-H8 cross peaks are observed, 
unlike the case of B conformation where the nOes of C(n-1)-H6/G(n)-H8 and C(n+1)-
H6/G(n)-H8 may be seen. Therefore G(n) and C(n+1) can be unambiguously assigned 
which was a result from nOes of C(n-1)-H6/G(n)-H8. Four H8/H6 nOes cross peaks 
(7.85 Æ 7.44 ppm, 7.88 Æ 7.46 ppm, 7.91 Æ 7.51 ppm, and 8.16/7.81 (G6-Ar) Æ 7.49 
(C7-H6) ppm, Figure 4.26e) were observed which allow the assignment of C1-H6 (7.50 
ppm) and G10-H8 (7.87 ppm). 
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The chemical shift of C1-H-3′ (4.67 ppm) was assigned from COSY (cross peaks 
of C1-H-2′/2′′ and C1-H-3′) and NOESY (C1-H6 and C1-H-3′) which allow further 
assignment of C1-H-5′/5′′ (3.17 ppm). The C1-H-5′/5′′ then correlated with G2-H8 (7.85 
ppm) as shown in Figure 4.27 which allowed an assignment of C3-H6 (7.44 ppm) since 
the nOe cross peak of G2-H8/C3-H6 has been previously found. Similarly, C3 can be 
connected to G4 through the cross peak between C3-H-5′/5′′ (3.85 ppm) and G4-H8 (7.88 
ppm) followed by an assignment of C5-H6 (7.46 ppm). The only unassigned pair of 
Figure 4.26 NOESY of Z-CG8CPh. The boxed regions show the nOe correlations of a) 
Ar/H-1′, b) H8/H-1′, c) H6/H-1′, d) Ar/H-2′/2′′, H8/H-2′/2′′, or H6/H-2′/2′′, and e) 
G(n):H8/C(n-1):H6.  
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H8/H6 has been assigned to G8-H8/C9-H6 (7.91/7.51 ppm). The H5, H-1′, and H-2′/2′′ 
were assigned, accordingly, to match with H8, H6, and Ar assignments.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Because the J-correlation of H-3′ and H-2′/2′′ were barely observed in high salt 
samples, the assignment of H-3′ was made based on nOes of H8/H-3′ and H6/H-3′ given 
the chemical shifts of H-3′ were expected to be in range of 4.8-5.1 ppm. Unlike in B-
CG8HMPh, the assignment of H-4′ and H-5′/5′′ was more problematic because of the 
Figure 4.27 NOESY of Z-CG8CPh showing the  nOe correlations of a) C1:H-
5′/5′′/G2:H8 and b) C3:H-5′/5′′/G4:H8. 
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overlapping H-3′ peaks. Therefore, the chemical shifts of H-4′ and H-5′/5′′ were made 
based on the correlation of H-4′ and H-5′/5′′ with intranucleotide Ar, H8 or H6 in 
NOESY and are not unequivocal. 
By following the assignment strategy, the non-exchangeable protons of Z-CG8CPh, 
Z-CG8HMPh, and Z-CG8MMPh were assigned (see Table 4.9 to 4.11 for chemical shift 
assignment). According to 1H NMR, COSY, and NOESY, the patterns of spectra have 
verified that the aryl modified CG decamers were in Z conformation which is in 
agreement with the data from CD experiment. Full 1H NMR, COSY, and NOESY spectra 
of Z-CG8CPh, Z-CG8HMPh, and Z-CG8MMPh can be found in Appendix C. 
 
Table 4.9 Non-exchangeable protons assignment of Z-CG8CPh 
 
Non-exchangeable 1H Chemical Shifts (ppm) of CG8CPh in Z Conformation Base 
H6/H8/Ar H5 H1' H2' H2'' H3' H4' H5'/H5'' 
C1 7.50 5.83 5.87 2.51 1.71 4.67 3.74 3.17 
G2 7.85 N/A 6.30 2.83 N/D 5.08 4.26 4.20 
C3 7.44 5.20 5.81 2.69 1.77 4.88 4.48 3.85 
G4 7.88 N/A 6.30 2.81 N/D 5.08 4.24 N/D 
C5 7.46 5.19 5.81 2.69 1.77 4.89 4.24 3.89 
G6 8.16, 7.81 N/A 6.33 2.94 2.77 5.05 4.19 3.99 
C7 7.49 5.29 5.81 2.69 1.77 4.89 4.48 3.87 
G8 7.91 N/A 6.34 2.88 N/D 5.09 4.28 N/D 
C9 7.51 5.29 5.94 2.73 1.82 4.90 4.48 4.29, 3.89 
G10 7.87 N/A 6.33 3.28 2.51 4.90 4.38 3.99 
  aN/A – not applicable, N/D – not determined. 
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Table 4.10 Non-exchangeable protons assignment of Z-CG8HMPh 
 
Non-exchangeable 1H Chemical Shifts (ppm) of CG8HMPh in Z Conformation Base 
H6/H8/Ar H5 H1' H2' H2'' H3' H4' H5'/H5'' 
C1 7.52 5.85 5.86 2.50 1.71 4.67 3.75 3.18, 2.84 
G2 7.85 N/A 6.30 2.82  N/D 5.08 4.46 4.19, 3.74 
C3 7.44 5.20 5.81 2.67 1.77 4.88 4.26 3.85, 2.83 
G4 7.88 N/A 6.30 2.82 N/D  5.06 4.46 4.21, 3.97 
C5 7.46 5.19 5.81 2.68 1.78 4.89 4.25 3.87, 2.82 
G6b 7.76, 7.73  N/A 6.30 2.94 2.76 5.05 4.46 4.19, 3.98 
C7 7.48 5.29 5.81 2.68 1.77 4.89 4.21 3.86 
G8 7.91 N/A 6.33 2.85  N/D 5.06 4.47 3.76 
C9 7.52 5.30 5.95 2.72 1.83 4.90 4.28 3.85, 2.78 
G10 7.89 N/A 6.33 3.28 2.53 4.90 4.39 4.20, 3.99 
  aN/A – not applicable, N/D – not determined. 
   bChemical shift of p-substituent on the aryl adduct; 4.50 (–CH2) 
 
 
 
Table 4.11 Non-exchangeable protons assignment of Z-CG8MMPh 
 
Non-exchangeable 1H Chemical Shifts (ppm) of CG8MMPh in Z Conformation Base 
H6/H8/Ar H5 H1' H2' H2'' H3' H4' H5'/H5'' 
C1 7.51 5.83 5.87 2.50 1.71 4.67 3.74 3.17 
G2 7.85 N/A 6.30 2.82  N/D 5.07 4.47 3.72 
C3 7.44 5.20 5.81 2.68 1.77 4.88 4.26 3.85, 2.83 
G4 7.89 N/A 6.30 2.81  N/D 5.08 4.47 3.99 
C5 7.46 5.19 5.81 2.68 1.77 4.88 4.25 3.87, 2.82 
G6b 7.77, 7.74 N/A 6.30 2.94 2.76 5.04 4.47 4.19, 3.98 
C7 7.48 5.29 5.82 2.68 1.78 4.88 4.25 3.87 
G8 7.91 N/A 6.33 2.84 N/D  5.09 4.47 3.98, 3.77 
C9 7.51 5.29 5.94 2.71 1.84 4.90 4.27 3.88, 2.84 
G10 7.87 N/A 6.32 3.29 2.51 4.90 4.38 4.19, 3.99 
  aN/A – not applicable, N/D – not determined. 
 bChemical shift of p-substituent on the aryl adduct; 4.49 (–CH2) and 3.60 (–OCH3) 
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The results obtained from NMR analysis support the CD data that indicates the 
predominant of Z form of the modified CG decamers at 500 mM NaCl, where the 
unmodified CG could not well adopt the left handed conformation. An increase in 
intensity of intranucleotide H8/H-1′ nOe cross peaks when high salt concentration was 
introduced to the oligonucleotide samples suggests the change in conformation of dG in 
CG decamer sequence from anti to syn conformation which suggests the conversion of B 
to Z form.  
The B-Z transition promoted by C8-arylguanine adducts have been confirmed by 
NMR and CD analysis. The p-substituents on the aryl adducts have significant impact on 
their effect on B- and Z-DNA stability, as the result has shown that different p-
substituents give diverse degrees of Z-DNA formation. What could be gleaned from the 
current dara set is that B-Z conversion is dependent upon more than a local steric effect 
of C8-aryl adduct that would destabilize B-DNA. Additional forces that override an 
unfavorable electronic interaction of Z-DNA may be necessary. The interplay of several 
factors, including hydrophobic, electronic, steric interaction, and H-bonding that helps 
stabilize Z-DNA and/or destabilize B-DNA are relevant in B-Z conversion process. 
Molecular modeling and free energy calculation of the B and Z-forms of CG decamers 
were conducted to help understanding the effect of aryl adduct on DNA conformation. 
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CHAPTER 5 
MOLECULAR MODELING OF THE B AND Z DNA FORMS OF CG 
DECAMERS CONTAINING C8-ARYL MODIFIED GUANINE 
 
Molecular modeling has become a significant tool to model and study biological 
macromolecules. Modeling studies can provide information regarding the molecular 
conformation of macromolecules, such as oligonucleotides, through the application of 
molecular mechanical (MM) and molecular dynamical (MD) methods.  More recently, 
molecular modeling methods have been utilized to predict the stability of 
macromolecules by the use of free energy perturbation (FEP) calculations. Here, we have 
applied both molecular modeling and FEP methods to the C8-aryl modified guanine 
containing oligonucleotides that were studied by CD and NMR. The aim of these studies 
is two-fold. First, molecular models obtained by MM/MD methods are useful for 
interpreting the experimental data. This is especially true for NMR NOESY data where 
correlations (appearance and intensity) are distance dependent. Second, computational 
methods allow deconvolution of the various contributors to the overall macromolecule 
conformation and, therefore, determination of the important factors that drive it. 
Analysis of the results of MM/MD calculations of the modified and unmodified 
oligonucleotides studied by CD and NMR, in both the B and Z conformations is 
necessary because base modifications often affect and distort a regular structure of DNA. 
Topology, helical symmetry, and base paring of DNA all can be altered and to various 
degrees as a result of the modification. Therefore, the changes in helicoidal and base 
pairing parameters are typically used to elucidate and to explain how the C8-arylguanine 
adduct affects the conformation of the CG decamer locally and globally. Figure 5.1 
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shows diagrams of these helicoidal parameters100 including inter-base pair, intra-base 
pair, and base pair-axis parameters that are considered as a part of this analysis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Diagrams showing the helicoidal parameters that describe the movement of 
base pairs and local and global conformation.   
 129
Free energy calculations of the B and Z DNA forms of the oligonucleotides result 
in a prediction of which form, B or Z DNA, is more favorable for a given modification.  
In addition to this prediction, the free energy calculations, extracted from the MD 
trajectories, provide a breakdown of the contributions from van der Waals interactions, 
electrostatics, etc., and may be used to estimate how the aryl adduct affects each 
component of the free energy. In turn, this may help elucidate how the aryl adducts 
facilitate B-Z transition, by destabilizing the B form, and/or stabilizing the Z form. It 
should be noted, however, that the methods used here (MM_PBSA and sietraj) are 
designed for protein-substrate while they binding and have been used with B-DNAs with 
limited success, they have not been used with Z DNAs.  
The computational studies described below are a continuation of work on the 10-
mers of unmodified CG, CG8Ph, CG8Tol, and CG8HMPh conducted by Heavner99,101 and 
some of these results are reproduced here for comparison purposes. The new studies refer 
to the CG8CPh and CG8MMPh derivatives. We also note that in Heavner’s work, the CD and 
NMR work was either incomplete or not conducted for CG8Tol and CG8HMPh and this body 
of work completes Heavner’s research.   
 
5.1 General 
The computational studies on CG8CPh and CG8MMPh generally following the 
protocol established by Heavner and applied to the CG, CG8Ph, CG8Tol, and CG8HMPh 
decamers. The basic steps were as follows. First, parameters not provided in the 
parm99.dat force field that is provided with the Amber suite of programs are developed. 
These parameters were generated using Gaussian (g03), to calculate the natural bond 
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lengths and stretching constants, bond angles and bending constants, the preferential 
torsion angles and the atom charges. The resulting parameters were processed by 
antechamber to create a prep file that modifies the Gaussian output by modifying the 
atom names and charges to be consistent with the parm99.dat force field as well as 
modifications needed by the Amber (version 8102, if not noted otherwise) modules xLEaP 
and sander. Subsquently, this file is examined by parmchk to screen for any remaining 
parameters that may be needed. The modified oligonucleotide is then built, suitable input 
files written for the MM calculations. MM was then run using the sander module of 
Amber to initially relax the oligonucleotide, solvent molecules that were added, or the 
entire system. MD simulations, also using sander, were then run and the resulting 
trajectories analyzed using utility programs contained within the Amber suite (e.g., ptraj, 
nmode, MM_PBSA) or other programs including Dials & Windows103, CURVES104 
(version 5.2) , X3DNA105, Moil-View106 and sietraj107,108.  
 
5.2 Force Field Development 
The structure of the C8-aryl modified dG (either CG8CPh or CG8MMPh) was built in 
Gaussview109, then the electrostatic potentials associated with atoms in the structure were 
calculated using Gaussian (g03). Antechamber was then applied to parameterize C8-aryl 
modified dG to provide the prepi file and a pdb file.  Atom types were consistent with the 
parm99.dat force field. The frcmod file was created by parmchk, using the prepi file as 
input. The pdb, prepi and frcmod files were loaded into xLEaP and a library file of the 
modified base generated and saved for later use. Note that in case of the C8-
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carboxyphenyl dG derivative, the carboxylic proton was removed and thus was prepared 
as the carboxylate since this is the form it is present as under physiological conditions.   
 
5.3 Initial Oligonucleotide Structure Building 
The starting point for the B DNA forms of the two structures built here was the 
structure of B-CG8HMPh from our previous study which was used as a template for the B-
DNA form of CG8CPh. The pdb file of B-CG8HMPh was loaded into xLEaP using the 
library file for the C8-hydroxymethylphenyl dG. The aryl residue was edited, replacing 
the p-hydroxymethyl group with the  p-carboxylate (p-COO-) substituent and the 
structure was then saved as a pdb of B-CG8CPh. The text editor was then used to correct 
the atom types, atom numbers, and assignment base of the modified dG residues (G6 and 
G16) in a pdb of B-CG8CPh in order to comply with frcmod and lib files of C8-
carboxyphenyl dG that has written previously, renaming them as CPG. The resulting pdb 
of B-CG8CPh was an initial structure of B-CG8CPh, in the deprotonated form (since it is 
assumed that the carboxylic group is ionized under physiological conditions) and was 
used as the starting structure for the MM and MD calculations. The initial structure of Z-
CG8CPh, B-CG8MMPh, and Z-CG8MMPh were constructed in the same way as described for 
the B-DNA form of CG8CPh.  
 
5.4 MM and MD Simulations 
MM and MD were performed using the sander module of Amber and the 
parm99.dat version of the Cornell force field. The pdb structure was loaded into xLEaP 
and a water box (TIP3) was added. Charges were then neutralized by the addition of 18 
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(19 for CG8CPh) sodium counter ions. A 10 Ǻ buffer zone between the box wall and 
solute, containing solvent, was used. The pdb, topology (top), and coordinate (crd) files 
of CG decamers including the solvent box and sodium ions were then saved and used in 
the simulations.  
The simulation protocol started with a MM to minimize the energy of the whole 
system with the DNA fixed with 500 kcal/mol Ǻ positional restraints on all solute atoms 
for 1000 steps of steepest descent and then 1500 steps of conjugated gradient 
minimization. Then, the entire system was energy minimized (i.e. positional restraints on 
DNA removed) with 500 steps steepest descent and 2000 steps conjugated gradient 
minimization. The next step, was a 25 ps MD with the DNA fixed, was performed to 
equilibrate water and counter ions followed by the isothermal-isobaric ensemble (300 K°, 
1 atm) 25 ps MD with the SHAKE algorithm on and a 9 Ǻ cutoff. An additional 3 ps MD 
with DNA fixed was performed in order to relax water and ions around the solute. 
Another 600 steps MM was conducted to equilibrate solvent box with 5 kcal/mol Ǻ 
positional restraints on all DNA atoms. Subsequently, the production MD with constant 
temperature and pressure (300 K°, 1 atm) was performed over 2 ns (4 ns for CG8MMPh).  
  
5.5 Most Representative Structure 
The most representative structure is the structure that has the lowest average root 
mean square derivation (RMSD) to all other member of the MD trajectory. This structure 
is used in this work as the input into the CURVES and X3DNA routines that determine 
helicoidal parameters. MOIL-view was used to select the most representative structure 
from each of the four production trajectories. Due to the size limitations imposed by 
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MOIL-view, trajectories were divided into 250 ps frame pieces. Each piece of trajectory 
was analyzed using the cluster analysis feature in MOIL-view (2 Å cut-off distance) to 
select the crd set of the most representative structure for each of the 250 ps frame pieces.  
All of these files were then merged into a new trajectory using ptraj and the analysis 
repeated on this new trajectory (typically comprised of 8-16 coordinate sets).  The most 
representative structure of the production run was generated by cluster analysis of this 
newly written trajectory. The pdb of most representative structure was made using 
ambpdb (Amber suite program) using the appropriate topology file and the coordinate set 
that was determined by MOIL-view to be the most representative.  
In addition to using this file for determination of the helicoidal parameters, it also 
provides a representative model that can assist with the NMR assignment of non-
exchangeable proton. The average distances between non-exchangeable protons obtained 
from the structure were most useful for NMR assignment in NOESY spectra. The most 
representative structures of all studied oligonucleotides in B forms are shown in Figure 
5.2 and Z forms are shown in Figure 5.3. By inspection of the most representative 
structures it is obvious that the B forms were distorted by the aryl adducts. The rise and 
incline of base pairs in the middle of sequence, where the modified base presented, were 
most notable. As far as we can see by mere visual inspection of the Z forms, the aryl 
adducts have little effect on structure with the exception of CG8CPh and CG8MMPh but a 
more quantitative evaluation is necessary to ascertain the extent of the effect. 
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Figure 5.2 The most representative structures of a) CG, b) CG8Ph, c) CG8Tol, d) 
CG8CPh, e) CG8MMPh, and f) CG8HMPh in the B-DNA conformation.  
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Figure 5.3 The most representative structures of a) CG, b) CG8Ph, c) CG8Tol, d) 
CG8CPh, e) CG8MMPh, and f) CG8HMPh in the Z-DNA conformation.  
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5.6 Structural Analysis 
5.6.1 B-DNA Oligonucleotides  
Dials & Windows was used to examine the trajectories over the course of 
production run to determine the helicoidal parameters of the oligonucleotides that vary 
the most over time and with respect to the unmodified derivative. This analysis gives an 
excellent presentation of the variation in these parameters as the system evolves over the 
course of the MD.  The analysis also guides the analysis of the helicoidal parameters of 
the most representative structure using CURVES. 
Figures 5.4, 5.5, and 5.6 show intra-base pair, inter-base pair, and base pair-axis 
parameters obtained from Dials & Windows of the unmodified and modified CG decamer 
in the B form over 2 ns trajectories (except for CG8MMPh that has a 4 ns trajectory), 
respectively, for the CG, CG8Ph, CG8Tol, CG8HMPh, CG8CPh and CG8MMPh oligonucleotides.  
There was no significant deviation of the intra base pair parameters of C8-aryl modified 
CG decamer observed when compared to the unmodified DNA with the possible 
exception of STG and BKL (these are low energy processes). Minor perturbations in 
these two parameters were seen for CG8Ph, CG8Tol and perhaps CG8MMPh at or near the 
modified base.    
In the case of inter-base pair parameters (Figure 5.5), RIS and SLD of G6:C15 
base pairs were altered. Both showed significant changes for CG8Ph, CG8Tol, and 
CG8HMPh, while mainly RIS was different for CG8CPh and CG8MMPh containing 
oligonucleotides in the B-DNA form. The increase in rise parameter and the change in 
slide to negative value were likely driven by the tendency toward stacking of the aryl 
adduct of G6 and pyrimidine C5. Paralleling these differences is the effect of the C8-  
 137
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Intra-base pair parameters for all base pairs obtained from Dials & 
Windows analysis of the production trajectories of the unmodified and modified CG 
decamers in the B-DNA form. 
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Figure 5.5 Inter-base pair parameters of all base pairs obtained from Dials & 
Windows analysis of the production trajectories of the unmodified and modified CG 
decamers in the B-DNA form. 
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Figure 5.6 Base pair-axis parameters of base pairs obtained from Dials & Windows 
analysis of the production trajectories of the unmodified and modified CG decamers in 
the B-DNA form. 
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substituent on YDP and INC (and to a lesser extent, TIP) as seen in Figure 5.6. Thus, the 
oligonucleotides that displayed significant effects on both SLD and TLT display large 
changes in YDP and INC and had little effect on SLD or TLT, only YDP was altered 
(e.g., CG8CPh and CG8MMPh).  
To put the changes pointed by Dials & Windows on a more quantitiative analysis, 
the helicoidal parameters were obtained utilizing the most representative structure. 
CURVES was used for this purpose with the results being compiled in Tables 5.1 and 
5.2.  Inspection of Table 5.1 indicates that STG and BKL are, as suggested by Dials & 
Windows, significantly affected by the C8-aryl adduct.  It should be noted, however, that 
STG and BKL are not energetically costly motions and are more likely in response to 
other conformational changes.   
As suggested by Dials & Windows, the inter-base parameters SLD and RIS are 
significantly different from the unmodified oligonucleotide. In all cases, SLD is nearly 1 
Å more negative than the unmodified oligonucleotide. RIS varied from a modest increase 
of 0.57 Å for CG8CPh to 3.12 Å for CG8Tol. To a lesser extent, changes in SHF and TWS 
are seen. In the case of SHF, the change was smallest for the CG8Ph (-0.49 Å) and largest 
for CG8MMPh (-1.08 Å). The changes in TWS also range from showing a modest decrease 
for CG8MMPh (3.15o) to very large decrease for CG8Tol (12.14o) indicating the C8-
arylguanine modification produces local unwinding of the helix. 
Based on values for the helicoidal parameters obtained from CURVES, the 
amount of rise (RIS), slide (SLD), and shift (SHF) were all significantly altered by the 
presence of the C8-arylguanine base. The only difference between the aryl groups, 
however, is the p-substituent. Furthermore, the observed changes in RIS, SLD, and SHF  
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Table 5.1 Helical parameters of the unmodified and modified CG decamers determined 
by CURVES analysis of the most representative structures in the B-DNA form.a 
              
Intra-Base Pair 
  CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
  G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 
SHR -0.12 (-0.10) -0.04 (-0.06) 0.01 (-0.27) -0.08 (0.09) 0.40 (-0.30) 0.00 (0.20) 
STR -0.03 (0.00) -0.20 (0.16) -0.17 (0.10) 0.23 (0.18) 0.04 (-0.25) -0.06 (0.06) 
STG 0.53 (0.10) -0.48 (-0.13) -0.67 (-0.20) -0.11 (0.09) -0.30 (-0.51) -0.33 (-0.08) 
BKL 9.80 (1.10) -0.93 (-3.27) 3.60 (-3.50) -4.57 (-0.36) -5.00 (-3.01) -15.6 (-2.89) 
PRP -12.1 (-12.0) -9.50 (-9.57) -6.71 (-10.5) -11.39 (-12.92) -9.85 (-8.15) -9.50 (-11.2) 
OPN -2.47 (-1.83) 4.90 (1.17) -2.12 (4.43) -0.04 (-2.31) 0.54 (-1.55) 2.09 (2.10) 
       
              
Inter-Base Pair 
  CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
  C5:G6 C5:G6 C5:G6 C5:G6 C5:G6 C5:G6 
SHF 0.81 (0.06) 0.32 (0.00) 0.36 (0.07) -0.08 (-0.01) -0.27 (-0.13) -0.22 (-0.05) 
SLD -0.44 (-0.14) -1.76 (-0.06) -1.69 (0.11) -1.27 (-0.01) -1.26 (-0.06) -1.63 (-0.04) 
RIS 3.00 (3.18) 5.55 (3.58) 6.12 (3.83) 3.57 (3.38) 3.95 (3.89) 4.74 (3.64) 
TLT -5.60 (-1.70) -0.65 (1.97) -10.3 (1.40) 3.24 (0.00) 7.53 (6.75) 5.30 (0.11) 
ROL 7.97 (5.04) 0.28 (7.24) -6.00 (7.09) 8.62 (2.26) 5.14 (1.50) 6.86 (7.79) 
TWS 32.2 (31.45) 21.5 (30.1) 20.6 (30.4) 33.05 (34.33) 29.05 (35.0) 22.0 (30.4) 
       
              
 Base Pair-Axis 
  CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
  G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 
XDP -2.22 (-2.06) -1.32 (-1.34) -0.75 (-0.71) -1.06 (-0.97) -0.79 (-0.61) -0.08 (0.08) 
YDP 0.31 (-0.17) -0.43 (-0.42) -0.36 (-0.37) -0.31 (-0.28) -1.40 (-1.57) -0.10 (-0.02) 
INC 1.65 (3.98) -11.5 (-4.97) -17.9 (-8.50) -1.57 (0.55) -2.35 (-1.06) -15.8 (-7.30) 
TIP -2.00 (-2.72) 1.00 (1.52) 2.50 (3.06) 2.29 (1.92) 11.99 (11.08) 1.61 (1.03) 
a Values in parenthesis are for the average over all bases 
 
all effect the extent to which the C8-aryl group of the modified base stacks over the 5′-
cytosine. The CG8Ph displays the most negative slide (-1.76) (the effect being augmented 
by STR (-0.20)) and gives rise to a significant stacking interaction between phenyl adduct 
and pyrimidine on the 5′ side. To accommodate these changes and relieve steric 
interactions, an increase in local rise (5.55 Å) occurs. The latter increase is responsible 
for the observed decrease in TWS. Note that while the observed changes result in the 
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stacking interaction and though similar SHF and SLD values are observed for the CG8Tol 
derivative, the unusually large negative roll (-6.00) and increase in rise prevent the p-tolyl 
from stacking well over the 5′ pyrimidine.  
The stacking interaction of CG8CPh, CG8MMPh, and CG8HMPh were expected to be 
lower than CG8Ph based on rise, slide, shift, and stretch parameters and is what is 
suggested by the most representative structures (Figure 5.2). In case of CG8HMPh, there is 
a possibility that hydroxyl proton of p-CH2OH H-bonding with nearby phosphate oxygen 
and this, in turn shifts slide back toward the unmodified oligonucleotide at the G6:C15 
base pair. If stacking arrangement observed computationally (and experimentally) for the 
CG8Ph, was adopted by CG8HMPh, it would disrupt the optimum distance (2.4 Å) between 
hydroxyl proton and phosphate oxygen and diminish the chance of H-bonding.  
The unfavorable electrostatic interaction between the negatively charge phosphate 
backbone of the oligonucleotide and the p-COO- substituent in CG8CPh appears to be the 
main reason for the decreased stacking in this oligonucleotide as the more interaction 
there is between the C5 pyrimidine and the aryl group of CG8CPh the more the carboxylate 
group interacts with the negatively charged oxygens on the backbone. In addition, this 
oligonucleotide shows a fair amount of SHF, which further decreases stacking 
interactions. 
The steric effect of the p-CH2OCH3 (with the phosphate backbone) is likely to be 
the cause of the decrease in stacking for CG8MMPh as it will decrease the amount of SLD 
relative to the unmodified oligonucleotide. Furthermore, the near zero values for 
inclination, a base pair-axis parameter, of G6:C15 of CG8CPh (-1.57) and CG8MMPh (-2.35) 
probably occurs to avoid unfavorable interactions between the p-substituents and the 
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backbone. Having the same degree of inclination like CG8Ph (-11.5) would put p-COO- 
and p-CH2OCH3 very close to the phosphate group of C5. 
In addition to the effect of aryl adducts on base pair parameters that may 
contribute to B-DNA destabilization, groove parameters also affected by the presence of 
aryl adducts. The minor groove widths obtained from the CURVES analysis of the most 
representative structures are shown in Table 5.2. The C8-aryl adducts on G6 generally 
reduce the minor groove width which may result in increasing the electrostatic repulsion 
caused by bringing the phosphates close together. Although the trend of minor groove 
reduction and the B-Z conversion were not well correlated, the effect likely plays a role 
in reducing the stability of the B-DNA form of the C8-arylguanine modified 
oligonucleotides.   
 
 
Table 5.2 Major and minor groove widths of the unmodified and modified CG decamers 
determined by CURVES analysis of the most representative structures in the B-DNA 
form. 
              
 Major Groove Width (A°) 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 12.20 16.80 21.94 12.14 13.21 15.96 
5 11.85 17.50 23.72 12.06 13.09 16.67 
6 11.36 17.55 23.90 13.14 11.18 15.45 
7 15.38 15.72 15.87 12.33 12.67 13.20 
Average 12.70 16.89 21.36 12.42 12.54 15.32 
              
 Minor Groove Width (A°) 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 7.91 7.22 5.00 6.60 5.73 6.83 
5 8.40 4.32 4.81 4.65 6.51 6.38 
6 7.00 5.99 5.41 7.01 5.47 7.74 
7 7.77 7.58 8.80 9.40 5.74 7.13 
Average 7.77 6.28 6.01 6.92 5.86 7.02 
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5.6.2 Z-DNA Oligonucleotides   
The intra-base pair, inter-base pair, and base pair-axis parameters obtained by 
Dials & Windows analysis of the unmodified and modified CG decamers in Z form over 
2-4 ns production runs are shown in Figure 5.7, 5.8, and 5.9. There was no significant 
difference observed between the unmodified and modified oligonucletides when the 
intra-base parameters (Figure 5.7) are considered except in the case of the CG8MMPh 
derivative where greater variation in STR and STG are observed, suggesting greater 
mobility of this base and therefore decreased stability of the base-pair.  Much the same 
can be said for the inter-base parameters (Figure 5.8). The alteration seen in SLD, RIS, 
ROL, and TWS are due to the alteration of the glycosidic bond of the pyrimidines (anti) 
and the purines (syn) in Z DNA. The main outlier is the SLD and RIS values for the C6-
G15 base pair. In most cases, SLD becomes more positive while RIS becomes more 
negative while in the case of the CG8CPh and CG8MMPh, just the opposite is observed. 
Finally, no real differences are observed for the base pair-axis parameters.  The different 
scales used for the last two panels corresponding to CG8CPh and CG8MMPh seem to suggest 
a difference but this is only a scaling effect. 
The helical parameters from the CURVES analysis of the most representative Z-
DNA structures are shown in Table 5.3.  Since the C8-aryl group of the modified guanine 
lies largely outside of the DNA helix in the Z-form, the aryl group should have little 
effect on DNA conformation (constraining the view to just the Z-DNA form). For the 
most part, and as expected from the most representative structures of CG8Ph, CG8Tol, and 
CG8HMPh in Z-DNA form shown in Figure 5.3, there were not many differences between 
the modified and unmodified CG oligonucleotides. The most notable differences seen in 
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the intra-base pair parameters are 1) the value for STR of CG8MMPh, which is quite 
negative, 2) PRP for both CG8CPh and CG8MMPh, both of which departed considerably 
from the unmodified oligonucleotide, albeit in opposite directions and 3) OPN for the 
CG8MMPh oligonucleotide.   
Differences were also observed in inter-base pair helical parameters. The overall 
trends are that the CG8CPh and CG8MMPh modified oligos alter inter-base parameters 
typically in the opposite direction as compared to the CG8Ph,  CG8Tol or CG8HMPh 
oligonucleotides (with the unmodified oligo as reference). The deviations from the 
unmodified oligonucleotide can be quite large (selected values of RIS, TLT, and ROL).   
In the case of Z-CG8CPh, an obvious outcome (see Figure 5.3) is that the aryl 
adduct is almost planar to purine ring of G6 unlike the rest of modified CG decamers in 
which the aryl group is approximately perpendicular to purine. It is not clear what the 
source of this unique structural feature of Z-CG8CPh is though the carboxylate group is 
very electron donating and therefore there may be a resonance effect with the relatively 
electron deficient guanine base. Such an effect would also reduce the base pair strength 
and increase base mobility (in turn, increasing BKL, PRP, OPN, etc.). This proposal is 
partially supported by the Dials & Windows results that showed considerable variation of 
helical parameters in the MD trajectories of CG8MMPh, especially in the middle of 
sequence at the site of modification.   
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Figure 5.7 Intra-base pair parameters for all base pairs obtained from Dials & 
Windows analysis of the production trajectories of the unmodified and modified CG 
decamers in the Z form. 
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Figure 5.8 Inter-base pair parameters for all base pairs obtained from Dials & 
Windows analysis of the production trajectories of the unmodified and modified CG 
decamers in the Z form. 
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Figure 5.9 Base base-axis parameters for all base pairs obtained from Dials & 
Windows analysis of the production trajectories of the unmodified and modified CG 
decamers in the Z form. 
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With the exception of CG8CPh and CG8MMPh with structures seemed to be 
relatively less sound, the modified CG decamers in Z-form look more rigid and the aryl 
adducts did not appear to interfere with the conformation, in general, based on helical 
parameters. Interestingly, minor groove widths in Z-DNA were wider in case of the 
modified CG decamers except for CG8HMPh. This effect is the reverse of what is observed 
for the B forms and could be one of the factors that stabilize Z form because increasing 
the minor groove width decreases the unfavorable electrostatic interaction.   
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Table 5.3 Helical parameters of the unmodified and modified CG decamers determined 
by CURVES analysis of the most representative structures in the Z-DNA form.a 
                
Intra-Base Pair 
    CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
    G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 
SHR -0.25 (-0.30) 0.03 (-0.02) 0.00 (-0.09) -0.18 (-0.01) -0.09 (0.04) -0.04 (-0.09) 
STR 0.03 (0.09) 0.24 (0.10) -0.04 (0.08) 0.17 (0.04) -0.75 (-0.06) 0.22 (0.08) 
STG 0.42 (0.00) 0.20 (0.20) 0.10 (0.11) -0.02 (0.14) 0.94 (0.29) -0.20 (0.02) 
BKL -3.50 (-2.30) -8.60 (1.07) -2.50 (0.80) 9.09 (1.32) 14.18 (1.53) -9.30 (-6.10) 
PRP -5.40 (0.56) -2.00 (-2.70) 4.20 (4.00) -25.28 (-11.37) -34.74 (-13.11) 3.10 (1.20) 
OPN 1.15 (-0.70) 0.45 (0.04) 0.44 (0.06) 4.01 (-0.38) -19.60 (-2.34) 1.26 (-0.21) 
        
                
Inter-Base Pair 
    CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
    C5:G6/ G6:C7 C5:G6/ G6:C7 C5:G6/ G6:C7 C5:G6/ G6:C7 C5:G6/ G6:C7 C5:G6/ G6:C7 
(C:G) 0.19 (0.03) 0.44 (0.35) 0.27 (0.28) -0.53 (0.06) -0.39 (0.27) 0.21 (0.14) 
SHF 
(G:C) -0.44 (-0.93) -0.49 (-0.42) -0.22 (-0.19) 0.17 (0.07) 0.28 (-0.32) -0.53 (-0.12) 
(C:G) 4.09 (4.26) 4.37 (4.27) 4.00 (4.22) 1.84 (3.65) 1.57 (3.93) 4.35 (4.31) 
SLD 
(G:C) -4.48 (-4.17) -4.67 (4.15) -3.81 (-4.00) -4.32 (-3.56) -3.99 (-3.88) -4.42 (-4.27) 
(C:G) 3.91 (4.26) 3.57 (4.34) 3.92 (4.46) 4.81 (5.17) 2.88 (4.36) 4.15 (3.71) 
RIS 
(G:C) 3.03 (2.86) 2.98 (2.88) 2.81 (2.77) 3.08 (2.71) 6.08 (3.79) 2.88 (3.35) 
(C:G) 4.90 (-3.58) 8.53 (-2.78) 2.04 (-2.49) -5.38 (3.19) -1.78 (-1.86) -8.28 (2.31) 
TLT 
(G:C) 3.22 (4.55) 0.45 (2.65) 1.50 (0.18) 3.27 (-0.31) 13.60 (-0.55) -3.63 (-1.37) 
(C:G) -1.90 (1.67) 7.07 (1.97) 11.47 (6.79) -26.47 (-5.51) 11.61 (-0.62) 4.01 (4.18) 
ROL 
(G:C) 3.73 (4.32) -8.74 (0.55) -2.76 (3.70) 3.41 (10.80) -4.04 (4.99) -7.90 (-2.28) 
(C:G) -8.49 (-10.7) -10.6 (-8.78) -10.70 (-13.4) -4.99 (-9.73) 13.46 (-5.76) -12.3 (-10.8) 
TWS 
(G:C) -44.7 (-45.3) -44.4 (-44.9) -38.6 (-41.6) -35.75 (-41.11) -39.29 (-42.90) -48.1 (-43.2) 
        
                
 Base Pair-Axis 
    CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
  G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 G6/G16 
XDP -2.15 (-2.18) -2.00 (-2.03) -1.55 (-1.55) -0.21 (-0.47) -1.72 (-1.64) 2.15 (-2.15) 
(C:G) -2.17 (-2.07) -1.86 (-1.80) -1.79 (-1.83) -1.68 (-2.14) -0.92 (-1.26) -2.15 (-2.10) 
YDP 
(G:C) 2.05 (2.18) 2.41 (2.35) 2.30 (2.34) 1.29 (1.47) 2.20 (2.71) 2.11 (2.11) 
INC 6.28 (7.78) 5.80 (6.76) 11.0 (10.5) 11.66 (16.44) -1.10 (7.42) 7.47 (6.33) 
TIP 179 (178) 180 (181) 182 (18.2) 1 (35.6) -171 (-139) 179 (179) 
a Values in parenthesis are for the average over all bases 
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Table 5.4 Major and minor groove widths of the unmodified and modified CG decamers 
determined by CURVES analysis of the most representative structures in the Z-DNA 
form. 
              
 Major Groove Width (A°) 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 12.28 10.92 13.27 14.48 22.91 12.92 
5 14.41 14.36 15.01 15.70 20.69 15.60 
6 10.50 12.40 11.76 15.29 19.42 11.15 
7 N/A N/A 15.31 N/A N/A N/A 
Average 12.40 12.56 13.84 15.16 21.01 13.22 
              
 Minor Groove Width (A°) 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 1.93 1.49 1.91 4.87 5.04 2.23 
5 4.15 4.79 4.79 7.03 5.14 4.29 
6 4.13 3.75 4.22 5.38 5.07 2.63 
7 4.13 4.98 4.13 4.99 5.08 4.27 
Average 3.59 3.75 3.76 5.57 5.08 3.36 
 
 
 
5.7 Free Energy Calculation 
The MM_PBSA module of Amber was used to calculate the absolute free 
energies of the modified DNAs in solution from Amber trajectories. The following set of 
equations show the breakdown of the components of the free energies obtained with 
MM_PBSA. 
 
GAS = ELE + VDW + INT                               Equation 5.1 
PBSOL = PBSUR + PBCAL                              Equation 5.2 
PBELE = PBCAL + ELE                                 Equation 5.3 
PBTOT = PBSOL + GAS                                Equation 5.4 
TSTOT = TSTRA + TSROT + TSVIB                     Equation 5.5 
ΔG_PB = PBTOT - TSTOT                               Equation 5.6 
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 From Equation 5.4 - 5.6, the free energy of the system (ΔG_PB) is calculated as 
the summation of the molecular mechanic energy (GAS), the solvation free energy 
(PBSOL), and the total entropy multiplied by the temperature (TSTOT). Sander was used 
to determine the GAS term (Equation 5.1), which represents electrostatic interaction 
(ELE), van der Waals (VDW), and internal energy (INT). Poisson-Boltzman (PB) 
approach using Delphi102 was applied to calculate the hydrophobic contribution to 
solvation free energy (PBSUR) and the reaction field energy (PBCAL) which are 
summed to give PBSOL (Equation 5.2). The total entropy (TSTOT), composed of 
translational (TSTRA), rotational (TSROT), and vibrational (TSVIB) entropies, were 
calculated using the nmode module in Amber 
 The production trajectories from frame 500 to 1950 ps were used in the 
MM_PBSA calculation after water and ions were stripped out. To insure the MM_PBSA 
results for CG8CPh and CG8MMPh were consistent and comparable with the previous data 
set for CG, CG8Ph, CG8Tol, and CG8HMPh, MM_PBSA in Amber version 7110 was used. 
Free energy calculations were performed on both the B and Z forms and by subtracting 
the free energy of B-DNA (ΔG_PB_B) from the free energy of Z-DNA (ΔG_PB_Z), 
ΔΔG_PB_ZB was obtained.  This value was then used to compare the effect of aryl 
adducts on B-Z conversion and determine the relative stability of the two forms. A 
negative value for ΔΔG_PB_ZB indicates that the transition from B to Z is energetically 
favorable. The free energies of the modified and unmodified CG decamers in B and Z 
form calculated by MM_PBSA method are reported in Table 5.5. 
Sietraj was used as an alternative method to MM_PBSA to calculate the free 
energy from molecular dynamic trajectory of CG decamers. Rather than setting DNA as a 
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single molecule in the system and calculating the absolute free energy, as we did in 
MM_PBSA calculation, a DNA duplex was considered to be two molecules binding, one 
a receptor and the second a ligand, though these two parts are identical. The binding free 
energy (ΔG) was then calculated as the difference in free energies between the isolated 
palindrome strands that comprise the duplex and the duplex itself. Generally, sietraj uses 
a similar approach as MM_PBSA to obtained ΔG with the following exceptions: sietraj 
neglects the vibration entropy, a different surface generation method is used107, and 
sietraj uses an internal Poisson solver111,112. As with the MM_PBSA calculations, a 
ΔG_ZB was calculated. The binding free energies of the modified and unmodified CG 
decamers in both B and Z form are reported in Table 5.6 as is ΔG_ZB negative values 
indicate the Z-DNA form is preferred. 
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Table 5.5 The free energies of the unmodified and modified CG decamers calculated with the MM_PBSA method 
 
CG CG8Ph CG8Tol CG8HMPh CG8CPh CG8MMPh Energy 
(kcal/mol) B Z B Z B Z B Z B Z B Z 
ELE -817.40 -63.41 -821.80 -65.69 -698.30 53.67 -812.71 -24.78 -765.59 -360.68 -730.40 -470.84 
VDW -164.30 -196.20 -169.60 -194.20 -171.80 -195.20 -171.10 -196.50 -177.38 -161.64 -153.52 -147.59 
INT 939.70 953.50 968.40 975.80 975.20 981.00 955.90 983.50 1111.28 1161.11 1150.98 1244.11 
GAS -42.00 693.89 -23.00 715.91 105.10 839.47 -27.91 762.22 168.31 638.79 267.06 625.68 
PBSUR 17.63 16.43 17.90 17.14 17.99 17.35 17.89 17.43 18.37 17.48 30.80 30.72 
PBCAL -4858.00 -5604.00 -4839.00 -5593.00 -4977.00 -5729.00 -4838.00 -5625.00 -4635.08 -5030.51 -4778.74 -5036.44 
PBSOL -4841.00 -5587.00 -4821.00 -5576.00 -4959.00 -5712.00 -4820.00 -5607.00 -4616.72 -5013.03 -4747.94 -5005.72 
PBELE -5676.00 -5667.00 -5661.00 -5659.00 -5676.00 -5675.00 -5651.00 -5649.00 -5400.67 -5391.19 5509.13 -5507.29 
PBTOT -4883.00 -4893.11 -4844.00 -4860.09 -4853.90 -4872.53 -4847.91 -4844.78 -4448.41 -4374.24 -4480.88 -4380.04 
TSTRA 15.57 15.57 15.59 15.59 15.60 15.60 15.60 15.60 15.61 15.61 15.61 15.61 
TSROT 15.18 15.20 15.22 15.23 15.23 15.24 15.21 15.25 15.19 15.29 15.24 15.32 
TSVIB 490.30 478.70 497.30 493.30 501.70 499.30 500.30 503.00 526.67 521.01 533.88 533.15 
TSTOT 521.05 509.47 528.11 524.12 532.53 530.14 531.11 533.85 557.47 551.91 564.73 564.08 
ΔG_PB -5404.05 -5402.58 -5372.11 -5384.21 -5386.43 -5402.67 -5379.02 -5378.63 -5005.88 -4926.15 -5045.61 -4944.12 
ΔΔG_PB_ZB 1.47 -12.10 -16.24 0.39 79.73 101.49 
 
 
Table 5.6 The free energies of the unmodified and modified CG decamers calculated with the sietraj method. 
 
CG CG8Ph CG8Tol CG8HMPh CG8CPh CG8MMPh Energy 
(kcal/mol) B Z B Z B Z B Z B Z B Z 
ΔG 673.71 649.39 676.46 646.85 663.48 649.40 656.04 634.13 851.66 782.18 780.43 740.72 
ΔΔG_ZB -24.32 -29.61 -14.08 -21.91 -69.48 -39.71 
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The experimental results obtained by CD and NMR have shown that the order of 
Z-DNA preference is CG8CPh, followed by CG8Ph, CG8MMPh, CG8HMPh, then CG8Tol, and 
finally CG based on the required salt concentration to obtain 50% of  Z-DNA form. The 
free energy analysis study has been conducted in order to try to elucidate the factors 
underlying these results and therefore be able to explain the effect of selected aryl 
adducts on both B and Z-DNA stability and help us understand how the aryl adducts 
cause the conformational change.   
The destabilization effect of aryl adduct on the B-DNA conformation was 
expected. This is based on the well known effect of the steric interaction that occurs 
between the the C8-arylguanine and the H-2′ proton which can be avoided if the 
nucleoside adopts a syn conformation. However, for base pair formation, the C8-
arylguanine base must adopt the anti in B-DNA. From the structural analysis of the 
computational data, B-DNA destabilization effect of C8-arylguanine adducts can be 
inferred from the helicoidal parameters that show the modified oligonucleotides are 
distorted from the unmodified oligonucleotide when in the B-DNA form. Besides steric 
effects, structure analysis on different p-substituent derivatives has suggested that an 
electronic effect may also be important in the B-DNA destabilization as seen in case of 
CG8CPh. The dual interactions, steric and electronic, of p-carboxyphenyl adduct may 
explain its remarkable effect on B-Z conversion. 
A more interesting question is how the aryl adducts affect Z-DNA stability. 
Because the aryl adducts can drive B to Z form without significantly increasing 
denaturation, which could be a reasonable alternative to B-Z conversion, one would 
expect that the C8-aryl adducts should stabilize Z form or at least would not destabilize it. 
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Structural analysis has shown the similarity of helical parameters among the unmodified 
CG, CG8Ph, CG8Tol, and CG8HMPh suggesting that phenyl, p-tolyl, and p-
hydroxymethylphenyl did not alter the conformation in any significant extent. On the 
other hand, p-carboxyphenyl and p-methoxymethylphenyl have distorted the Z form of 
CG decamer in the way that would destabilize Z form which would contradict to our 
initial idea toward these two adducts. In contrast, since, in the Z-DNA form, the purines 
adopt a syn conformation and substituents located on the C8-guanine position lie outside 
of the DNA helix, little effect upon the stability of the Z-DNA forms is expected. This 
may be modulated some by the substituents attached to the phenyl ring. Groups that are 
hydrophobic will tend to destabilize the Z-DNA form while just the opposite is expected 
from hydrophilic substituents. 
The free energy analysis of the models, then, should help verify the proposed 
effects and also determine the relative weights of steric and electronic interactions.  
MM_PBSA and sietraj were used to calculate the free energies of the unmodified and 
modified CG decamers in both B and Z form. As seen in Table 5.5, MM_PBSA 
calculation predicts that B-Z conversion would be favorable if CG decamer is modified 
with a phenyl or tolyl adduct. Based on ΔG_PB_ZB, the remaining adducts should prefer 
to adopt the B-DNA form, opposite from what we have observed experimentally. The 
results from sietraj are different than the MM_PBSA and predict that Z-DNA should be 
preferred for all of the CG decamers.  It could be that the ‘zero’ point needs to be 
calibrated (e.g., set the free energy of the unmodified decamer to favor the B form).  
However, the predicted stability trend is also out of order based on the experimental 
results. 
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While the overall free energy values do not correlate with the experimental trends, 
the trends of the individual components, in many cases, make some sense. Shown in 
Figure 5.10 are plots of GAS and PBSOL. The unmodified and the modified 
oligonucleotides are arranged along the X-axis with respect to the salt concentration at 
which the fZ is 0.5. The Y-axis is the indicated value calculated by MM_PBSA. The plot 
for GAS shows a slight downward trend in the stability of the B forms with the 
methoxymethyl and carboxy derivative calculated to be least stable ones. The B forms of 
CG8HMPh and CG8Ph are less destabilized than might be predicted assuming a linear 
relationship, but the previously discussed hydrogen bonding interactions form p-CH2OH 
and stacking interactions for phenyl must attenuate the unfavorable steric interactions. In 
contrast, relative to the unmodified oligonucleotide, the modified base can either 
destabilize the Z form (CG8Tol), have little effect (CG8HMPh or CG8Ph), or stabilize it 
(CG8CPh or CG8MMPh). The effect may, in part, be due to the 
hydrophobicity/hydrophilicity of the aryl group. For example, the tolyl group is the most 
hydrophobic and the carboxy the most hydrophilic which parallels the Z destabilization 
or stabilization caused by these groups relative to the unmodified derivative.   
The plot for PBSOL, for the B form is fairly consistent with the expections.  
Ingoring the values for the CG8CPh (these are the ones that are at 100 mM on the X-axis), 
there is little variation in PBSOL. PBSOL is the sum of PBSUR and PBCAL (the 
reaction field term) and is dominated by the latter. The specific values PBSOL for CG8CPh 
(B or Z forms) suggest it is destabilized. As previously discuss, we expect the p-
carboxylate group to destabilize the B-DNA form and may also destabilizing the Z-DNA 
form due to the increase in negative charge, the factor that most destabilizes the Z form 
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of DNA.  Then, if the numbers that are used to calculate ΔG generally make sense, then 
why aren’t the computational results better correlated with the experimental results? In 
part the problem is that the numbers being used to calculate the difference in free energy 
between the B and Z forms are both large but the difference is small. Thus, small errors 
in the free energy calculation for the B form or Z form are much less significant than 
when the difference is calculated.   
 
 
 
 
 
 
 
 
 
 
 
The current data from the free energy calculations from both methods are 
inconclusive and cannot be used to accurately predict preferred conformational stabilities 
(B or Z).  However, this does not appear to be due to a fundamental problem with the 
approach rather it more like is a problem with the accuracy of the method used. 
Refinement of the methods, may in time, allow more accurate predictions.    
 
Figure 5.10 Plots of a) GAS or b) PBSOL vs NaCl concentration required to have 
50% Z conformation of CG (3600 mM), CG8Tol (1000 mM), CG8HMPh (694 mM), 
CG8MMPh (669 mM), and CG8CPh (131 mM). 
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CHAPTER 6 
DISCUSSION AND CONCLUSIONS 
 
Aryl hydrazines and related compounds are known for their carcinogenicity4. The 
mechanism of carcinogenesis is believed to initiate from metabolic activation5,6 of aryl 
hydrazines which lead to the formation of harmful reactive intermediates, 
arenediazonium ions and aryl radicals. Consequently, DNA adducts can form from the 
reactive aryl hydrazine metabolites and these have been suggested to be the cause of 
genetic alterations which eventually lead to carcinogenesis. Among several potential 
hypotheses, carcinogenesis through Z-DNA stabilization by the DNA aryl adduct has 
particularly caught our attention and has been one of our major research questions. 
To evaluate the relevant of Z-DNA stability in aryl hydrazine carcinogenesis, the 
effect of various C8-aryl adducts on B-Z conversion has been investigated using both 
experimental and computational methods. We have reported on the CG decamers that 
contain a C8-phenylguanine modified base22. The modification forms from 
arenediazonium ions or aryl radicals generated during the metabolism of phenyl 
hydrazine and may be involved in the mutagenicity of phenyl hydrazine. The resulting 
adduct causes a shift in the B/Z-DNA equilibrium toward the Z-conformation. In this 
study, additional examples of CG decamers that contain C8-arylguanine adducts is 
described. The adducts selected for study form by metabolism of known carcinogenic 
aryl hydrazines. The correlation between aryl hydrazine carcinogenicity and the shift in 
B/Z-DNA equilibrium were expected, if Z-DNA stabilization or/and B-DNA 
destabilization is the only major factor involved in aryl hydrazine carcinogenesis.    
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The aryl modified dG phosphoramidites have been synthesized in order to prepare 
the modified CG decamers through automated DNA synthesis. CD and NMR analysis 
have been extensively used in this study to examine the effect of selected aryl adducts on 
Z-DNA stability. The experimental results have shown there is a remarkable effect 
caused by the C8-arylguanine adduct on B-Z equilibrium which is partially supported by 
the computational study. The results from both methods will be discussed in this chapter. 
The connection between aryl hydrazine carcinogenesis and Z-DNA stabilization/ B-DNA 
destabilization will also be addressed.  
 
6.1 Modified Oligonucleotide Synthesis  
Generally speaking, the preparation of the phosphoramidites used to prepare the 
C8-arylguanine modified oligonucleotides was the same as previously reported22. The 
syntheses utilized a Suzuki coupling to introduce the aryl residue, and the subsequent 
steps used to introduce the protecting groups, are standard. Nevertheless, a few 
adaptations were made, particularly for the preparation of the p-hydroxymethylphenyl 
derivative, which requires TBS protection of the benzyl alcohol group. 
Using intermediates that contained the unprotected p-hydroxymethyl substituent 
was found to be problematic. The nucleophilic nature of the free hydroxyl group was 
expected to interfere with reactions that mechanistically required nucleophilic 
substitution. However, due to the success we had making the CG8CPh oligonucleotide 
without using a protected p-carboxyphenyl dG phosphoramidite, the synthesis of 
CG8HMPh without p-hydroxymethyl protection was attempted. Although, the free p-
hydroxymethyl substituent did not hinder Suzuki coupling or N2 protection, 5′OH 
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protection was affected. Similar to 5′OH, the p-hydroxymethyl substituent seemed to also 
be reactive toward DMTr-Cl. Thus, we obtained a bis-tritylated product. This product 
was isolated and used to prepare the phosphoramidite. However, the use of this material 
for automated DNA synthesis failed to provide the desired oligonucleotide, CG8HMPh. 
Failure to make the desirable oligonucleotide confirmed that protection of the p-
hydroxymethyl substituent would be necessary. 
The TBS group, which has commonly been used to protect the 2′-OH hydroxyl 
group of the ribose sugar in automated RNA synthesis68, was selected to serve as the 
protecting group for p-hydroxymethyl substituent since it is known to survive automated 
synthesis and can be removed with the same reagent as used to remove other protecting 
groups following automated synthesis. Initially, 4-(TBS-O-methyl)-phenyl boronate 
pinacol ester was made (Scheme 6.1) and used in the in Suzuki coupling to make 
compound (6). Likely due to the hydrophobicities of the TBS and pinacol protecting 
groups, the reaction was found to proceed very slowly with a very low yield of the 
desired product. A suspension formed during the reaction, performed in aqueous ACN, 
and the TBS protected starting material precipitated and therefore was present as a 
suspension. The reaction conditions, including the amount, ratio, or type of organic 
solvent (ACN, THF, DME), palladium ligands (TPPTS, TXPTS), and reaction 
temperature, were varied in an attempt to cope with solubility problems and improve 
reactivity and hence the overall yield but all modifications explored were found to be 
ineffective.  
Substitution of 4-(TBS-O-methyl)-phenyl boronic acid (compound (3)) in this 
reaction scheme (Scheme 6.1) combined with increasing the ACN content in the coupling 
 162
was found to alleviate the solubility problem and lead to acceptable yields of the desired 
product (Table 6.1). Without pinacol protection, the hydrophobicity had been reduced. In 
addition, by increasing the organic content of the solvent (using 1:1 instead of 2:1 
water:ACN), the solubility problem was completely eliminated.    
 
 
 
 
 
 
 
        
        
Other than the problem with solubility described above, the aqueous Suzuki 
coupling between 8-BrdG and aryl boronic acids has been proven to be an effective 
method to make C8-aryl modified dG. While the approach only provides medium to 
moderately high product yields (Table 6.1), it is a very clean and simple synthetic 
procedure and obviates the need for any intermediate protection or deprotection steps. 
Workup only involves precipitating the coupling products by the addition of 10% HCl to 
adjust the pH to between 6-7. This step is not always necessary as compound 6 
precipitated as soon as the reaction mixture was diluted with water. In this particular case 
we found that by washing the precipitate with ethyl acetate was all that was required to 
remove excess starting material, compound 3. Generally, it was found that precipitation 
Scheme 6.1 Synthesis of 4-(TBS-O-methyl)-phenylboronate pinacol ester 
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of the coupling products, without further purification, provided sufficiently pure material 
as confirmed by NMR and ESI-MS analysis of the coupling products.  
 
Table 6.1 Synthesis yields of C8-aryl modified dG and derivatives prepared by Suzuki 
coupling.  
 
Percentage Yield (%) 
p-Substituent 
on Aryl Adduct Suzuki Coupling N2 Protection 5'OH Protection 
COOH 82.6 95.7 30.9 
CH2OCH3 67.1 87.6 54.5 
CH2OTBS 71.8 77.3 41.4 
 
The protection reaction of the N2 amine of 2′-deoxyguanosine residue of the 
modified base produced good yields of the desired product (typically > 75%, Table 6.1). 
Based on 1H NMR analysis, the nucleoside precursor was completely consumed resulting 
in only the production of N2 protected nucleoside and the by-product, DMF. We found 
that by precipitation of N2 protection product by the addition of water was an effective 
way to remove the DMF and thereby further purify the crude product, but this procedure 
resulted in a loss of product in the case of compounds (8) and (9) likely because these 
products were slightly water soluble. The product of p-carboxy derivative (compound 
(7)) was quite water soluble and thus could not be precipitated. Since DMF does not 
interfere with 5′OH tritylation, we did not typically remove it from a crude product prior 
to conducting this step. 
Unlike the previous two reactions, the 5′OH protection reaction required column 
chromatography to isolate the trityl protected product. The yield was relatively low (30-
50 %, Table 6.1) probably because of several factors including, product degradation, side 
reactions, and loss of sample during column chromatography. The glycosidic bond of C8-
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aryl modified dG is weaken relative to the unmodified nucleoside, and is very acid 
sensitive. In addition, the DMTr protected 5′OH is, itself, an acid labile functional group 
which is easily cleaved off, reverting back to the unprotected 5′OH in the presence of 
protic acid. Based on TLC obtained during the reaction, the tritylation did not go to 
completion after 12 hours. Using extended reaction times, longer than 4 hours, resulted in 
the production of the undesired double tritylation product (tritylation of both 5′OH and 
3′OH). Thus, in order to minimize by-product formation at the cost of product yield the 
reaction was stopped after 4 hours. Finally, as with the previously synthesized C8-
arylguanosine derivatives, using acidic silica gel as a stationary phase causes degradation 
of the trityl protected product.  Therefore, neutral or basic Al2O3 gel has to be used to 
minimize the degradation.  
Among the three nucleosides prepared in this work, the yield of the 
carboxyphenyl derivative (compound (10)) was the lowest yield (Table 6.1).  This is due 
to the purification process we had to use - precipitation instead of column 
chromatography. Because the carboxylate substituent strongly bound to the Al2O3, 
column chromatography purification was not possible. However, the carboxylate 
derivative 10 displayed poor solubility in dichloromethane (the reaction solvent) was low 
enough such that we were able to isolate it from crude product by precipitation. Although 
this method’s effectiveness has appeared to be moderately low, it was more practical than 
column chromatography.  
In the case of the p-hydroxymethyl derivative, the instability of TBS protecting 
group toward basic conditions may explain the low yield of (12). The basicity of pyridine 
and TEA used in the reaction, to neutralize the HCl formed, may also have caused 
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deprotection of TBS group in (12) or the starting material. As expected the p-
methoxymethylphenyl derivative did not have any significant solubility or stability issue, 
therefore, the product yield of (11) was, relatively higher.   
The intermediates, especially after introduction of the aryl group, were prone to 
decomposition via cleavage of the glycosidic bond. The intermediates leading up to the 
phosphoramidite could be purified but, even with chromatography on basic alumina, 
significant decomposition occurred. Purification of phosphoramidite resulted in 
degradation of product and has shown to be unnecessary since crude phosphoramidites 
were effectively used to make the modified oligonucleotides. 1H NMR analysis was used 
as a quick method to screen a crude phosphoramidite used in DNA synthesis. This is 
somewhat complicated by the fact that the chiral phosphoramidite group was introduced 
on the 3′OH and significantly increased the the multiplicity of peaks, especially sugar 
protons, as the number of diastereomers present doubled.   
The phosphoramidites prepared as described were successfully used to make 
oligonucleotides but exhibited an unfortunate behavior of aggregate formation and 
precipitation in ACN, though this behavior was not seen with other solvents. Once 
formed, this material was insoluble in most aprotic solvents. The aggregate was not 
identified but we speculate that it may be related to the G-quartet. Guanosine and 
derivatives are known to form gels though gel formation tends to require the presence of 
a metal cation. While it is unknown what the constitution of the gel is, it is relevant to 
note here as it directly affects oligonucleotides synthesis.  
Gel formation is relatively fast, occurring over a few minutes and this may hinder 
addition of the base for coupling during oligonucleotides synthesis by limiting the access 
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of phosphoramidite solution to CPG surface where base coupling takes place. It is 
unlikely that the manual addition procedure was directly responsible for the relatively 
low yields obtained as manual addition of unmodified bases did not decrease yields. 
Instead, the lower yield with the C8-arylmodified guanines was more likely due to the 
acid sensitivity of the glycosidic bond. Each base addition cycle on an automated DNA 
synthesizer exposes, albeit it briefly, the growing oligonucleotide to strong acid (TCA) 
which may cause partial decomposition. 
Because of the possibility of incomplete extension and decomposition of 
oligonucleotides containing the C8-arylguanine modification during synthesis, 
purification was necessary. FPLC chromatograms of the crude CG8CPh or CG8MMPh 
oligonucleotides shows a series of minor peaks associated with incomplete sequences and 
degraded products that appear before the major peak of the desired product. In the case of 
CG8HMPh, two large peaks were observed in the chromatogram and we believe them to be 
the peaks of TBS protected and unprotected CG8HMPh oligonucleotides, which was 
subsequently proved to be true by ESI-MS analysis. The TBS protected CG8HMPh was 
collected and re-reacted with NH4OH to give CG8HMPh.  
As expected, the retention time of CG8MMPh was shorter than CG8HMPh because the 
methoxy residue decreases the hydrophilicity and thus the affinity for anion exchange 
resin relative to a hydroxyl group. CG8CPh was expected to elute more slowly than the 
other two oligonucleotides due to the polar nature of the –COOH group and that, under 
the FPLC conditions, it is negatively charged (the FPLC conditions used to separate 
oligonucleotides based on charge and hydrophobicity). Interestingly, the results from the 
FPLC have shown otherwise as it was found that CG8CPh eluted faster than CG8HMPh. It is 
 167
possible that the conformation of the carboxy bearing oligonucletide is different that that 
with the hydroxymethyl derivative, perhaps screening it from the stationary phase.    
Overall, in this study, we have demonstrated that our previously used methods can 
be considered a standard approach for the preparation of C8-aryl modified guanine 
phosphoramidites. Further, these phosphoramidites can be used for the preparation of 
oligonucleotides though the utilization of them requires manual addition. The possibility 
that they are sensitive to acid should be noted as it may impact on decisions as to where 
to place modified oligonucleotides in a sequence. Since automated DNA synthesis is 
typically from the 3′ end, decomposition will be minimized if the modified base is nearer 
the 5′ end, given that the option exists. According to FPLC and ESI-MS, the synthesized 
oligonucleotides were pure enough to use in structural and conformational analysis by 
CD and NMR.  
 
6.2 CD Analysis and Molar Fraction Calculation 
 The global conformation of oligonucleotides can be determined from the shape of 
the CD curves. Therefore, the transition of B form to Z form of CG decamers can be 
observed as can the B/Z equilibrium constant using CD spectroscopy. The C8-
arylguanine adducts have been shown to effect the B-Z equilibrium, shifting it toward the 
Z-DNA form. This can be demonstrated since the modified CG decamers required much 
lower salt concentrations as compared to the unmodified CG decamer. With the 
exception of C8-carboxyphenyl adduct, which is obviously the best at shifting the B-Z 
equilibrium toward the Z-DNA form of the CG decamer, the remaining two aryl adduct 
containing oligonucleotides were similar to the phenyl derivative. At the same time and 
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as will be discussed below, the NMR data and modeling results suggested that the three 
oligonucleotides studied here adopted conformations different from that adopted by the 
phenyl derivative. Here, we sought to put the effect on a quantitative basis and determine 
equilibrium constants and therefore thermodynamic parameters.    
The molar fractions of three DNA conformations (random coil, B, and Z forms) 
that may be present in sample solutions of our modified oligonucleotides have been 
calculated from CD data. The effect of adducts on B-Z conversion has been determined 
with comparisons made based on the salt concentrations that are required to obtain CG 
decamers in 50 % in the Z form (fZ = 0.5, Figure 4.13). The lower the salt concentration 
needed to achieve this indicates a greater effect on B-Z equilibrium. Based on the 
response to salt concentrations, then, CG8CPh was found to be the most prone to form the 
Z-DNA conformation followed by CG8Ph, CG8MMPh, CG8HMPh, and finally CG8Tol.  
The effect is partially due to destabilization of B-DNA form, as suggested from 
Figure 4.14, which illustrates the modified DNA have higher concentrations of the single-
stranded DNA (ssDNA) forms under a given set of conditions (i.e., denaturation of the B 
DNA is occurring) than the unmodified DNA, especially at lower salt concentrations, 
conditions under which the B form should be predominant. To the extent that the ssDNA 
and Z forms are in equilibrium and that increasing the concentration of the ssDNA form 
will tend to drive the equilibrium toward the Z form, this may be one of the possible 
factors that affect the B-Z equilibrium. The position of the B-Z equilibrium is one 
measure of the effect of the aryl modification. However, it is a relative one and does not 
directly address if the effect is one of destabilizing the B-DNA form, stabilizing the Z-
DNA form, or both. To explore this aspect, we used the melting temperature (Tm) data 
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(Figure 6.1) and, in particular, selected the conditions under which molar fraction was fss 
= 0.5. For the unmodified CG decamer, Tm continuously dropped as salt concentration 
increased. Ignoring the effect of salt concentration on Tm (for a B DNA, increasing the 
salt concentration tends to increase the Tm), the overall decline in Tm (e.g., above 500 
mM NaCl) reflects the shift in the B-Z equilibrium toward the Z form, which 
predominates at high salt concentration. Thus, based on Tm, the Z-DNA form is less 
stable than the B-DNA form.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 The Tm of the unmodified and modified CG decamers in phosphate buffer 
pH 7.4 with NaCl concentration of a) 0-4000 mM. The expansion of 0-500 mM is 
shown in plot b). 
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Introduction of the aryl adduct clearly altered the stabilities of B and Z-DNA.   
The effect was the most pronounced for the B form and the aryl group tended to 
destabilize as can be seen by considering the decline of Tm at low salt concentration for 
all modified CG decamers. The source of this destabilization, in part, is likely due to a 
steric effect of C8-aryl as there is limited space around C8-position of an anti G6 in B 
form of CG decamer. In this regard, the Tm of CG8CPh, CG8Tol and CG8HMPh are unique 
and show a sharp and substantial decline, initially, as the salt concentration is increased 
and this is not observed for the CG8Ph or CG8MMPh oligonucleotides. This behavior does 
not seem to be consistent with being caused by only steric interactions to explain the Tm 
results since p-CH3, p-COO- and p-CH2OH are all of similar size to the p-CH2OCH3 
group. An electrostatic interaction may play an additional role to destabilize B form of 
CG8CPh as, at pH 7.4, the carboxylic group will be negatively charged and may 
unfavorably interact with the phosphate backbone. While not charged, and potentially H-
bonding to the phosphate backbone, the p-CH2OH also bears lone-pairs and, if H-bonding 
is occurring, will also be more negatively charged than an isolated alcohol oxygen. The 
suggestion of electronic destabilization is supported by the molecular modeling results. 
Based on the most representative structures of B-CG8CPh and B-CG8HMPh, the nearest 
distance between negatively charged oxygens of p-COO- and C5 phosphate oxygen was 
3.4 Å while the neutral oxygen of p-CH2OH was even closer to C5 phosphate oxygen 
with the distance of 2.8 Å (Figure 6.2). The distances were far more than 10 Å in Z form 
of both oligonucleotides, diminishing the electronic effect that may be existed in B form. 
Note that the lack of negatively charge of p-CH2OCH3 and longer distance from C5 
phosphate may explain why the Tm of CG8MMPh does not follow this trend (though it may 
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and additional points near 0 mM NaCl need to be collected). The most representative 
structure and helical parameters obtained from structure analysis in computational study 
does support the idea of B-DNA destabilization. However, electrostatic interactions like 
those described for B-CG8CPh and B-CG8HMPh clearly are not possible for CG8Tol and other 
or additional factors must be involved.  
 
 
 
 
 
 
 
 
 
Although the destabilization of B form can be extrapolated from the Tm data, the 
effect of the aryl adduct on Z-DNA stability is more difficult to ascertain. This is because 
as the temperature increases and the Tm approached, an ever increasing amount of the Z 
DNA form converts to the B-DNA form prior to melting. Therefore, it is not necessarily 
correct to compare the stability of Z-DNA based on the observed Tm only, even at higher 
salt concentrations. Nevertheless, if it can be assumed that at 4000 mM NaCl, that most 
of the modified oligonucleotides are in the Z-DNA conformation during melting, then 
some comparisons can be made.  In particular, if there is destabilization of the Z-form 
then the order is CG8Tol > CG8MMPh > CG8HMPh > CG8Ph > CG8CPh. 
Figure 6.2 Snapshot shows possible electrostatic interaction between C5 phosphate 
and the p-substituents of aryl adducts on CG8HMPh (left) and CG8CPh (right). 
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6.3 NMR Analysis 
 In addition to the global conformation of DNA that can be detected by CD, the 
determination of local conformation can be obtained from NMR analysis. The results 
from the NMR studies were mainly in agreement with the CD data.  Thus, they confirm 
that at low salt the modified CG decamers were in B form while Z form was a 
predominant conformation in samples containing high salt concentrations. The latter is 
demonstrated by the strong nOe cross peak of H8/H-1′ suggesting that the purines (dG) 
were adopting the syn-conformation as they are in Z-DNA.  
The chemical shifts of C8-aryl adduct of G6 (Table 6.2) have implications for 
what is the local structure of G6 in the B and Z forms. The aryl adduct protons of the B 
form were found to be upfield relative to these protons in the Z form. This indicates that, 
in the B conformation, G6 may be positioned in such a way that the aryl ring of the 
adducts are under an influence of the π system of the 5′ pyrimidine ring (C5). This would 
produce a shielding effect on aryl adduct protons, shifting them upfield. This suggestion 
is supported by the molecular modeling results that show partial stacking/overlapping 
aryl ring of the C8-aryl adduct located at the G6 and the pyrimidine at C5 in B form of 
modified CG decamers. Unlike B forms, the aryl adducts in Z forms are pointed away 
from and are entirely outside of the helical axis and therefore cannot be shielded by 
neighboring bases.  
It is also key to note that there were five distinct chemical shifts observed for the 
phenyl adduct in B form. This is not what was observed for the new adducts, rather the 
protons located at both the ortho and meta protons relative to the p-substituent were 
equivalent and displayed a the typical AA′XX′ pattern of a 1,4-disubstituted benzene ring 
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and not four distinct resonances. One explanation for this is that there is free rotation 
about the aryl-dG bond in the p-substituted aryl systems such that the two ortho or meta 
protons can interconvert, but not in the phenyl substituted system. Based on structural 
analysis in computational study, the helical parameter suggested more stacking between 
phenyl adduct and pyrimidine of C5 which may constraint the phenyl adduct so that it 
can not rotate as fast as other adducts. 
   
Table 6.2 1H NMR assignment of C8-aryl G6 adduct in CG decamers. 
  
Chemical shifts of aryl adducts protons (ppm) 
DNA 
B form Z form 
CG8Ph 6.35 ,7.04 ,7.28 ,7.32 ,7.33 7.55, 7.65, 7.84 
CG8Tol 6.28, 6.86 7.64, 7.69 
CG8CPh 6.72, 7.79 7.81, 8.16 
CG8MMPh 6.38, 7.08 7.74, 7.77 
CG8HMPh 6.37, 7.09 7.73, 7.76 
 
 The assignment of non-exchangeable protons to each base in CG decamer 
sequences has shown some interesting trends in chemical shifts that contain structural 
implications. The aryl adducts have structurally affected their neighboring base as we 
observed from the altered chemical shifts. In case of the unmodified B-CG (Figure 6.3a), 
the chemical shifts for most of a given type of proton were fairly constant except at the 
ends were fraying effects modulate shifts, and are consistent with well oriented base pairs 
in a double helix. In contrast, the C8-aryl adduct on G6 of, for example, B-CG8MMPh 
(Figure 6.3b), caused discontinuities in chemical shift of all protons of G6 and C5 (G15 
and C16) suggestive of a local disruption in structure. This also supports the CD results 
that show the aryl adduct destabilized B form.  
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Molecular modeling studies suggested the same idea and have been used to help 
explain some of the abnormality in chemical shifts of the modified CG decamers. For 
instance, in the model of the B-CG8MMPh, C5:H6 and C5:H-2′ are located right above the 
aryl adduct on G6 which should position them such that they should be shielded and be 
upfield shifted as observed. Likewise, the unusual downfield H-1′ of C7 could be a 
consequence of a remarkably close distance (2 Å) between the H-1′ and G8:N7, which 
were generally farther (5 Å) for other cytosines. All aryl adducts (except for p-
carboxyphenyl due to unavailable NMR assignment of B-CG8CPh) have been show to 
cause similar patterns in chemical shift plots of protons in oligonucleotides in B form.  
The conformational transition of B to Z form requires rearrangement of the DNA 
structure that is reflected in the change in proton chemical shift. By comparison of proton 
chemical shift plots of the B-CG (Figure 6.3a) and Z-CG8CPh (Figure 6.4a) or Z-CG8MMPh 
(Figure 6.4b), we can observe the differences in chemical shift between B and Z-DNA. 
The most notable ones were including the downfield shifts of G:H-1′, C:H5, and the 
upfield shift of C:H-2′. The key to these chemical shift changes is based on the transition 
of anti-dG to syn-dG as occurs when B-DNA converts to the Z conformation. In B form, 
dG bases are in the anti-conformation such that H-1′ of dG are positioned deep inside the 
helix and are probably shielded by neighboring pyrimidines. Similarly, H5 of dC 
experience a shielding effect caused by the purine of 5′ dG. Once the conformation of dG 
reverses to syn, the shielding effects are no longer possible resulting in downfield 
chemical shifts of G:H-1′ and C:H5. On the other hand, the syn conformation of dG 
places H-2′ of dC closer to N2 amino group of 5′ dG causing C:H-2′ to be slightly 
upfield.  
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Figure 6.3 The plots of non-exchangeable proton chemical shifts of each base in a) B-
CG and b) B-CG8MMPh 
Figure 6.4 The plots of non-exchangeable proton chemical shifts of each base in a) Z-
CG8CPh and b) Z-CG8MMPh 
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As we can see from the continuity of plot of chemical shift in Z form, the aryl 
adducts do not seem to disrupt the structure of Z form as they did in B form. This remark 
is generally supported by the model of modified CG in the Z-DNA conformation with the 
exception of Z-CG8CPh. In this case, the aryl adduct is pointed away from the helical axis 
due to syn-glycosidic bond of G6 that position such that the steric interaction between H8 
and H-2′/2′′ was reduced. Consequently, this would prevent the aryl adduct from 
interacting and interfering with base pairing, unlike what occurs when this adduct adopts 
the B-DNA form. NMR analysis has suggested additional structural information that the 
aryl adducts favor Z over B conformation. 
 
6.4 Computational study 
The most representative structures and helical parameters have shown that the 
aryl adducts, in general, distorted the B conformation. Based on general considerations, 
the bulkiness of aryl adducts is the likely cause of the structural deformations. However, 
the simulations of various aryl modified CG decamers have pointed toward the possibility 
that other interactions may also play important roles with respect to the effect of them on 
the B-DNA conformation, both locally and globally. A major factor is the occurrences of 
stacking interactions between the C8-aryl adduct on G6 and pyrimidine ring of C5 was 
found to be energetically possible, especially in the case of the phenyl adduct. 
Structurally, this interaction requires, locally, increase rise and negative slide of the base 
pair which, in turn, stretches the duplex. These changes decrease the overall contribution 
of base-base stacking and destabilize the B-DNA conformation. 
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There may also be electrostatic repulsion between the p-substituent that further 
decreases the overall stability of the B-DNA. All of the aryl adducts have been shown to 
cause compression of the minor groove (decreased width). Decreasing the minor groove 
width causes the phosphate groups to be closer to one another causing an unfavorable 
electrostatic interaction. In addition, depending upon the specific adduct, additional 
unfavorable electrostatic factors may further destabilize the B-DNA form as in the case 
of the p-COO- derivative in which the negatively charged carboxylate group is position 
near the negatively charged phosphate backbone. This additional factor is the likely cause 
of the low stability of B-CG8CPh that observed in Tm profile (Figure 6.1).  
The simulations of the C8-arylguanine adducts in the Z-DNA conformation have 
not elucidated the order of stability experimentally determined. Except for CG8CPh and 
CG8MMPh, in which the aryl adducts seemed to have caused some effects on duplex 
structure. Nevertheless, with current data from the structure analysis, the computational 
studies have not fully explained how the aryl adducts are effecting Z-DNA stability.  
The free energy calculation was conducted in an attempt to gain more information 
regarding Z-DNA stability, but the free energy calculations based on MM_PBSA or 
sietraj are not in agreement with the experimental results. There are several potential 
reasons for this that were previously discussed and additional reasons, such as the effect 
of the choice of sampling (i.e., which structures are used to calculate the free energy) 
which has been shown to provide different free energy results. Also, it is possible that the 
length of simulations were insufficient. This is particularly true for the Z-CG8MMPh as the 
RMSd plot indicated that the structure was still drifting from the starting structure and 
changing helicoidal parameters determined with Dials & Windows, even after 4 ns of 
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MD. Revision or continuation of the simulation(s) of the Z-DNAs may be required to sort 
out the problem with the computation and thereby resolve the differences observed 
between the experimental and computational results. 
 
6.5 Thermodynamic study 
The B-DNA destabilization effect of the aryl adducts seems to be clear based on 
the CD, NMR, and computational studies. The effect on the Z-DNA form is still 
ambiguous. Thermodynamic studies may be able to aid in understanding what is driving 
the shift in the B-Z equilibrium as a function of the aryl adducts. The van’t Hoff plot of 
the B-Z equilibrium has been made to obtain thermodynamic parameters including ΔH, 
ΔS, and ΔG20,21,85. The system equilibrium has been simplified to ease the calculation as 
depicted in Figure 6.5, and assumes that B, Z, and ssDNA are the only species present 
and simplifies the analysis by assuming that only the B and Z forms interconvert (KB-Z). 
The alternative is that this is a three species equilibrium (i.e., B/ss followed by ss/Z rather 
than B/Z) but is much more difficult to fit.  
 
 
 
 
 
 
 
 
Figure 6.5 A diagram shows equilibrium between B-, Z-, and ssDNA 
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The van’t Hoff equation was derived as following 
 
                                                                  ΔG = ΔH – TΔS                               Equation 6.1 
                                                                  ΔG = -RTlnKB-Z                                              Equation 6.2 
                                                           lnKB-Z = -ΔH/RT + ΔS/R                        Equation 6.3 
                                                          ln(fZ/fB) = -ΔH/RT + ΔS/R                       Equation 6.4 
                                                           ln(fB/fZ) = ΔH/RT - ΔS/R                        Equation 6.5 
 
Based on Equation 6.5, by plotting ln(fB /fZ) against 1/T, ΔH can be obtained from 
slope (ΔH/R) and ΔS can be obtained from intercept (-ΔS/R), where R is the gas constant 
(1.9872 cal mol-1K-1). The van’t Hoff plots of B-Z transition of the unmodified and 
modified CG decamers are shown in Figure 6.6 and the thermodynamic parameter are 
reported in Table 6.3. From the thermodynamic data, the B-Z conversion was mainly 
enthalpy driven. The aryl adducts make the transition to the Z-form more favorably by 
lowering energy of the Z-DNA form based on significant enthalpy change, even though 
the B-Z conversion process of the modified oligonucleotides reduces the entropy of the 
system. Although the negative ΔG of B-Z conversion indicates that the process was 
energetically favorable (which is obvious), it does not elucidate the source of the 
stabilization.    
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Table 6.3 Thermodynamic parameters for B-Z transition of the unmodified and modified 
CG decamer in phosphate buffer pH 7.4 with 500 mM NaCl at 298°K (25°C). 
 
DNA Slope Intercept R2 ΔH  
(cal mol-1) 
ΔS  
(cal mol-1 K°-1) 
ΔG  
(kcal mol-1) 
CG -5.33 22.52 0.95 -10594 -44.75 2.74 
CG8Ph -16.30 52.65 0.99 -32389 -104.62 -1.21 
CG8Tol -15.06 49.98 1.00 -29933 -99.33 -0.33 
CG8CPh -10.85 33.04 0.99 -21553 -65.66 -1.99 
CG8HMPh -14.63 47.74 0.99 -29071 -94.86 -0.80 
CG8MMPh -13.30 43.39 0.98 -26426 -86.23 -0.73 
 
To further explore the idea that the aryl adducts stabilize the Z-DNA form and 
thus work synergistically with their effect of destabilizating the B-form, ΔG of Z and B-
DNA duplex binding have been estimated using the same method as used for B-Z 
Figure 6.6 The van’t Hoff plot of B-Z transition of the unmodified and modified CG 
decamer in phosphate buffer pH 7.4 with 500 mM NaCl. 
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conversion. A decline in ΔG (i.e., more negative) would be expected if the duplex in the 
Z-form was stabilized in the presence of an aryl adduct, since this means higher energy is 
required to denature double strand DNA to single strand DNA. On the other hand, 
increase in ΔG means CG decamer duplex was destabilized by an aryl adduct. The 
thermodynamic parameter of B-DNA and Z-DNA duplex binding are shown in Table 6.4 
and 6.5.  
 
Table 6.4 Thermodynamic parameters for B-DNA duplex binding (ssÆB) of the 
unmodified and modified CG decamer in phosphate buffer pH 7.4 with 500 mM NaCl at 
298°K (25°C). 
 
DNA Slope Intercept R2 ΔH  
(cal mol-1) 
ΔS  
(cal mol-1 K°-1) 
ΔG  
(kcal mol-1) 
CG -21.22 59.65 0.98 -42176 -118.53 -6.85 
CG8Ph -7.11 20.65 0.95 -14123 -41.03 -1.90 
CG8Tol -6.65 19.16 0.91 -13213 -38.07 -1.87 
CG8CPh -7.28 21.78 0.93 -14475 -43.28 -1.58 
CG8HMPh -7.88 23.35 0.96 -15655 -46.40 -1.83 
CG8MMPh -8.45 24.44 0.96 -16793 -48.58 -2.32 
 
Table 6.5 Thermodynamic parameters for Z-DNA duplex binding (ssÆZ) of the 
unmodified and modified CG decamer in phosphate buffer pH 7.4 with 1000a mM NaCl 
at 298°K (25°C). 
 
DNA Slope Intercept R2 ΔH  
(cal mol-1) 
ΔS  
(cal mol-1 K°-1) 
ΔG  
(kcal mol-1) 
CG -16.94 52.58 0.99 -33655 -104.48 -2.52 
CG8Ph -27.86 85.28 0.97 -55353 -169.46 -4.85 
CG8Tol -20.19 62.37 1.00 -40130 -123.94 -3.20 
CG8CPh -15.46 46.06 0.95 -30718 -91.52 -3.44 
CG8HMPh -27.55 84.17 0.97 -54743 -167.26 -4.90 
CG8MMPh -19.04 57.74 0.99 -37840 -114.74 -3.65 
 
a Data points at 1000 mM were used in van’t Hoff plot of Z-DNA Æ ssDNA instead of at 500 
mM due to the fZ data of the unmodified CG that available only at higher salt concentration.  
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By comparing ΔG of the modified CG decamers to the unmodified one, we have 
again confirmed that the aryl adduct destabilized B form and by far B-CG8CPh was the 
least stable one as expected from experimental and computational studies. More 
importantly, we have finally demonstrated that the aryl adducts actually stabilized Z-
DNA as ΔG of Z-DNA binding were lower in case of the modified CG decamers.  
The aryl adduct stabilizes the Z-DNA by reducing system enthalpy and suggests, 
from the thermodynamic parameters obtained and shown in Table 6.5, except in the case 
of the p-carboxyphenyl adduct. This unique behavior was actually observed in the most 
representative structure in which the Z-CG8CPh seemed to bind relatively loose compared 
to the rest of CG decamers.  
Note that Z-DNA is known to be unusually rigid20,21 as compared to its 
counterpart B conformation or other DNA conformations. The decrease in entropy of the 
modified CG decamers compared with the unmodified one may suggest that the aryl 
adducts have affected the structure of Z-DNA such that it is even more rigid than the 
unmodified version. The computational study has shown us that the Z form of CG8CPh 
seemed to be more flexible compared to the rest of modified CG decamers. This notion 
corresponds to the free energy estimation that formation of Z-CG8CPh has the smallest 
entropic penalty. The unique electronic effect of p-COO- is likely involved in driving 
structural change in a way that lowered rigidity of Z form compared to other aryl adducts. 
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6.6 Relevance of the B-Z Transition in Aryl Hydrazine Carcinogenesis 
To evaluate the role of B-Z transition in aryl hydrazine carcinogenesis, we have 
set out to make the modified CG decamers with selected C8-arylguanine adduct. By 
linking the effect of the aryl adduct on Z-DNA stabilization/B-DNA destabilization and 
carcinogenic profile of the aryl hydrazine that serves as the precursor to adduct 
formation; we hoped to show the relevance of B-Z equilibrium in carcinogenesis will be 
revealed. While it has been shown in our study that all studied carcinogenic aryl 
hydrazines can generate aryl adducts that stabilized Z-DNA and/or destabilized B-DNA 
and shift the B-Z equilibrium toward the Z-DNA form, we also hoped that a ranking of 
the effect would correlate with the carcinogenicity of the aryl hydrazines.   
There have been numerous studies of the mutagenicity and/or carcinogenicity of 
aryl hydrazines and related chemicals. These studies have been conducted in a wide range 
of several cell lines and animals4. Although the pool of carcinogenic data is large, a 
consistent data set (e.g., same dose, species, etc.) in which the carcinogenicities of 
various aryl hydrazines were compared under identical conditions is unavailable. Usually 
different models or conditions were used for each study and a clear ranking is difficult to 
create. The most comprehensive carcinogenic profile was from Lawson, T., et al., work 
that was conducted in collaboration with our lab in 199546. In this study, the 
mutagenicities of selected aryl hydrazine metabolites, including MBD, HMBD, MMBD, 
and CBD, were measured in TA102 and V79 cells. The result on TA102 (Figure 6.7) 
suggests that the mutagenic potency of arenediazonium ions was in order of MBD > 
HMBD > MMBD > CBD, which turned out completely opposite to the trend the resulting 
adducts derived from the benzenediazonium ions have on the B-Z equilibrium found in 
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this study. Note that MBD gives p-tolyl adduct while HMBD, MMBD, and CBD give p-
hydroxymethylphenyl, p-methoxymethylphenyl, and p-carboxyphenyl adducts 
respectively. 
 
 
 
 
 
 
 
 
 
 
Considering that the known mechanism of mutagenesis in TA102 model was 
based on the frame shift caused by mutation specifically at a ‘hot spot’ comprised of five 
consecutive A-T base pairs113, the data seemed to be less relevant and may not be directly 
applicable to our work that used CG decamer sequence as a testing model of B-Z 
equilibrium.   
The result obtained from the V79 assay, a more difficult but more relevant assay 
(mammalian cells rather than bacteria). The assay itself is run in Chinese hamster ovarian 
cells and is based on the mutation of the hypoxanthine-guanine phosphoribosyl 
transferase (HGPRT)114,115. The mutagenicity of the arenediazonium ions based on this 
mutational analysis are shown in Figure 6.8 and show a different pattern of mutagenicity 
Figure 6.7 Mutagenicity of arenediazonium ions in TA102 cells 
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in which MBD is now the weakest mutagen and the order of the remaining three 
arenediazonium ions is as observed in the Ame’s assay. 
        
 
 
 
 
 
 
 
 
 
 
The mutagenic trend of arenediazonium ions in the V79 assay was better 
correlated with the results we had obtained regarding the Z-DNA stabilization effect 
observed for the modified oligonucleotides we had examined (p-hydroxymethylphenyl > 
p-methoxymethylphenyl > p-carboxyphenyl > p-tolyl) though the p-carboxyphenyl was 
out of order depending upon whether the effect of salt or Tm was used for the 
comparison. However, if the effect of the adducts on B-DNA stabilization is included, the 
mutagenic trend seemed to be unrelated to the effect of the adducts on B-Z equilibrium. 
The situation is further complicated if the stability of arenediazonium ions (tested in 
aqueous solution) is taken into account. If this factor is included then a possible 
correlation between mutagenicity and the B-Z equilibrium can be made. In particular, 
Figure 6.8 Mutagenicity of arenediazonium ions in V79 cells. 
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arenediazonium ions are highly electrophilic and decompose very fast in cells culture 
media. The stability of arenediazonium in Williams medium E (WE) used in V79 study 
decrease in the order HMBD > MBD > MMBD > CBD (29%, 26%, 20%, and 14% 
remaining after 16 hrs in WE). The corresponding p-substituted phenols form as the 
arenediazonium ions decomposed. The degradation of the tested chemical in WE could 
greatly affect their mutagenicity and should be considered along with the reported data. 
The adjusted trend (Figure 6.9) on mutagenicity of aryl hydrazines was generally 
aligned with the trend observed for the effect of the aryl adducts on the B-Z equilibrium.  
The tolyl adduct, which had the least effect on B-Z equilibrium forms from MBD, the 
weakest mutagen in V79 study. In addition, the V79 mutagenicity of HMBD was 
significantly higher than MMBD at a 10 µM dose, but the difference disappeared when 
tested at higher concentrations (50 µM and 100 µM dose) as the p-hydroxymethylphenyl 
and p-methoxymethylphenyl adduct have similar effect on B-Z conversion. Finally, as 
seen in Figure 6.8, the mutagenicity of CBD was relatively low, but after the stability of 
CBD in WE was considered, CBD was among the strongest mutagenic in the series and 
correlates with the result that p-carboxyphenyl adduct was the best at promoting B-Z 
transition. 
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An additional factor that needs to be considered is repair. While this is not an 
issue in the Ame’s assay, in other settings, the rate of repair of damaged DNA (e.g., 
following adduct formation) is of considerable importance. A famous example of this is 
the O6-methyl and N7-methyl guanine adducts that form from N,N-dimethylnitrosamine.  
The latter is formed in vivo in amounts that are ten times that of the former116. However, 
the N7-methyl adduct is rapidly repaired while the O6-methyl adduct persists117. In the 
present case, the adducts all cause some degree of distortion of the DNA they are in. The 
tolyl adduct causes the greatest amount of distortion and is likely to be ‘seen’ by repair 
enzymes much more readily than the p-hydroxymethylphenyl adduct which produce only 
minor distortion of the DNA. Thus, how long the adducts persist may also play a 
significant role in the carcinogenicity of the parent aryl hydrazines. 
 Overall, it is unlikely that a simple correlation will be found between, for 
example, the Ames’ Assay, V79 assay, repair assays, etc. Instead, all data, including the 
Figure 6.9 Mutagenicity in V79 cells factoring with arenediazonium ions stabilities. 
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conformational effects of the adducts will need to be considered to ascertain the role the 
B-Z equilibrium may play in aryl hydrazine mutagenesis and/or carcinogenesis. At the 
same time, our data do suggest the possibility of a correlation between aryl hydrazine 
carcinogenesis and B-Z equilibrium and therefore provides reasonable cause to continue 
with studies in a more biological setting (cellular level or in vivo) to more clearly 
determine the relationship between carcinogenicity and the effect of the aryl adducts on 
B-Z equilibrium.    
 
6.7 Conclusion 
 Aryl hydrazines and related compounds have been known to be carcinogens 
several decades. Likewise, they have been extensively studied yet a mechanism or 
mechanisms of carcinogenesis is still unclear. The DNA aryl purine adducts generated 
from reactive metabolites of aryl hydrazines, including arenediazonium ions and aryl 
radicals, are suspected to be involved in or the cause of carcinogenesis like other adducts 
generate from non-hydrazine carcinogens (aminofluorene17, PAHs48, etc.). Several 
possible effects of the aryl adduct on DNA that may lead to genetic alterations have been 
suggested, among them the effect on the B-Z equilibrium as caused by aryl adducts has 
caught our interest. 
 The biological relevance of Z-DNA has been extensively studied and debated 
especially during the 1980’s, though the debate continues and the scientific community as 
since largely ignored Z-DNA in a biological context. A similar history occurred for 
triplex DNA as when if was first discovered in 1957 it was consider an anomaly and 
nearly 30 years passed before a biological role was found. It was not until recently that Z-
 189
DNA regained biological interest as Z-DNA formation has been shown to be an 
intermediate in activation process of CSF-137 which indicates possible biological role of 
Z-DNA in gene transcription. In addition, the mutagenic potential of Z-DNA has been 
proposed based on the result that links Z-DNA to DNA damage such as genetic deletions 
in mammalian cells45. These studies have pointed out the possibility that unregulated Z-
DNA formation could consequently trigger genetic alteration and lead to carcinogenesis. 
With the possibility that aryl adducts formed from aryl hydrazines may promote B-Z 
transition like the well-known C8-bromo or C8-methyl guanine adducts, we have 
proposed that aryl hydrazine carcinogenesis may occur through altering the B-Z 
equilibrium facilitated, in the case of aryl hydrazines, by the aryl adduct. Therefore, we 
have set out to investigate 1) the effect of aryl adducts formed from aryl hydrazines on B-
Z DNA equilibrium and 2) the relevancy between Z-DNA formation and aryl hydrazine 
carcinogenesis. 
 To this end, the CG decamer has been selected as the model system to investigate 
the effect of C8-arylguanine adducts on B-Z transition. The unmodified and modified CG 
decamers, including CG8Ph, CG8Tol, CG8CPh, CG8MMPh, and CG8HMPh, were successfully 
made through Suzuki coupling and phosphoramidite chemistry. Structural and 
conformational analyses of the synthesized oligonucleotides, conducted by using CD and 
NMR, indicates that C8-arylguanine adducts have facilitates Z-DNA formation. The 
quantitated effect of adducts on B-Z transition estimated from salt concentration required 
to have CG decamers in Z form at a level of 50% suggests the preference on Z-DNA 
formation is in the order CG8CPh > CG8Ph > CG8MMPh > CG8HMPh > CG8Tol. The melting 
temperature data shows that the adducts destabilize the B-DNA form. The 
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thermodynamic studies have confirmed the B-DNA destabilizing effect and show a 
simultaneous stabilizing effect on the Z-DNA form is caused by the C8-arylguanine 
adducts.  
Computational studies have been used to understand and explain the local and 
global effects of the aryl adducts that drive B-Z conversion. The steric effect from C8-
arylguanine adduct related to the anti dG form and the stacking interaction observed 
between the aryl adduct and C5 pyrimidine are most likely the main cause of the 
observed distortion seen for the B-DNA form and indicate a destabilizing effect on this 
conformation. Depending upon the adduct, there may be addition destabilizing effects.  
For example, the carboxylate group of the CG8CPh oligonucleotide is also destabilized by 
electrostatic repulsion between the p-COO- and the phosphate backbone and is likely the 
explanation for its unique effects relative to the other adducts on B-DNA destabilization. 
With current data, the Z-DNA stabilization effect of the aryl adducts can not be clearly 
explained except that in general, the adducts do not seem to interfere with the Z-DNA 
structure and therefore are not expected to decrease the stability of Z form like they do in 
B form.  
We expected to find a correlation between carcinogenic potential of an aryl 
hydrazine and the effect on B-Z equilibrium. However, given the multitude of other 
factors that may impinge on the carcinogenicity of aryl hydrazines discussed above and 
additional factors such as absortion, distribution, etc., a perfect correlation is 
unreasonable to expect. However, based on the consideration noted above, CBD can be 
argued to be the most potent carcinogen followed by HMBD, MMBD, and MBD and this 
trend generally correlated with the trend observed for the position of the B-Z equilibrium 
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of CG8CPh, CG8HMPh, CG8MMPh, and CG8Tol. Based on the knowledge that all C8-
arylguanine adducts formed from carcinogenic aryl hydrazines and that these adducts 
drive equilibrium toward the Z conformation, a better than expected correlation with 
mutagenicity and perhaps carcinogenicity has been revealed. Thus, this study has shown 
a potential connection between Z-DNA formation and aryl hydrazine carcinogenesis 
opening the possibility to advance the investigation to the next level.  
 
6.8 Future Direction 
The current data from this study suggests a possible link between Z-DNA and 
carcinogenesis by aryl hydrazines. Additional studies, however, will be required in order 
to obtain sufficient data to strongly support the proposed hypothesis.  
 In vitro studies have shown that the aryl adducts affect the relative stability of B 
and Z-DNA forms such that they shift the equilibrium toward the Z-DNA form. At the 
same time, we can not be certain that the aryl adducts will have the same effect in vivo. 
Although it may be true that some factors in the physiological environment such as Z-
DNA binding proteins and other cations could promote Z-DNA formation, several factors 
may limit the formation of Z-DNA in physiological condition such as relatively low salt 
concentration, abundance of Z-DNA forming sequences, etc. Therefore, investigation of 
Z-DNA formation in vivo, as a result of adduct formation is needed. The presence of Z-
DNA in physiological system is generally transient which will make observing it in vivo 
more difficult. No matter, it has been shown to be detectable by several methods 
including Z-DNA specific antibody binding assay35,118-120, reaction with DEPC37,121, and 
enzyme restriction of the B-Z junction45. In addition, detection of the binding to Z-DNA 
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specific proteins such as ADAR142,98, DML198,122, or E3L123-125 would be a probable 
alternative or at least a first step toward detection of Z-DNA in vivo.  
 Ultimately, a more relevant, comprehensive carcinogenic profile of aryl 
hydrazines or arenediazonium ions from in vivo studies that incorporates the detection of 
Z-DNA formation as an intermediate process will be necessary to establish the 
correlation between Z-DNA and aryl hydrazines carcinogenesis. 
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APPENDIX A 
ABBREVIATIONS 
 
          Chemicals                                                        Experimentals 
 
8-BrdG, 8-bromo-2′-
deoxyguanosine 
A, adenine 
ACN, acetonitrile 
BD, benzenediazonium ion 
C, cytosine 
CBD, p-
carboxybenzenediazonium ion 
CE-PA, cyanoethyl 
phosphoramidites 
CG, d(CGCGCGCGCG)2 
CG8CPh, d(CGCGCG8CPhCGCG)2 
CG8HMPh, 
d(CGCGCG8HMPhCGCG)2 
CG8MMPh, 
d(CGCGCG8MMPhCGCG)2 
CG8Ph, d(CGCGCG8PhCGCG)2 
CG8Tol, d(CGCGCG8TolCGCG)2 
D2O, deuterium oxide 
DEME, diethylaminoethyl 
dG, 2′-deoxyguanosine 
DME, dimethylether 
DMF, N’N-dimethylformamide 
DMTr, dimethoxytrityl 
dsDNA, double strand DNA 
G, guanine 
HMBD,  p-
hydroxymethylbenzenediazoniu
m ions 
MBD,  p-
methylbenzenediazonium ions 
MMBD,  p-
methoxymethylbenzenediazoniu
m ions 
NBS, N-bromosuccinimide 
Pd(OAc)2, palladium acetate 
ssDNA, single strand DNA 
T, thymine 
TBS, t-butyldimethylsilyl 
TCA, trichloroacetic acid 
1D, one dimension 
2D, two dimensions 
COSY, correlation spectroscopy 
Css, conc. of ssDNA (µM) 
Cds, conc. of dsDNA (µM) 
CB, conc. of B-DNA (µM) 
CZ, conc. of Z-DNA (µM) 
CD, circular dichroism 
CD295, CD at 295 nm 
CI, chemical ionization 
CPG, controlled pore glass 
CSF-1, colony stimulating 
factor-1 
EI, electron ionization 
ESI, electrospray ionization 
FEP, free energy perturbation 
FPLC, fast protein liquid 
chromatography 
HETCOR, heteronuclear 
correlation spectroscopy 
HPLC, high pressure liquid 
chromatography 
M, molecular mass 
MD, molecular dynamic 
MM, molecular mechanic  
MS, mass Spectrometry 
MW, molecular weight 
m/z, mass to charge ratio 
NMR, nuclear magnetic 
resonance 
nOe, nuclear Overhauser 
enhancement 
NOESY, nuclear Overhauser 
effect correlation spectroscopy 
Nα, lower energy state nuclei 
Nβ, higher energy state nuclei 
 
 
 
pD, apparent pD 
R, gas constant 
RF, radio frequency  
RMSD, root mean square 
derivation 
RP-TLC, reverse phase thin  
layer chromatography 
SPE, solid phase extraction 
TLC, thin layer chromato- 
graphy 
Tm, melting temperature  
UV, ultraviolet 
ΔE, energy gap  
ΔG, free energy 
ΔH, enthalpy 
ΔS, entropy 
A, absorbance 
B0, magnetic field strength 
b, path length 
fss, molar fraction of ssDNA 
fds, molar fraction of dsDNA 
fB, molar fraction of B-DNA 
fZ, molar fraction of Z-DNA 
h, Plank’s constant 
I, spin number 
J, coupling constant 
n, charge state of the molecule 
(MS); number of adjacent 
protons with the same coupling 
constant (NMR) 
v, applied radio frequency 
veff, effective radio frequency 
σ, shielding constant 
δ, chemical shift 
ε, molar absorptivity 
є, total ellipticity 
Δє, molar ellipticity 
γ, gyromagnetic ratio 
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APPENDIX B 
CHEMICAL STRUCTURES 
 
1) 8-Bromo-2′-deoxyguanosine 
 
2) 4-(TBS-O-methyl)-phenyl bromide 
 
3) 4-(TBS-O-methyl)-phenyl boronic acid 
 
4) 8-(4-Carboxyphenyl)-2′-deoxyguanosine 
 
5) 8-(4-Methoxymethylphenyl)-2′-deoxyguanosine 
 
6) 8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine 
 
7) N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine 
 
8) N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-deoxyguanosine 
 
9) N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine 
 
10) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-carboxyphenyl)-2′-
deoxyguanosine 
 
11) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-
deoxyguanosine 
 
12) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-
deoxyguanosine 
 
13) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N-
dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine 
 
14) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N-
dimethylformamidine)-8-(4-methoxymethylaryl)-2′-deoxyguanosine 
 
15) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N-
dimethylformamidine)-8-(4-(TBS-O-methyl)aryl)-2′-deoxyguanosine 
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Chemicals Formular MW 
 
 
C10H12O4N5Br 
 
346.14 
 
 
C13H21OSiBr 
 
301.30 
 
 
C13H23O3BSi 
 
266.22 
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Chemicals Formular MW 
 
 
C17H17O6N5 
 
387.35 
 
 
C18H21O5N5 
 
387.40 
 
 
C23H33O5N5Si 
 
487.63 
 
 
 218
Chemicals Formular MW 
 
 
C20H22O6N6 
 
442.43 
 
 
C21H26O5N6 
 
442.47 
 
 
C26H38O5N6Si 
 
542.71 
 
 
 219
Chemicals Formular MW 
 
 
C41H40O8N6 
 
744.80 
 
 
C42H44O7N6 
 
744.85 
 
 
C47H56O7N6Si 
 
845.08 
 
 
 220
Chemicals Formular MW 
 
 
C50H57O9N8P 
 
945.02 
 
 
C51H61O8N8P 
 
945.07 
 
 
C56H73O8N8SiP 
 
1045.30 
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